Shahrokh Shariat
#61,653
Most Influential Person Now
Austrian surgeon
Shahrokh Shariat's AcademicInfluence.com Rankings
Shahrokh Shariatmedical Degrees
Medical
#519
World Rank
#704
Historical Rank
Urology
#3
World Rank
#3
Historical Rank
Surgery
#43
World Rank
#64
Historical Rank
Shahrokh Shariatphilosophy Degrees
Philosophy
#2819
World Rank
#4699
Historical Rank
Logic
#802
World Rank
#1342
Historical Rank
Download Badge
Medical Philosophy
Shahrokh Shariat's Degrees
- Doctorate Medicine Medical University of Vienna
- PhD Urology Medical University of Vienna
Why Is Shahrokh Shariat Influential?
(Suggest an Edit or Addition)According to Wikipedia, Shahrokh François Shariat is currently professor and chairman of the Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria. He is also adjunct professor of urology at Weill Cornell Medical Center, New York, NY; adjunct professor of urology at the University of Texas Southwestern Medical Center, Dallas, TX, USA; adjunct professor of urology at the Faculty of Medicine, Charles University, Prague, CZ; adjunct professor of urology at I.M. Sechenov First Moscow State Medical University, Moscow, RU; honorary professor of urology, University of Jordan, Amman, JO; doctor honoris causa, Carol Davila University of Medicine and Pharmacy, Bucharest, RO; and doctor honoris causa, Semmelweis University, Budapest, Hungary. He has published more than 1500 peer-reviewed research papers, more than 600 non-peer-reviewed papers, and 26 book chapters. Shahrokh Shariat specializes in treating urologic malignancies. He has been voted as the most influential urologist in 2020 and also the most cited prostate cancer researcher in the German speaking area.
Shahrokh Shariat's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. (2013) (1985)
- EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. (2017) (1867)
- Epidemiology and risk factors of urothelial bladder cancer. (2013) (1625)
- Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration (2009) (906)
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. (2019) (848)
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. (2015) (744)
- Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. (2006) (648)
- Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. (2004) (516)
- Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. (2012) (464)
- European guidelines on upper tract urothelial carcinomas: 2013 update. (2013) (433)
- Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. (2016) (426)
- Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. (2012) (426)
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. (2015) (404)
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. (2020) (402)
- Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. (2012) (393)
- Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. (2003) (364)
- Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. (2012) (355)
- Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. (2012) (344)
- Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. (2007) (329)
- Distribution of metastatic sites in patients with prostate cancer: A population‐based analysis (2014) (312)
- p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. (2004) (302)
- Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. (2011) (296)
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). (2021) (291)
- Urothelial carcinoma of the bladder and the upper tract: disparate twins. (2013) (272)
- Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. (2014) (272)
- Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. (2011) (270)
- Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. (2001) (269)
- The effect of age and gender on bladder cancer: a critical review of the literature (2010) (268)
- Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. (2012) (266)
- An updated catalog of prostate cancer predictive tools (2008) (260)
- Comparison of Nomograms With Other Methods for Predicting Outcomes in Prostate Cancer: A Critical Analysis of the Literature (2008) (257)
- Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. (2004) (246)
- Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes (2014) (246)
- Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. (2001) (241)
- Nomograms Provide Improved Accuracy for Predicting Survival after Radical Cystectomy (2006) (235)
- Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. (2013) (230)
- Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. (2015) (227)
- Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. (2001) (225)
- Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. (2015) (224)
- Stage specific lymph node metastasis mapping in radical cystectomy specimens. (2004) (222)
- ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers. (2013) (221)
- Epigenetics in prostate cancer: biologic and clinical relevance. (2011) (221)
- Radical versus partial nephrectomy (2009) (220)
- Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. (2006) (220)
- Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. (2010) (216)
- Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) (2017) (215)
- The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. (2003) (212)
- Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma. (2021) (209)
- Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder (2013) (208)
- Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. (2009) (207)
- Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. (2015) (207)
- Impact of gender on bladder cancer incidence, staging, and prognosis (2011) (207)
- Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. (2007) (204)
- Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. (2013) (204)
- Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. (2014) (201)
- Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. (2001) (201)
- Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis. (2007) (200)
- Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy (2008) (199)
- A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. (2015) (194)
- Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy (2005) (193)
- Challenges of cancer biomarker profiling. (2007) (193)
- Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. (2004) (192)
- Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review. (2018) (189)
- Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. (2009) (187)
- Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. (2010) (186)
- Urinary cytology has a poor performance for predicting invasive or high‐grade upper‐tract urothelial carcinoma (2011) (184)
- The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. (2010) (184)
- Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. (2011) (182)
- Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. (2011) (182)
- Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. (2016) (181)
- Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. (2009) (179)
- Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. (2009) (178)
- Survivin expression is associated with features of biologically aggressive prostate carcinoma (2004) (178)
- Association of Pre- and Postoperative Plasma Levels of Transforming Growth Factor β1 and Interleukin 6 and Its Soluble Receptor with Prostate Cancer Progression (2004) (177)
- Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. (2010) (176)
- Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. (2010) (176)
- Tumor markers in prostate cancer I: Blood-based markers (2011) (174)
- A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. (2011) (174)
- Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review. (2017) (173)
- Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. (2010) (172)
- Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study. (2012) (171)
- The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. (2012) (169)
- Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. (2014) (167)
- Critical review of prostate cancer predictive tools. (2009) (166)
- Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. (2006) (165)
- Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. (2014) (165)
- Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. (2007) (164)
- Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle‐invasive and non‐organ confined disease in patients with upper tract urothelial carcinoma (2012) (162)
- Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patients (2009) (162)
- Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder. (2005) (162)
- Precystectomy nomogram for prediction of advanced bladder cancer stage. (2006) (161)
- Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. (2013) (159)
- Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort (2011) (158)
- A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. (2007) (157)
- Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus (2014) (156)
- Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. (2010) (155)
- The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? (2009) (154)
- Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. (2010) (153)
- Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1 and CIS) (2014) (153)
- Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. (2002) (153)
- The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. (2010) (152)
- Prostate specific antigen density of the transition zone for early detection of prostate cancer. (1998) (152)
- Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. (2012) (152)
- Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression. (2011) (149)
- Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. (2013) (149)
- International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy (2010) (147)
- Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. (2009) (147)
- Frequent truncating mutations of STAG2 in bladder cancer (2013) (146)
- Ki-67 Is an Independent Predictor of Bladder Cancer Outcome in Patients Treated with Radical Cystectomy for Organ-Confined Disease (2006) (146)
- Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma (2011) (143)
- A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. (2010) (143)
- Characteristics and clinical significance of histological variants of bladder cancer (2017) (143)
- EAU guidelines on robotic and single-site surgery in urology. (2013) (142)
- Caveolin‐1 overexpression is associated with aggressive prostate cancer recurrence (2007) (140)
- Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder (2006) (140)
- Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. (2009) (139)
- Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. (2012) (139)
- Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness (2007) (138)
- Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer (2008) (138)
- Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma. (2007) (137)
- Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. (2011) (137)
- European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel. (2021) (136)
- A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population‐based study (2009) (135)
- Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. (2014) (135)
- Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder. (2014) (135)
- Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay. (2013) (133)
- Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. (2010) (132)
- Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. (2004) (131)
- A population based assessment of perioperative mortality after cystectomy for bladder cancer. (2009) (130)
- A non-cancer-related survival benefit is associated with partial nephrectomy. (2012) (129)
- Adjuvant chemotherapy for high-risk upper tract urothelial carcinoma: Results from the Upper Tract Urothelial Carcinoma Collaboration. (2009) (129)
- Using biopsy to detect prostate cancer. (2008) (129)
- Bladder cancer in the elderly. (2009) (128)
- Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. (2014) (127)
- Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder. (2003) (125)
- The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder (2010) (125)
- Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation (2006) (124)
- A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients. (2014) (124)
- Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy. (2014) (123)
- Clinicians are poor raters of life‐expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer (2007) (123)
- A systematic review of the volume-outcome relationship for radical prostatectomy. (2013) (122)
- E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup. (2001) (119)
- Predictors of prostate cancer after initial negative systematic 12 core biopsy. (2004) (119)
- Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. (2013) (119)
- Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature. (2010) (118)
- Statistical consideration for clinical biomarker research in bladder cancer. (2010) (118)
- Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. (2006) (117)
- Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. (2014) (117)
- Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomy (2013) (117)
- Evidence-based validation of the predictive value of the American Association for the Surgery of Trauma kidney injury scale. (2007) (116)
- Advanced patient age is associated with inferior cancer‐specific survival after radical nephroureterectomy (2009) (116)
- Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy. (2004) (115)
- Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling (2019) (115)
- Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. (2004) (113)
- Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? (2010) (113)
- Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi‐institutional study (2011) (112)
- The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin (2016) (110)
- Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer. (2006) (110)
- The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. (2014) (109)
- Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. (2010) (109)
- Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. (2010) (109)
- Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. (2013) (109)
- EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. (2019) (108)
- The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review. (2017) (108)
- Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. (2006) (108)
- Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. (2012) (107)
- Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. (2009) (107)
- Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016". (2018) (106)
- Local Therapy Improves Survival in Metastatic Prostate Cancer. (2017) (106)
- Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia. (1999) (106)
- Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. (2013) (106)
- Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy. (2016) (104)
- Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers. (2010) (104)
- Can nomograms be superior to other prediction tools? (2009) (103)
- Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. (2009) (102)
- Critical evaluation of urinary markers for bladder cancer detection and monitoring. (2008) (102)
- Urine markers for detection and surveillance of bladder cancer. (2014) (101)
- Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. (2010) (101)
- Survivin: a promising biomarker for detection and prognosis of bladder cancer (2008) (101)
- Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population‐based analysis (2012) (100)
- A review of integrated staging systems for renal cell carcinoma. (2012) (99)
- Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. (2002) (97)
- Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. (2014) (97)
- Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors. (2014) (97)
- Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. (2013) (96)
- Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy (2012) (96)
- Nomograms for bladder cancer. (2008) (96)
- PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact (2018) (96)
- Prognostic factors for upper urinary tract urothelial carcinoma (2011) (96)
- Head-to-head comparison of PI-RADS v2 and PI-RADS v1. (2016) (96)
- Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy. (2009) (95)
- Preoperative plasma levels of transforming growth factor β1 strongly predict clinical outcome in patients with bladder carcinoma (2001) (94)
- A delay in radical nephroureterectomy can lead to upstaging (2010) (94)
- Treatment Management of Small Renal Masses in the 21st Century: A Paradigm Shift (2012) (94)
- Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis. (2006) (93)
- Landmarks in the treatment of muscle-invasive bladder cancer (2017) (93)
- Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis. (2019) (93)
- Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. (2013) (93)
- Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. (2012) (92)
- Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer. (2011) (92)
- What Is the Significance of Variant Histology in Urothelial Carcinoma? (2020) (91)
- The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. (2010) (91)
- What Is the Significance of Variant Histology in Urothelial Carcinoma? (2020) (91)
- Prostate volume and adverse prostate cancer features: fact not artifact. (2007) (90)
- Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. (2003) (90)
- Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta‐analysis (2017) (90)
- Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). (2013) (90)
- Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. (2005) (90)
- Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. (2013) (89)
- Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. (2012) (89)
- Inventory of prostate cancer predictive tools (2008) (88)
- Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers (2008) (88)
- An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer (2018) (88)
- Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies. (2014) (88)
- Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder (2010) (88)
- Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. (2012) (88)
- Contemporary 90-day mortality rates after radical cystectomy in the elderly. (2014) (87)
- Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment. (2010) (87)
- Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio‐recurrent prostate cancer (2005) (87)
- Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort (2011) (87)
- Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer (2018) (87)
- Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination. (1997) (87)
- Outcomes of minimally invasive simple prostatectomy for benign prostatic hyperplasia: a systematic review and meta-analysis (2015) (87)
- Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature (2017) (86)
- Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation (2012) (85)
- Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer. (2012) (84)
- Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer. (2001) (84)
- Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. (2007) (84)
- Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph‐node density (2009) (83)
- Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. (2014) (82)
- Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome. (2007) (82)
- 68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making (2017) (82)
- Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. (2009) (82)
- A population‐based competing‐risks analysis of the survival of patients treated with radical cystectomy for bladder cancer (2011) (82)
- The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy (2011) (81)
- Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study (2017) (81)
- Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series. (2017) (81)
- Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma? (2011) (80)
- E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. (2001) (80)
- Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. (2010) (80)
- Highly predictive survival nomogram after upper urinary tract urothelial carcinoma (2010) (79)
- Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography – a systematic review and meta-analysis (2016) (79)
- Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients (2011) (79)
- Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening. (2004) (78)
- Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? (2011) (77)
- Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder. (2000) (76)
- Smoking and Bladder Cancer: A Systematic Review of Risk and Outcomes. (2015) (76)
- Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. (2010) (76)
- Conditional survival after radical nephroureterectomy for upper tract carcinoma. (2015) (75)
- Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes. (2019) (75)
- Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. (2003) (75)
- Predictors of cancer‐specific mortality after disease recurrence following radical cystectomy (2013) (75)
- Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. (2009) (74)
- Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy. (2007) (74)
- p53 expression in patients with advanced urothelial cancer of the urinary bladder (2010) (74)
- Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study (2009) (74)
- New circulating biomarkers for prostate cancer (2008) (73)
- The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder (2016) (73)
- Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors (2011) (73)
- Mortality at 120 days after prostatic biopsy: A population‐based study of 22,175 men (2008) (73)
- Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer. (2016) (73)
- A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. (2009) (72)
- Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist. (2009) (72)
- Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. (2013) (72)
- Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma. (2009) (72)
- A comparative performance analysis of total prostate‐specific antigen, percentage free prostate‐specific antigen, prostate‐specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy (2012) (71)
- Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. (2012) (71)
- An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer (2018) (71)
- Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series. (2012) (71)
- Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. (2014) (71)
- High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. (2012) (71)
- Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. (2010) (70)
- Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita. (2020) (70)
- Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder. (2003) (70)
- Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy (2013) (70)
- Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. (2013) (70)
- Survivin expression is associated with bladder cancer presence, stage, progression, and mortality (2007) (69)
- Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer (2018) (69)
- Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel. (2020) (69)
- Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis. (2018) (69)
- Time to recurrence is a significant predictor of cancer‐specific survival after recurrence in patients with recurrent renal cell carcinoma – results from a comprehensive multi‐centre database (CORONA/SATURN‐Project) (2013) (69)
- Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis. (2009) (69)
- Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. (2012) (69)
- Lynch Syndrome: A Primer for Urologists and Panel Recommendations. (2015) (69)
- Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy. (2013) (69)
- Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder. (2013) (68)
- First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. (2021) (68)
- Predicting individual outcomes after radical cystectomy: an external validation of current nomograms (2010) (67)
- Guidelines on Non-muscle invasive Bladder Cancer (2013) (67)
- The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study. (2014) (67)
- Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer (2009) (66)
- External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy. (2008) (66)
- Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. (2010) (66)
- A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome (2007) (65)
- Immunohistochemical biomarkers for bladder cancer prognosis (2011) (65)
- BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma. (2014) (65)
- Radiographic predictors of need for angiographic embolization after traumatic renal injury. (2009) (65)
- Disparities in access to care at high‐volume institutions for uro‐oncologic procedures (2012) (65)
- Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer. (2004) (65)
- Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. (2012) (64)
- Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy. (2017) (64)
- Impact of clinical factors, including a point‐of‐care nuclear matrix protein‐22 assay and cytology, on bladder cancer detection (2009) (64)
- Screening for bladder cancer: rationale, limitations, whom to target, and perspectives. (2013) (64)
- Postoperative nomogram to predict cancer‐specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis (2014) (64)
- Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder. (2009) (64)
- Lymphadenectomy for bladder cancer at the time of radical cystectomy. (2013) (64)
- Stage‐specific impact of pelvic lymph node dissection on survival in patients with non‐metastatic bladder cancer treated with radical cystectomy (2012) (64)
- Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. (2008) (64)
- Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. (2014) (63)
- Thirty-day mortality after nephrectomy: clinical implications for informed consent. (2009) (63)
- Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. (2012) (63)
- A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma. (2010) (63)
- The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial. (2013) (62)
- Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. (2020) (62)
- Molecular markers in bladder cancer (2008) (62)
- New blood‐based biomarkers for the diagnosis, staging and prognosis of prostate cancer (2008) (62)
- Association of diabetes mellitus and metformin use with oncological outcomes of patients with non‐muscle‐invasive bladder cancer (2013) (62)
- Transcriptomic heterogeneity in multifocal prostate cancer. (2018) (62)
- Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. (2010) (61)
- Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review (2017) (61)
- Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder. (2007) (61)
- Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy. (2012) (61)
- Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: Comparison over the three decades (2012) (61)
- Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. (2010) (60)
- The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer. (2016) (60)
- Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy (2013) (60)
- Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC) (2014) (60)
- Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. (2013) (60)
- Soluble Fas—A promising novel urinary marker for the detection of recurrent superficial bladder cancer (2006) (60)
- Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. (2009) (60)
- Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma (2015) (59)
- Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy. (2004) (59)
- Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer. (2016) (58)
- Mortality and Morbidity After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Population-Based Study (2011) (58)
- p53 predictive value for pT1-2 N0 disease at radical cystectomy. (2009) (58)
- Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer. (2017) (58)
- Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer. (2018) (58)
- Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy. (2011) (58)
- The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma. (2015) (58)
- Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy. (2003) (57)
- Predictive value of expression of transforming growth factor‐β1 and its receptors in transitional cell carcinoma of the urinary bladder (2001) (57)
- High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. (2014) (57)
- Cost‐analysis comparison of robot‐assisted laparoscopic radical cystectomy (RC) vs open RC (2011) (57)
- Biomolecular Predictors of Urothelial Cancer Behavior and Treatment Outcomes (2012) (57)
- Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder. (2008) (57)
- Predictive Value of Plasma Hepatocyte Growth Factor/Scatter Factor Levels in Patients with Clinically Localized Prostate Cancer (2008) (56)
- External validation of the updated briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection (2013) (56)
- Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. (2011) (56)
- Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle‐invasive bladder cancer and negative cytology (2011) (56)
- Cancer specific outcomes in patients with pT0 disease following radical cystectomy. (2006) (56)
- Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder (2013) (55)
- Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy. (2017) (55)
- Clinical outcomes of primary bladder carcinoma in situ in a contemporary series. (2010) (55)
- Gender differences in incidence and outcomes of urothelial and kidney cancer (2015) (55)
- Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. (2010) (55)
- Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate Cancer (2017) (55)
- Conditional survival predictions after nephrectomy for renal cell carcinoma. (2009) (55)
- In-hospital mortality and failure to rescue after cytoreductive nephrectomy. (2013) (54)
- Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein. (2003) (54)
- The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy. (2014) (54)
- Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma (2009) (54)
- The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study (2011) (53)
- The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer. (2008) (53)
- CEACAM1: a novel urinary marker for bladder cancer detection. (2010) (53)
- 64Cu-PSMA-617 PET/CT Imaging of Prostate Adenocarcinoma: First In-Human Studies. (2016) (53)
- Predictive factors of recurrence and survival of upper tract urothelial carcinomas (2011) (53)
- No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study (2011) (53)
- Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma (2017) (52)
- Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. (2015) (52)
- Development of a highly accurate nomogram for prediction of the need for exploration in patients with renal trauma. (2008) (52)
- Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology–Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration (2017) (52)
- Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma. (2013) (52)
- Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort. (2015) (52)
- Female with bladder cancer: what and why is there a difference? (2016) (52)
- Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice. (2014) (51)
- Impact of peri‐operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder (2014) (51)
- Validation of Neutrophil‐to‐lymphocyte Ratio in a Multi‐institutional Cohort of Patients With T1G3 Non–muscle‐invasive Bladder Cancer (2018) (51)
- Accurate preoperative prediction of non‐organ‐confined bladder urothelial carcinoma at cystectomy (2013) (51)
- Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer. (2012) (51)
- Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy (2011) (51)
- Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy? (2015) (50)
- Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer (2012) (50)
- Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men (2007) (50)
- Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment. (2016) (50)
- The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy. (2004) (50)
- Comparison of partial vs radical nephrectomy with regard to other‐cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities (2013) (50)
- Risk of Cancer-specific Mortality following Recurrence After Radical Nephroureterectomy (2012) (50)
- A comparative population‐based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma (2010) (50)
- Features and outcomes of patients with grade IV renal injury (2006) (50)
- Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer. (2011) (50)
- Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer (2019) (50)
- Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma (2014) (49)
- Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature. (2020) (49)
- Prognostic Value of PD‐1 and PD‐L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma (2017) (49)
- Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy. (2014) (49)
- EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†. (2019) (49)
- Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis (2019) (48)
- Decreased DOC-2/DAB2 Expression in Urothelial Carcinoma of the Bladder (2007) (48)
- Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy. (2012) (48)
- Sex disparities in cancer mortality: the risks of being a man in the United States. (2013) (48)
- Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials. (2020) (48)
- Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. (2015) (48)
- Predicting survival after radical cystectomy for bladder cancer (2008) (48)
- Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases. (2018) (48)
- Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle‐invasive carcinoma of the bladder: Does histologic subtype matter? (2019) (48)
- Morbidity and mortality of radical prostatectomy differs by insurance status (2012) (48)
- Prevalence and Trends in Kidney Stone Among Adults in the USA: Analyses of National Health and Nutrition Examination Survey 2007-2018 Data. (2020) (47)
- Differences in trends in the use of robot‐assisted and open radical cystectomy and changes over time in peri‐operative outcomes among selected centres in North America and Europe: an international multicentre collaboration (2019) (47)
- Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI (2020) (47)
- Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer. (2008) (47)
- Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61. (2017) (47)
- Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer. (2014) (47)
- Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients (2018) (47)
- Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients. (2018) (46)
- Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience. (2016) (46)
- Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy (2004) (46)
- Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature. (2019) (46)
- Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. (2013) (46)
- Assessment of the learning curves for photoselective vaporization of the prostate using GreenLight™ 180-Watt-XPS laser therapy: defining the intra-operative parameters within a prospective cohort (2014) (46)
- Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy (2008) (46)
- Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques (2012) (45)
- A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia. (1999) (45)
- Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy. (2012) (45)
- Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial. (1999) (45)
- Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey. (2017) (45)
- Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. (2014) (45)
- Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC) (2015) (45)
- A systematic review and meta‐analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens (2018) (45)
- Survival after radical cystectomy of non‐bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing‐risks analysis (2012) (45)
- External validation of the updated partin tables in a cohort of French and Italian men. (2009) (45)
- Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery (2016) (44)
- Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma (2014) (44)
- Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer (2008) (44)
- Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy. (2013) (44)
- Marital status: a gender‐independent risk factor for poorer survival after radical cystectomy (2012) (44)
- 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19 (2021) (44)
- Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology. (2004) (44)
- Robot-assisted versus laparoscopic nephroureterectomy for upper-tract urothelial cancer: A population-based assessment of costs and perioperative outcomes. (2014) (44)
- Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. (2012) (44)
- Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy. (2002) (44)
- Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness. (2014) (44)
- Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers. (2012) (43)
- Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy. (2003) (43)
- Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study (2011) (43)
- Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder. (2007) (43)
- Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder. (2007) (43)
- Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor (2019) (43)
- Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy. (2007) (43)
- Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis? (1999) (43)
- Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. (2010) (43)
- Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors. (2009) (43)
- Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer. (2013) (42)
- Prediction of delayed graft function after renal transplantation. (2013) (42)
- Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer. (2004) (42)
- Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study. (2012) (42)
- Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors? (2015) (42)
- Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma. (2014) (42)
- Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis (2018) (42)
- Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT. (2012) (42)
- External validation of the updated Partin tables in a cohort of North American men. (2008) (42)
- National trends and disparities in the use of minimally invasive adult pyeloplasty. (2012) (41)
- Smoking reduces the efficacy of intravesical bacillus Calmette-Guérin immunotherapy in non-muscle-invasive bladder cancer. (2012) (41)
- Upper urinary tract urothelial carcinoma with loco‐regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration (2011) (41)
- Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy. (2000) (41)
- Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. (2013) (41)
- Prevalence and Trends in Urinary Incontinence Among Women in the United States 2005-2018. (2021) (41)
- Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy. (2004) (41)
- Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer. (2018) (41)
- Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance (2016) (41)
- A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis. (2011) (41)
- Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. (2008) (41)
- Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. (2012) (40)
- Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study (2017) (40)
- Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia. (2006) (40)
- Development and Validation of a Reference Table for Prediction of Postoperative Mortality Rate in Patients Treated with Radical Cystectomy: A Population-based Study (2011) (40)
- Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics. (2012) (40)
- Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis. (2015) (40)
- Characteristics of normal prostate vascular anatomy as displayed by power Doppler (2001) (40)
- Lymphocyte‐to‐monocyte ratio and neutrophil‐to‐lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy (2017) (39)
- Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. (2012) (39)
- Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy (2014) (39)
- The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis. (2016) (39)
- An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer (2016) (39)
- Population‐Based Validation of the 2014 ISUP Gleason Grade Groups in Patients Treated With Radical Prostatectomy, Brachytherapy, External Beam Radiation, or no Local Treatment (2017) (39)
- Gender differences in incidence and outcomes of urothelial and kidney cancer (2015) (39)
- Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy (2017) (38)
- First results from the phase 3 CheckMate 274 trial of adjuvant nivolumab vs placebo in patients who underwent radical surgery for high-risk muscle-invasive urothelial carcinoma (MIUC). (2021) (38)
- Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study (2012) (38)
- Aurora A Kinase as a diagnostic urinary marker for urothelial bladder cancer (2014) (38)
- External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. (2019) (38)
- Rates of open versus laparoscopic and partial versus radical nephrectomy for T1a renal cell carcinoma: A population‐based evaluation (2013) (38)
- Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks (2019) (38)
- Impact of risk factors on the performance of the nuclear matrix protein 22 point‐of‐care test for bladder cancer detection (2008) (38)
- Response assessment using [68Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer (2019) (38)
- Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder. (2014) (38)
- Clinical outcome of primary versus secondary bladder carcinoma in situ. (2010) (37)
- Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction (2017) (37)
- Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion (2018) (37)
- Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection. (2004) (37)
- Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends. (2010) (37)
- Prospective external validation of a bladder cancer detection model. (2014) (37)
- Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. (2012) (37)
- Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study. (2017) (36)
- Determinants of long-term survival of patients with locally advanced prostate cancer: the role of extensive pelvic lymph node dissection (2015) (36)
- Robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years. (2013) (36)
- Tolerability of high energy transurethral microwave thermotherapy with topical urethral anesthesia: results of a prospective, randomized, single-blinded clinical trial. (1998) (36)
- Radical prostatectomy at academic versus nonacademic institutions: a population based analysis. (2011) (36)
- Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer (2014) (36)
- Cardiovascular mortality in patients with metastatic prostate cancer exposed to androgen deprivation therapy: a population-based study. (2015) (36)
- Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein. (2000) (36)
- Preoperative radiographic parameters predict long-term renal impairment following partial nephrectomy (2013) (36)
- Impact of smoking on outcomes after intravesical bacillus Calmette–Guérin therapy for urothelial carcinoma not invading muscle of the bladder (2011) (36)
- Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder. (2005) (35)
- Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection. (2010) (35)
- KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC. (2020) (35)
- Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model. (2013) (35)
- Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy (2016) (35)
- A urinary microRNA (miR) signature for diagnosis of bladder cancer. (2018) (35)
- Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool. (2018) (35)
- Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best. (2008) (35)
- The changing role of lasers in urologic surgery. (2019) (35)
- Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy (2014) (35)
- Urologic Complications Following Pelvic Radiotherapy. (2018) (35)
- Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort. (2013) (35)
- The effect of surgical volume, age and comorbidities on 30‐day mortality after radical prostatectomy: a population‐based analysis of 9208 consecutive cases (2008) (35)
- Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder. (2014) (34)
- Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis (2020) (34)
- Molecular markers in bladder cancer (2018) (34)
- Is continent cutaneous urinary diversion a suitable alternative to orthotopic bladder substitute and ileal conduit after cystectomy? (2015) (34)
- Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. (2014) (34)
- Cost‐effective treatment of low‐risk carcinoma not invading bladder muscle (2013) (34)
- A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis (2012) (34)
- Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology (2016) (34)
- A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer. (2018) (34)
- Biochemical staging of prostate cancer. (2003) (34)
- Genetic determinants for chemo- and radiotherapy resistance in bladder cancer (2017) (34)
- Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. (2020) (34)
- Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions (2015) (34)
- Conditional survival predictions after surgery for patients with penile carcinoma (2011) (34)
- The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. (2020) (34)
- Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. (2014) (34)
- In-hospital length of stay after major surgical oncological procedures. (2018) (34)
- Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy. (2006) (33)
- Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy (2016) (33)
- Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men. (2008) (33)
- Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: Value of extranodal extension and size of the largest LN metastasis (2014) (33)
- Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts. (2007) (33)
- The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead? (2020) (33)
- Management of bladder cancer in older patients: Position paper of a SIOG Task Force. (2020) (33)
- Reliability of Serial Prostate Magnetic Resonance Imaging to Detect Prostate Cancer Progression During Active Surveillance: A Systematic Review and Meta-analysis. (2021) (33)
- The hypothalamic–pituitary–gonadal axis and prostate cancer: implications for androgen deprivation therapy (2014) (33)
- Transperineal radiofrequency interstitial tumor ablation (RITA) of the prostate. (1998) (33)
- Survival benefit of local versus no local treatment for metastatic prostate cancer—Impact of baseline PSA and metastatic substages (2018) (33)
- Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era (2017) (33)
- The impact of lymph node dissection and positive lymph nodes on cancer‐specific mortality in contemporary pT2‐3 non‐metastatic renal cell carcinoma treated with radical nephrectomy (2018) (33)
- Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails. (2020) (33)
- Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma (2013) (33)
- Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder. (2014) (33)
- Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract. (2015) (32)
- Radical cystectomy for patients with pT4 urothelial carcinoma in a large population‐based study (2011) (32)
- Penile rehabilitation after radical prostatectomy: does it work? (2015) (32)
- Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature. (2014) (32)
- Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. (2015) (32)
- Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer (2014) (32)
- Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy (2010) (32)
- Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis (2020) (32)
- Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups. (2016) (32)
- Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer? (2012) (32)
- Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer. (2015) (32)
- Pilot study of salvage laparoscopic prostatectomy for the treatment of recurrent prostate cancer (2011) (32)
- Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial (2012) (32)
- Postoperative Nomogram for Relapse‐Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma (2017) (32)
- Innovations in diagnostic imaging of localized prostate cancer (2014) (32)
- Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought (2018) (31)
- Current Disease Management of Primary Urethral Carcinoma. (2019) (31)
- A Contemporary Population-Based Assessment of the Rate of Lymph Node Dissection for Penile Carcinoma (2011) (31)
- Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder (2018) (31)
- Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma. (2011) (31)
- Prognostic Role of Neutrophil‐to‐Lymphocyte Ratio in Primary Non–muscle‐invasive Bladder Cancer (2017) (31)
- Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time (2013) (31)
- Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series. (2017) (31)
- Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. (2014) (31)
- Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib (2014) (31)
- Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study. (2021) (31)
- Comparison of the Q-tip test and voiding cystourethrogram to assess urethral hypermobility among women enrolled in a randomized clinical trial of surgery for stress urinary incontinence. (2006) (31)
- Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin (2007) (31)
- Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: a population-based study. (2012) (31)
- Risk of fracture after radical cystectomy and urinary diversion for bladder cancer. (2014) (31)
- A Simple and Accurate Model for Prediction of Cancer-Specific Mortality in Patients Treated with Surgery for Primary Penile Squamous Cell Carcinoma (2009) (31)
- In‐hospital mortality and failure‐to‐rescue rates after radical cystectomy (2013) (30)
- Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma (2013) (30)
- Partin Tables cannot accurately predict the pathological stage at radical prostatectomy. (2009) (30)
- Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling (2012) (30)
- The addition of urinary urokinase-type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer. (2003) (30)
- Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology? (2014) (30)
- Novel therapeutics for the management of castration‐resistant prostate cancer (CRPC) (2012) (30)
- Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review (2017) (30)
- Pre‐treatment biomarker levels improve the accuracy of post‐prostatectomy nomogram for prediction of biochemical recurrence (2009) (30)
- Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model. (2015) (30)
- Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. (2015) (30)
- Laparoscopic and Open Partial Nephrectomy: Complication Comparison Using the Clavien System (2012) (30)
- Association Between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes Following Radical Cystectomy: Systematic Review and Meta-Analysis. (2020) (30)
- Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy (2013) (30)
- The role of adjuvant chemotherapy for lymph node‐positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study (2015) (30)
- Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis (2018) (29)
- Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer. (2014) (29)
- Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy. (2008) (29)
- Bilharzial vs non‐bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase‐2 expression (2011) (29)
- Urinary levels of urokinase‐type plasminogen activator and its receptor in the detection of bladder carcinoma (2002) (29)
- Cytoreductive nephrectomy in the elderly: a population‐based cohort from the USA (2012) (29)
- Gender‐specific effect of smoking on upper tract urothelial carcinoma outcomes (2013) (29)
- Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer. (2003) (29)
- Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml. (2006) (29)
- Is there any evidence of a "July effect" in patients undergoing major cancer surgery? (2014) (29)
- Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma. (2011) (29)
- Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy? (2014) (29)
- Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [11C]acetate PET as a prognostic marker (2015) (29)
- En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature. (2019) (29)
- PRE-TREATMENT BIOMARKER LEVELS IMPROVE THE ACCURACY OF POST-PROSTATECTOMY NOMOGRAM FOR PREDICTION OF BIOCHEMICAL RECURRENCE (2009) (29)
- Getting out of a tight spot: an overview of ureteroenteric anastomotic strictures (2016) (29)
- Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United States (2012) (29)
- Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease (2017) (29)
- Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis. (2015) (29)
- Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy (2019) (28)
- First North American validation and head‐to‐head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy (2018) (28)
- Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival (2016) (28)
- Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy. (2011) (28)
- Assessment of the quality-of-life and functional outcomes in patients undergoing cystectomy and urinary diversion for the management of radiation-induced refractory benign disease. (2015) (28)
- Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis. (2011) (28)
- Gastrointestinal hemorrhage as first manifestation of metastatic testicular tumor. (2005) (28)
- Comparison of perioperative complications and health‐related quality of life between robot‐assisted and open radical cystectomy: A systematic review and meta‐analysis (2019) (28)
- Novel approaches to improve prostate cancer diagnosis and management in early‐stage disease (2012) (28)
- Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma (2008) (28)
- Surgical checklist impact on recurrence‐free survival of patients with non‐muscle‐invasive bladder cancer undergoing transurethral resection of bladder tumour (2018) (28)
- Upper urinary tract disease: what we know today and unmet needs (2015) (28)
- Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis. (2019) (28)
- Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy (2012) (28)
- Prognostic value of syndecan‐1 expression in patients treated with radical prostatectomy (2007) (28)
- A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States. (2009) (28)
- Rates of Positive Surgical Margins and Their Effect on Cancer‐specific Mortality at Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer (2019) (27)
- Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data (2014) (27)
- Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder. (2014) (27)
- Quantitative Apparent Diffusion Coefficient Measurements Obtained by 3-Tesla MRI Are Correlated with Biomarkers of Bladder Cancer Proliferative Activity (2014) (27)
- Evidence-Based Comparison of Robotic and Open Radical Prostatectomy (2010) (27)
- Blood biomarkers for prostate cancer detection and prognosis. (2007) (27)
- Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder. (2011) (27)
- Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool. (2014) (27)
- The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy. (2019) (27)
- Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy. (2019) (27)
- Node‐positive renal cell carcinoma in the absence of distant metastases: predictors of cancer‐specific mortality in a population‐based cohort (2012) (27)
- Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin (2011) (27)
- pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder. (2011) (27)
- Preoperative Plasma HER2 and Epidermal Growth Factor Receptor for Staging and Prognostication in Patients with Clinically Localized Prostate Cancer (2007) (27)
- HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC) (2017) (27)
- Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. (2016) (26)
- Tissue-based molecular markers for renal cell carcinoma. (2011) (26)
- Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer (2012) (26)
- Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma. (2020) (26)
- Anomalies of the wolffian duct derivatives encountered at radical prostatectomy. (2005) (26)
- Health care‐associated infections after major cancer surgery (2013) (26)
- Pelvic Lymph Node Dissection in Prostate Cancer: Indications, Extent and Tailored Approaches (2017) (26)
- Predictors of Survival in Patients With Soft Tissue Surgical Margin Involvement at Radical Cystectomy (2013) (26)
- Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysis (2014) (26)
- Prediction of cancer‐specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision‐making (2016) (26)
- Guidelines on Urothelial Carcinomas of the Upper Urinary Tract (2013) (26)
- Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter. (2016) (26)
- 3D T2-weighted imaging to shorten multiparametric prostate MRI protocols (2017) (25)
- A comprehensive review of genomic landscape, biomarkers and treatment sequencing in castration-resistant prostate cancer. (2016) (25)
- Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy (2019) (25)
- Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment (2014) (25)
- Accuracy of life tables in predicting overall survival in patients after radical prostatectomy (2008) (25)
- Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer. (2005) (25)
- Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival (2007) (25)
- Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology. (2020) (25)
- Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy. (2014) (25)
- Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma. (2014) (25)
- Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder. (2005) (25)
- A critical assessment of the value of lymph node dissection at radical prostatectomy: A population‐based study (2011) (25)
- Comparison of Complications from Radical Cystectomy between Old-Old versus Oldest-Old Patients (2014) (25)
- Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy (2017) (25)
- Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense? (2017) (25)
- The interaction of gender and smoking on bladder cancer risks (2019) (25)
- Effect of statin use on outcomes of non‐muscle‐invasive bladder cancer (2013) (25)
- Role of salvage lymph node dissection in prostate cancer (2016) (25)
- Robot-assisted vs. laparoscopic partial nephrectomy: utilization rates and perioperative outcomes. (2013) (25)
- Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic review. (2020) (24)
- The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes. (2019) (24)
- Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium. (2007) (24)
- Postoperative nomogram for disease recurrence and cancer-specific death for upper tract urothelial carcinoma: comparison to American Joint Committee on Cancer staging classification. (2014) (24)
- Sex hormone-binding globulin: a novel marker for nodal metastases prediction in prostate cancer patients undergoing extended pelvic lymph node dissection. (2009) (24)
- Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. (2016) (24)
- Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis (2021) (24)
- The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer (2019) (24)
- Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review. (2009) (24)
- Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis (2019) (24)
- Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients (2017) (24)
- Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma (2013) (23)
- Location of Metastases in Contemporary Prostate Cancer Patients Affects Cancer‐Specific Mortality (2018) (23)
- Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption. (2014) (23)
- Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. (2010) (23)
- Review: Use of nomograms for predictions of outcome in patients with advanced bladder cancer (2009) (23)
- Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma (2010) (23)
- Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases (2019) (23)
- Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy. (2016) (23)
- Predictors of survival in patients with disease recurrence after radical nephroureterectomy (2014) (23)
- Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: A systematic literature review and meta-analysis. (2019) (23)
- Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years? (2011) (23)
- Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study. (2016) (23)
- EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. (2019) (23)
- Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis (2019) (23)
- Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis (2020) (23)
- Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis. (2019) (23)
- Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer Studies (2017) (23)
- Impact of Surgical Experience on In-Hospital Complication Rates in Patients Undergoing Minimally Invasive Prostatectomy: A Population-Based Study (2011) (23)
- Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis. (2020) (23)
- Sociodemographic disparities in the treatment of small renal masses (2013) (23)
- Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta (2015) (22)
- Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study (2016) (22)
- How to optimize patient selection for robot-assisted radical prostatectomy: functional outcome analyses from a tertiary referral center. (2014) (22)
- A Systematic Review and Meta-analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. (2020) (22)
- International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis (2012) (22)
- Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia. (2009) (22)
- Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder. (2019) (22)
- Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms. (2007) (22)
- Pelvic lymph node dissection for prostate cancer: Adherence and accuracy of the recent guidelines (2013) (22)
- Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy? (2015) (22)
- Multiparametric MRI of the prostate at 3 T: limited value of 3D 1H-MR spectroscopy as a fourth parameter (2016) (22)
- Update on intravesical agents for non-muscle-invasive bladder cancer. (2010) (22)
- Discharge patterns after radical prostatectomy in the United States of America. (2013) (22)
- The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. (2011) (22)
- Percentage of high‐grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score (2014) (22)
- Combination of High-Resolution Optical Coherence Tomography and Raman Spectroscopy for Improved Staging and Grading in Bladder Cancer (2018) (22)
- External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma (2009) (22)
- Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years. (2018) (22)
- Adjuvant cisplatin‐based combined chemotherapy for lymph node (LN)‐positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients (2015) (22)
- Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia (2019) (22)
- Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients? (2020) (22)
- Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy. (2004) (21)
- Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice (2018) (21)
- Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer. (2007) (21)
- Decreased elastin gene expression in noncompliant human bladder tissue: a competitive reverse transcriptase-polymerase chain reaction analysis. (1998) (21)
- ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy. (2015) (21)
- Cell-cycle markers do not improve discrimination of EORTC and CUETO risk models in predicting recurrence and progression of non-muscle-invasive high-grade bladder cancer. (2016) (21)
- Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis. (2020) (21)
- Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis (2021) (21)
- Quality Indicators for Bladder Cancer Services: A Collaborative Review. (2020) (21)
- Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer. (2018) (21)
- Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid (2015) (21)
- Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer Patients (2018) (21)
- Effect of Immunotherapy on Local Treatment of Genitourinary Malignancies. (2019) (21)
- Population‐Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients (2017) (21)
- Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019? (2019) (21)
- Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1–2 N0 M0 renal cell carcinoma (2017) (21)
- Prognostic effect of serum and tissue YKL-40 levels in bladder cancer. (2014) (21)
- Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis (2019) (21)
- Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma. (2008) (21)
- Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer. (2018) (21)
- Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate Cancer. (2016) (20)
- Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. (2016) (20)
- Prognostic significance of lymphovascular invasion in radical prostatectomy specimens (2011) (20)
- Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies. (2013) (20)
- BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia. (2005) (20)
- Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis (2020) (20)
- Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma. (2019) (20)
- Limited prognostic value of tumor necrosis in patients with renal cell carcinoma. (2010) (20)
- Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. (2021) (20)
- Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis (2020) (20)
- EXPRESSION OF SURVIVIN AND APOPTOTIC BIOMARKERS IN BENIGN PROSTATIC HYPERPLASIA (2006) (20)
- North American Population‐Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer (2017) (20)
- Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literature (2017) (20)
- Role of cigarette smoking in urological malignancies and clinical interventions for smoking cessation (2016) (20)
- Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients (2017) (20)
- Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer. (2019) (19)
- Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study. (2017) (19)
- Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma (2015) (19)
- Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of 68 Ga-PSMA and 11 C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections (2020) (19)
- Bladder Cancer: Depression, Anxiety, and Suicidality Among the Highest-risk Oncology Patients. (2019) (19)
- Long-term follow-up data more than 5 years after surgical management of benign prostate obstruction: who stands the test of time? (2016) (19)
- Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy--results from a multicenter study. (2008) (19)
- Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma) (2009) (19)
- Robot-assisted radical cystectomy with intracorporeal urinary diversion – The new ‘gold standard’? Evidence from a systematic review (2018) (19)
- PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients (2018) (19)
- Survival after nephroureterectomy for upper tract urothelial carcinoma: A population‐based competing‐risks analysis (2014) (19)
- Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis. (2021) (19)
- The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia (2021) (19)
- Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities. (2020) (19)
- Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables. (2009) (19)
- Life expectancy in metastatic prostate cancer patients according to racial/ethnic groups (2021) (19)
- Evaluation of ABO blood group as a prognostic marker in renal cell carcinoma (RCC) (2014) (19)
- Prognostic value of tissue and circulating levels of IMP3 in prostate cancer (2014) (19)
- Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept (2020) (19)
- Validation of the Social Security Administration Life Tables (2004-2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results database. (2019) (19)
- Efficacy of Preoperative Chemotherapy in High-Risk Upper Tract Urothelial Carcinoma (UTUC). (2020) (19)
- Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based Study. (2016) (19)
- Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma. (2019) (19)
- How to optimally manage elderly bladder cancer patients? (2016) (19)
- Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer. (2019) (19)
- Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis (2017) (18)
- Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study. (2017) (18)
- Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature (2016) (18)
- Impact of Patients' Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis. (2020) (18)
- High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. (2008) (18)
- Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy. (2020) (18)
- Prospective evaluation of molecular markers for the staging and prognosis of upper tract urothelial carcinoma. (2012) (18)
- Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy (2020) (18)
- Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer. (2017) (18)
- Differential Effect of Sex on Outcomes After Radical Surgery for Upper Tract and Bladder Urothelial Carcinoma: A Systematic Review and Meta-Analysis. (2020) (18)
- Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? (2012) (18)
- Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis. (2022) (18)
- Elevated preoperative neutrophil–lymphocyte ratio predicts upgrading at radical prostatectomy (2017) (18)
- Prospective two‐arm study of the testicular function in patients with COVID‐19 (2022) (18)
- Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort. (2009) (18)
- Nodal involvement at nephrectomy is associated with worse survival: A stage‐for‐stage and grade‐for‐grade analysis (2013) (18)
- Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis (2021) (18)
- Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy (2015) (18)
- GENDER IS AN IMPORTANT PREDICTOR OF CANCER-SPECIFIC SURVIVAL IN PATIENT WITH TRANSITIONAL CELL CARCINOMA AFTER RADICAL CYSTECTOMY (2009) (17)
- Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients. (2018) (17)
- Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy. (2011) (17)
- Kidney-sparing surgery for upper tract urothelial cancer (2015) (17)
- Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium. (2020) (17)
- Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma (2016) (17)
- Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer (2018) (17)
- Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients (2021) (17)
- Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study (2015) (17)
- Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis (2019) (17)
- Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series. (2020) (17)
- External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy. (2011) (17)
- Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study. (2015) (17)
- The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage? (2015) (17)
- Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy. (2014) (17)
- Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma. (2014) (17)
- Does histologic subtype affect oncologic outcomes after nephron-sparing surgery? (2009) (17)
- Risk factors associated with positive surgical margins’ location at radical cystectomy and their impact on bladder cancer survival (2021) (17)
- Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy. (2018) (17)
- Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. (2012) (17)
- Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL. (2007) (17)
- Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis (2021) (17)
- Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy. (2013) (17)
- Screening for prostate cancer: an update. (2008) (17)
- A proposal of a new nomogram for predicting upstaging in contemporary D’Amico low-risk prostate cancer patients (2017) (17)
- The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer. (2016) (17)
- Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi‐institutional study (2017) (17)
- EVIDENCE-BASED GENDER RELATED OUTCOMES AFTER RADICAL CYSTECTOMY: RESULTS OF A LARGE MULTICENTER STUDY (2009) (17)
- Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. (2014) (17)
- Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy (2017) (16)
- The treatment of muscle-invasive bladder cancer in geriatric patients (2016) (16)
- Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy (2018) (16)
- Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma. (2020) (16)
- Metastatic transitional cell carcinoma of the urinary bladder to the shoulder girdle. (2002) (16)
- Prognostic Value of Serum Cholinesterase in Non–muscle‐invasive Bladder Cancer (2018) (16)
- Biomarkers in personalised treatment of renal-cell carcinoma. (2012) (16)
- The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes. (2017) (16)
- Preoperative frailty predicts adverse short‐term postoperative outcomes in patients treated with radical nephroureterectomy (2020) (16)
- Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis (2019) (16)
- Comprehensive analysis of serum chromogranin A and neuron‐specific enolase levels in localized and castration‐resistant prostate cancer (2020) (16)
- Serum Adiponectin Predicts Cancer-specific Survival of Patients with Renal Cell Carcinoma. (2016) (16)
- Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification. (2017) (16)
- Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis. (2019) (16)
- The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer (2018) (16)
- Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin. (2021) (16)
- Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes after Surgery (2011) (16)
- Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis. (2020) (16)
- Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy (2013) (16)
- Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy. (2016) (16)
- Importance of prostate volume in the stratification of patients with intermediate‐risk prostate cancer (2015) (16)
- Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma. (2021) (16)
- Predicting the 5-Year Risk of Biochemical Relapse After Postprostatectomy Radiation Therapy in ≥PT2, pN0 Patients With a Comprehensive Tumor Control Probability Model. (2016) (16)
- An evidence-based guide to the selection of sequential therapies in metastatic renal cell carcinoma (2013) (16)
- Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract. (2016) (16)
- What to do during Bacillus Calmette–Guérin shortage? Valid strategies based on evidence (2018) (16)
- Optimal Management of Upper Tract Urothelial Carcinoma: an Unmet Need (2019) (15)
- More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis. (2018) (15)
- Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis (2019) (15)
- Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors. (2019) (15)
- Quantitative Apparent Diffusion Coefficient Derived From Diffusion-Weighted Imaging Has the Potential to Avoid Unnecessary MRI-Guided Biopsies of mpMRI-Detected PI-RADS 4 and 5 Lesions (2018) (15)
- The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients. (2018) (15)
- Highlights from the first symposium on upper tract urothelial carcinoma. (2014) (15)
- High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study (2018) (15)
- Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner. (2011) (15)
- Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy (2013) (15)
- Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma. (2020) (15)
- Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy (2016) (15)
- Population‐based assessment of cancer‐specific mortality after local tumour ablation or observation for kidney cancer: a competing risks analysis (2016) (15)
- Venous thromboembolism after radical prostatectomy: the effect of surgical caseload (2012) (15)
- Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma. (2011) (15)
- Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients. (2020) (15)
- Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-onset Testosterone Deficiency. (2020) (15)
- Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database. (2018) (15)
- Erratum: Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection (BJU International (2009) 103 (1368-1374)) (2010) (15)
- Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer. (2009) (15)
- Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent (2013) (15)
- Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis? (2019) (15)
- First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysis. (2021) (15)
- Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study. (2016) (15)
- Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer (2020) (15)
- Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy (2011) (15)
- Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis. (2020) (15)
- Prognostic value of insulin‐like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy (2012) (15)
- Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy. (2012) (14)
- High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer (2008) (14)
- Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long‐term Outcomes (2017) (14)
- Local tumor destruction in renal cell carcinoma--an inpatient population-based study. (2014) (14)
- Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer. (2018) (14)
- The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysis. (2018) (14)
- Long‐term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large‐scale population‐based analysis (2019) (14)
- Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective (2022) (14)
- Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma. (2019) (14)
- Secretion of severe acute respiratory syndrome coronavirus 2 in urine (2020) (14)
- Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer. (2019) (14)
- Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample (2014) (14)
- Prognostic value of Caveolin‐1 in patients treated with radical prostatectomy: a multicentric validation study (2016) (14)
- Neoadjuvant and adjuvant treatment in high-risk prostate cancer (2018) (14)
- The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysis. (2019) (14)
- Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy (2018) (14)
- Smoking and bladder cancer: review of the recent literature. (2020) (14)
- Construct, content and face validity of the camera handling trainer (CHT): a new E-BLUS training task for 30° laparoscope navigation skills (2016) (14)
- More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder (2019) (14)
- Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients. (2020) (14)
- Differences in Patient Characteristics among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice - Analysis of Surveillance, Epidemiology, and End Results Database (2016) (14)
- Robotic assisted simple prostatectomy: recent advances (2018) (14)
- Comparison of Perioperative Outcomes Between Open and Robotic Radical Cystectomy: A Population-Based Analysis. (2018) (14)
- Dynamic Prognostication Using Conditional Recurrence and Progression Estimates for Patients with Nonmuscle Invasive Bladder Cancer. (2016) (14)
- The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy. (2019) (14)
- Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study. (2012) (14)
- Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes? (2019) (14)
- Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer. (2008) (14)
- Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma. (2019) (14)
- Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve Analysis. (2016) (14)
- Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis (2020) (14)
- Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer. (2016) (14)
- Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). (2018) (14)
- Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis (2020) (14)
- Diagnosis and kidney-sparing treatments for upper tract urothelial carcinoma: state of the art. (2018) (14)
- Predictors of Cancer‐specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence (2018) (14)
- Associations Between Presenting Symptoms, Clinicopathological Parameters, and Prognosis in a Contemporary Series of Patients With Renal Cell Carcinoma (2014) (14)
- The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomy (2018) (14)
- Tissue-based molecular markers for bladder cancer. (2010) (14)
- Diagnostic, prognostic and surveillance urinary markers in nonmuscle invasive bladder cancer: any role in clinical practice? (2018) (13)
- Impact of systemic Immune-inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer. (2021) (13)
- Role of quantitative computed tomography texture analysis in the prediction of adherent perinephric fat (2018) (13)
- Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis. (2013) (13)
- Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration (2021) (13)
- The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening. (2008) (13)
- Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non‐muscle‐invasive bladder cancer: a systematic review and network meta‐analysis of randomized trials (2021) (13)
- Trends of Retroperitoneal Lymphadenectomy Use in Patients with Nonseminomatous Germ Cell Tumor of the Testis: A Population-Based Study (2011) (13)
- Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study. (2021) (13)
- The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: A systematic review. (2019) (13)
- The "Is mpMRI Enough" or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy. (2020) (13)
- Renal Cell Carcinoma: Comparison Between Variant Histology and Clear Cell Carcinoma Across all Stages and Treatment Modalities. (2020) (13)
- Update on ablative therapies of renal tumors (2016) (13)
- Thyroid and androgen receptor signaling are antagonized by μ‐Crystallin in prostate cancer (2020) (13)
- Open radical prostatectomy in the elderly: a case for concern? (2012) (13)
- The impact of moderate wine consumption on the risk of developing prostate cancer (2018) (13)
- Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer (2021) (13)
- Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder (2012) (13)
- Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. (2016) (13)
- Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer. (2020) (13)
- Regional differences in total hospital charges between open and robotically assisted radical prostatectomy in the United States (2018) (13)
- Effect of the number of biopsy cores on prostate cancer detection and staging. (2010) (13)
- How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder. (2019) (13)
- Contemporary National Assessment of Robot-Assisted Surgery Rates and Total Hospital Charges for Major Surgical Uro-Oncological Procedures in the United States. (2019) (13)
- Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy. (2020) (13)
- Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma. (2018) (13)
- Salvage therapeutic strategies for bacillus Calmette–Guerin failure (2019) (13)
- Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy (2016) (13)
- Impact of Gender on Chemotherapeutic Response and Oncologic Outcomes in Patients Treated With Radical Cystectomy and Perioperative Chemotherapy for Bladder Cancer: A Systematic Review and Meta-Analysis. (2019) (13)
- Incidence and Predictors of 30‐Day Readmission After Robot‐Assisted Radical Prostatectomy (2017) (13)
- Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal? (2019) (13)
- Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA (2017) (13)
- Diagnosis and management of upper tract urothelial carcinoma. (2015) (12)
- Magnetic resonance imaging-targeted prostate biopsy: back to the future. (2013) (12)
- The impact of gender on oncologic outcomes of bladder cancer (2019) (12)
- A contemporary analysis of radiotherapy effect in surgically treated retroperitoneal sarcoma. (2018) (12)
- Higher perioperative morbidity and in‐hospital mortality in patients with end‐stage renal disease undergoing nephrectomy for non‐metastatic kidney cancer: a population‐based analysis (2012) (12)
- Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta‐analyses (2020) (12)
- Novel biomarkers to predict response and prognosis in localized bladder cancer. (2015) (12)
- Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics (2015) (12)
- Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy. (2012) (12)
- The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment. (2011) (12)
- Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC? (2021) (12)
- Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study (2018) (12)
- The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers (2021) (12)
- Current perspectives of sentinel lymph node dissection at the time of radical surgery for prostate cancer. (2016) (12)
- The Risk of New Onset Dementia And/Or Alzheimer's Disease Among Prostate Cancer Patients Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-analysis. (2020) (12)
- Adjuvant Therapies in Nonmetastatic Renal‐Cell Carcinoma: A Review of the Literature (2018) (12)
- Leapfrog volume thresholds and perioperative complications after radical prostatectomy (2012) (12)
- Urothelial cancer of the upper urinary tract: emerging biomarkers and integrative models for risk stratification. (2016) (12)
- Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. (2021) (12)
- Contemporary conditional cancer‐specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract (2020) (12)
- Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. (2022) (12)
- Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder (2012) (12)
- Can the addition of clinical information improve the accuracy of PI-RADS version 2 for the diagnosis of clinically significant prostate cancer in positive MRI? (2020) (12)
- The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy (2015) (12)
- Immune therapy meets precision medicine. (2017) (12)
- Adjuvant chemotherapy for bladder cancer does not alter cancer‐specific survival after cystectomy in a matched case‐control study (2008) (12)
- Charlson score as a single pertinent criterion to select candidates for active surveillance among patients with small renal masses (2014) (12)
- Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy. (2019) (12)
- The impact of surgical experience on total hospital charges for minimally invasive prostatectomy: a population‐based study (2011) (11)
- Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation. (2021) (11)
- Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscleinvasive and non-organ confined disease in patients with upper tract urothelial carcinoma (2011) (11)
- Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population‐based analysis (2019) (11)
- Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis (2019) (11)
- Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature. (2018) (11)
- Placebo Response in Patients with Oral Therapy for Overactive Bladder: A Systematic Review and Meta-analysis. (2021) (11)
- Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider? (2016) (11)
- A population‐based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy (2012) (11)
- The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC). (2020) (11)
- Prospective Questionnaire-Based Evaluation of the Prevalence of Urinary Incontinence in Women with Chronic Cough (2009) (11)
- The Prognostic Impact of Intraductal Carcinoma of the Prostate: A Systematic Review and Meta-Analysis. (2020) (11)
- Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer. (2017) (11)
- Primary Ta high grade bladder tumors: Determination of the risk of progression. (2020) (11)
- Re-assessment of 30-, 60- and 90-day mortality rates in non-metastatic prostate cancer patients treated either with radical prostatectomy or radiation therapy. (2013) (11)
- Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer. (2021) (11)
- Waiting in the wings: the emerging role of molecular biomarkers in bladder cancer (2018) (11)
- Incidence and Predictors of 30-Day Readmission in Patients Treated With Radical Cystectomy: A Single Center European Experience. (2016) (11)
- Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes (2019) (11)
- Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer (2019) (11)
- Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study. (2019) (11)
- Tumor Size Predicts Muscle-invasive and Non-organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy. (2021) (11)
- The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy (2016) (11)
- Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram (2018) (11)
- Prognostic Role of N‐cadherin Expression in Patients With Invasive Bladder Cancer (2017) (11)
- Predictors of cancer-specific mortality after disease recurrence in patients with squamous cell carcinoma of the penis. (2014) (11)
- Bladder cancer: Nomogram aids clinical decision making after radical cystectomy (2010) (11)
- Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder (2017) (11)
- Poly(ADP-ribose) polymerase inhibitors in prostate and urothelial cancer. (2020) (11)
- Screening for prostate cancer in 2007: the PSA era and its challenges are not over. (2008) (11)
- Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysis. (2021) (10)
- Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration. (2019) (10)
- Can we apply nomograms derived in the United States to European patients? Yes, we can! (2012) (10)
- The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer (2018) (10)
- The Effect of Obesity on Perioperative Outcomes Following Percutaneous Nephrolithotomy. (2016) (10)
- The effect of insurance status on outcomes after partial nephrectomy (2012) (10)
- North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients (2018) (10)
- Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy (2018) (10)
- Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study (2016) (10)
- Where do urologists stand in the era of novel coronavirus-2019 disease (2020) (10)
- 1653: Loss of Doc-21Dab2 Expression is Associated with Aggressive Features of Bladder Cancer (2007) (10)
- Phase III study of pembrolizumab (pembro) plus chemoradiotherapy (CRT) versus CRT alone for patients (pts) with muscle-invasive bladder cancer (MIBC): KEYNOTE-992. (2020) (10)
- Contemporary Gender-Specific Outcomes in Germany After Radical Cystectomy for Bladder Cancer (2014) (10)
- Prognostic Value of Hemoglobin in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis. (2019) (10)
- En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology (2022) (10)
- Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates. (2019) (10)
- Antibiotic Therapy Versus Appendectomy for Acute Appendicitis (2010) (10)
- Preoperative chemotherapy for bladder cancer (2012) (10)
- Single-Incision Transumbilical Surgery (SITUS) versus Single-Port Laparoscopic Surgery and conventional laparoscopic surgery: a prospective randomized comparative study of performance with novices in a dry laboratory (2014) (10)
- Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis. (2019) (10)
- Management of advanced bladder cancer in the era of targeted therapies. (2015) (10)
- Sural Nerve Interposition Grafting during Radical Prostatectomy. (2002) (10)
- Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patients. (2005) (10)
- Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy. (2020) (10)
- A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality. (2019) (10)
- 200 Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma (2015) (10)
- Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study (2018) (10)
- What Is Better for Predicting Morbidity of Robotic Partial Nephrectomy-A Score or Your Clinical Judgement? (2020) (10)
- Words of wisdom: re: a prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. (2013) (10)
- Surgical Caseload is an Important Determinant of Continent Urinary Diversion Rate at Radical Cystectomy: A Population-Based Study (2011) (10)
- Management of upper urinary tract urothelial carcinoma (2010) (10)
- A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma (2021) (10)
- Penile Rehabilitation Strategy after the Nerve-Sparing Radical Prostatectomy: A Systematic Review and Network meta-Analysis of Randomized Trials. (2021) (10)
- Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. (2020) (10)
- Cost analysis of prostate cancer detection including the prostate health index (phi) (2018) (10)
- The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients (2016) (10)
- Non‐cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy (2021) (10)
- Les biomarqueurs émergents du diagnostic, du staging et du pronostic du cancer de la prostate (2011) (10)
- The evolving role of percutaneous biopsy in renal masses (2018) (10)
- Rectal preparation significantly improves prostate imaging quality: Assessment of the PI-QUAL score with visual grading characteristics. (2022) (10)
- Das fortgeschrittene Urothelkarzinom der Harnblase beim älteren Patienten (2012) (10)
- Collaborative research networks as a platform for virtual multidisciplinary, international approach to managing difficult clinical cases: an example from the Upper Tract Urothelial Carcinoma Collaboration. (2012) (10)
- Immune checkpoint inhibition in muscle-invasive and locally advanced bladder cancer. (2020) (10)
- Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening. (2008) (10)
- Incidence rates and contemporary trends in primary urethral cancer (2021) (10)
- Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies. (2020) (10)
- Underestimation of PET/CT Scan in Assessing Tumour Burden of Men With Nodal Recurrence From Prostate Cancer: Head-to-Head Comparison OF 68Ga-PSMA and 11C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections. (2020) (10)
- Intravesical therapy for bladder cancer in the pandemic of Covid-19 (2020) (9)
- An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer (2020) (9)
- The surgical management of patients with clinical stage T4 bladder cancer: A single institution experience. (2017) (9)
- Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer—A Systematic Review and Meta-Analysis (2021) (9)
- Bladder outlet obstruction (BOO) in men with castration‐resistant prostate cancer (2014) (9)
- Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization (2019) (9)
- Perspectives on prostate cancer biomarkers. (2008) (9)
- The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration (2020) (9)
- Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients (2018) (9)
- LYMPHOVASCULAR INVASION IS A POWERFUL PREDICTOR OF CLINICAL OUTCOMES IN NODE-NEGATIVE RADICAL CYSTECTOMY PATIENTS: AN INTERNATIONAL EXTERNAL VALIDATION STUDY (2009) (9)
- The effect of lymph node dissection on cancer‐specific survival in salvage radical prostatectomy patients (2021) (9)
- Liquid biopsies in bladder cancer—did we find the Holy Grail for biomarker analyses? (2016) (9)
- Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma. (2020) (9)
- Histopathology and prognosis of de novo bladder tumors following solid organ transplantation (2015) (9)
- A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals. (2017) (9)
- Enhanced Recovery after Radical Cystectomy (2019) (9)
- Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer (2020) (9)
- Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder. (2011) (9)
- Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review. (2021) (9)
- Unmarried status is a barrier for access to treatment in patients with metastatic renal cell carcinoma (2019) (9)
- Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review. (2021) (9)
- Stage pT0 after radical cystectomy: are all patients equal? (2011) (9)
- Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis (2019) (9)
- Conditional survival of patients with stage I–III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality (2019) (9)
- Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation Therapy. (2021) (9)
- Re: Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma (2009) (9)
- Impact of Preoperative Serum Albumin-Globulin Ratio on Disease Outcome After Radical Cystectomy for Urothelial Carcinoma of the Bladder. (2020) (9)
- Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer (2021) (9)
- Intracorporeal versus extracorporeal urinary diversion in robot-assisted radical cystectomy: a systematic review and meta-analysis (2021) (9)
- Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma (2016) (9)
- TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma (2015) (9)
- Factors affecting outcome in renal cell carcinoma (2010) (9)
- Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (2021) (9)
- The Prognostic Association of Prostate MRI PI-RADS v2 Assessment Category and Risk of Biochemical Recurrence after Definitive Local Therapy for Prostate Cancer: A Systematic Review and Meta-analysis. (2021) (9)
- New surgical approaches for clinically high-risk or metastatic prostate cancer (2017) (9)
- Suboptimal use of pelvic lymph node dissection: Differences in guideline adherence between robot-assisted and open radical prostatectomy. (2016) (9)
- The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy (2012) (9)
- The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group (2020) (9)
- Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery. (2019) (9)
- Bladder tumors : molecular aspects and clinical management (2011) (9)
- Trends in Sexual Activity and Associations With All-Cause and Cause-Specific Mortality Among US Adults. (2020) (9)
- Six essential conditions for bladder-sparing strategies in bacillus Calmette-Guérin unresponsive bladder cancer. (2019) (9)
- Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis. (2021) (9)
- Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study (2016) (9)
- Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer (2018) (9)
- [Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer]. (2011) (9)
- Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population‐Based Study (2019) (9)
- A review of thulium-fiber laser in stone lithotripsy and soft tissue surgery (2020) (9)
- Genomics: a preview of genomic medicine (2008) (9)
- An update on systemic therapy for penile cancer. (2020) (9)
- The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort. (2020) (9)
- The effect of age on bladder cancer incidence, prognosis and therapy (2010) (8)
- Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study. (2011) (8)
- Does partial nephrectomy at an academic institution result in better outcomes? (2012) (8)
- Prognostic Value of Gleason Score at Positive Surgical Margin in Prostate Cancer: A Systematic Review and Meta-analysis. (2020) (8)
- Association Between Body Fat Mass and Kidney Stones in US Adults: Analysis of the National Health and Nutrition Examination Survey 2011-2018. (2021) (8)
- HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial Carcinomas (2018) (8)
- Sex- and age-related differences in the distribution of bladder cancer metastases. (2021) (8)
- Difference in the in-hospital mortality of unstable angina pectoris between men and women. (1999) (8)
- Bladder-preserving strategies for Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer; where are we and what will be expected? (2020) (8)
- Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence (2016) (8)
- Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study. (2017) (8)
- Effect of body mass index on prostate‐specific antigen and percentage free prostate‐specific antigen: Results from a prostate cancer screening cohort of 1490 men (2009) (8)
- Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art (2022) (8)
- Catalog of exogenous risk factors for bladder carcinogenesis. (2020) (8)
- The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence? (2013) (8)
- Association between Inflammatory Potential of Diet and Bladder Cancer Risk: Results of Three United States Prospective Cohort Studies. (2019) (8)
- The Effect of Institution Teaching Status on Perioperative Outcomes After Robotic Partial or Radical Nephrectomy. (2018) (8)
- External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study. (2017) (8)
- Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomy. (2021) (8)
- Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis. (2021) (8)
- Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer (2017) (8)
- Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration‐resistant prostate cancer (2018) (8)
- Competing‐risks analysis in patients with T1 squamous cell carcinoma of the penis (2013) (8)
- Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy? (2013) (8)
- Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis (2021) (8)
- Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma. (2018) (8)
- The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis. (2020) (8)
- Histomorphological analysis of false positive PI-RADS 4 and 5 lesions. (2020) (8)
- Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma (2017) (8)
- Prostate biopsy: guidelines and evidence (2018) (8)
- Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study (2019) (8)
- Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years. (2020) (8)
- COMBINATION OF CELL CYCLE REGULATING BIO-MARKERS IMPROVES PROGNOSIS IN PATIENTS WITH ORGAN CONFINED UROTHELIAL CANCER AT RADICAL CYSTECTOMY (2008) (8)
- Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy? (2014) (8)
- Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria. (2019) (8)
- Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities (2021) (8)
- Safety and short-term oncological outcomes of thulium fiber laser en-bloc resection of non-muscle-invasive bladder cancer: A prospective non-randomized phase II trial (2020) (8)
- Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy. (2021) (8)
- Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer. (2019) (8)
- Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma. (2020) (8)
- Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer (2018) (8)
- Comparison of clinicopathologic and oncological outcomes between Trans-Urethral En Bloc (TUEB) Resection and Conventional Trans-Urethral Resection of Bladder Tumor (cTURBT): a systematic review, meta-analysis and network meta-analysis with focus on Different energy sources. (2021) (8)
- Pathomics in urology (2020) (8)
- Molecular diagnosis of prostate cancer (2004) (8)
- Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. (2022) (8)
- Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C. (2018) (7)
- Contemporary patterns of presentation, diagnostics and management of upper tract urothelial cancer in 101 centres: the Clinical Research Office of the Endourological Society Global upper tract urothelial carcinoma registry (2021) (7)
- Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: A systematic review by the European Association of Urology Guidelines Panel on non-muscle-invasive bladder cancer (2018) (7)
- Screening for bladder cancer using urine-based tumor markers. (2008) (7)
- The prognostic impact of tumour NSD2 expression in advanced prostate cancer (2020) (7)
- Original article Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma (2012) (7)
- ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder. (2017) (7)
- Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis. (2022) (7)
- Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer. (2019) (7)
- Differential prognostic impact of different Gleason patterns in grade group 4 in radical prostatectomy specimens. (2020) (7)
- Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study. (2021) (7)
- Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database. (2017) (7)
- Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer (2021) (7)
- Upper Tract Urothelial Carcinoma (2015) (7)
- Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma. (2020) (7)
- Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities (2020) (7)
- Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long‐Term Survival Rates After Radical Cystectomy in Previous 25 Years (2017) (7)
- Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder. (2020) (7)
- The effect of race on stage at presentation and survival in upper tract urothelial carcinoma. (2021) (7)
- Herbal/Hormonal Dietary Supplement Possibly Associated with Prostate Cancer Progression (2008) (7)
- Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review (2021) (7)
- Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification? (2019) (7)
- Impact of Intra‐ and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy (2017) (7)
- Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects. (2008) (7)
- Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis (2020) (7)
- Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis (2021) (7)
- Keynote-676: Phase 3 study of bacillus calmette-guerin (BCG) with or without pembrolizumab (pembro) for high-risk (HR) non–muscle invasive bladder cancer (NMIBC) that is persistent or recurrent following BCG induction. (2019) (7)
- External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients (2021) (7)
- Endoscopic resection of a giant fibrovascular polyp of the oesophagus with the assistance of ultrasonic shears (2016) (7)
- Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis (2020) (7)
- Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC) (2020) (7)
- The clinical pharmacology of the medical treatment for overactive bladder in adults (2020) (7)
- Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors (2021) (7)
- Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma. (2021) (7)
- The effect of immune checkpoint inhibitor combination therapies in metastatic renal cell carcinoma patients with and without previous cytoreductive nephrectomy: A systematic review and meta-analysis. (2022) (7)
- Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder (2020) (7)
- Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice? (2018) (7)
- The use of 5α-reductase inhibitors for the prevention and treatment of prostate cancer. (2011) (7)
- Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer. (2017) (7)
- Acute kidney injury in COVID-19: are kidneys the target or just collateral damage? A comprehensive assessment of viral RNA and AKI rate in patients with COVID-19 (2021) (7)
- Ureteral and urethral recurrence after radical cystectomy: a systematic review. (2020) (7)
- EXTERNAL-BEAM RADIATION THERAPY INCREASES THE RATE OF SECONDARY MALIGNANCIES RELATIVE TO RADICAL PROSTATECTOMY IN MEN WITH PROSTATE CANCER (2008) (7)
- Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different? (2015) (7)
- The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy (2021) (7)
- Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis. (2022) (7)
- The effect of race/ethnicity on active treatment rates among septuagenarian or older low risk prostate cancer patients. (2021) (7)
- Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy. (2018) (7)
- Analysis of hematological parameters as prognostic markers for toxicity and survival of 223Radium treatment (2018) (7)
- Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma. (2020) (7)
- Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer (2019) (7)
- Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review (2020) (7)
- Value of tumour‐infiltrating immune cells in predicting response to intravesical BCG in patients with non‐muscle‐invasive bladder cancer: a systematic review and meta‐analysis (2020) (7)
- Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients. (2019) (7)
- Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma (2019) (7)
- Evaluation of Patterns of Presentation, Practice, and Outcomes of Upper Tract Urothelial Cancer: Protocol for an Observational, International, Multicenter, Cohort Study by the Clinical Research Office of the Endourology Society (2020) (7)
- Bladder cancer stage and mortality: urban vs. rural residency (2020) (7)
- Aristolochic acid and its effect on different cancers in uro-oncology. (2020) (7)
- Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound. (2022) (7)
- Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy (2021) (7)
- Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy. (2019) (7)
- Critical review of biomarkers for the early detection and surveillance of bladder cancer (2009) (6)
- Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages-A SEER-based Study. (2020) (6)
- Comparison Between Urothelial and Non-Urothelial Urethral Cancer (2021) (6)
- Life-threatening haematuria caused by vancomycin-induced thrombocytopenia (2015) (6)
- Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer. (2020) (6)
- Assays for Prostate Cancer (2013) (6)
- Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma: systematic review and network meta-analysis (2021) (6)
- Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity. (2022) (6)
- Partial nephrectomy in frail patients: Benefits of robot-assisted surgery. (2021) (6)
- The impact of hormones and reproductive factors on the risk of bladder cancer in women: results from the Nurses' Health Study and Nurses' Health Study II. (2019) (6)
- Immunotherapy-based combinations in the first-line treatment of metastatic renal cell carcinoma with sarcomatoid features: a systematic review and network meta-analysis (2021) (6)
- [How radical nephrectomy compares to partial nephrectomy for the treatment of pT1a papillary renal cell carcinomas?]. (2010) (6)
- Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients. (2020) (6)
- The changing face of renal cell carcinoma: the impact of systematic genetic sequencing on our understanding of this tumor's biology. (2013) (6)
- Making a case “against” focal therapy for intermediate-risk prostate cancer (2020) (6)
- Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study (2020) (6)
- Impact of statin use on oncologic outcomes of patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. (2013) (6)
- Novel urinary markers for detection of bladder cancer-are we failing? (2014) (6)
- Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered? (2018) (6)
- Role of lasers in urology. (2019) (6)
- Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis (2020) (6)
- Erratum: Tumour architecture is an independent predictor of outcomes after nephroureterectomy: A multi-institutional analysis of 1363 patients (BJU International 2009 (103) 307-311) (2009) (6)
- 847: Institutional Variability in Predictive Accuracy of Urinary Cytology for Prediction of Transitional Cell Carcinoma Recurrence (2005) (6)
- Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma (2016) (6)
- Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients (2022) (6)
- Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma. (2020) (6)
- Health-related quality of life in bladder cancer patients: bladder cancer-specific instruments and domains. Part 2 (2021) (6)
- The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder (2019) (6)
- Incidence and preoperative predictors for major complications following radical nephroureterectomy (2020) (6)
- Quality indicators for the management of high-risk upper tract urothelial carcinoma requiring radical nephroureterectomy (2021) (6)
- Words of wisdom. Re: Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial. (2013) (6)
- The Application of Artificial Intelligence in Prostate Cancer Management—What Improvements Can Be Expected? A Systematic Review (2020) (6)
- A preoperative nomogram to predict major complications after robot assisted partial nephrectomy (UroCCR-57 study). (2019) (6)
- Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis (2021) (6)
- Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. (2021) (6)
- Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma. (2021) (6)
- Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: a meta-analysis. (2022) (6)
- Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy. (2022) (6)
- Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project) (2017) (6)
- Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer. (2020) (6)
- Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study (2019) (6)
- Contralateral inguinal herniation of a transplant ureter causing obstructive uropathy in a renal transplant recipient (2017) (6)
- Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes. (2019) (6)
- Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy. (2015) (6)
- Role of serum cholinesterase in patients treated with salvage radical prostatectomy. (2019) (6)
- Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines (2021) (5)
- Do we need repeat TUR after en bloc resection for pT1 bladder cancer? (2022) (5)
- Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients. (2018) (5)
- Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma (2018) (5)
- Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study. (2019) (5)
- Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer. (2022) (5)
- MP70-15 LONG TERM OUTCOMES OF SALVAGE LYMPH NODE DISSECTION FOR CLINICALLY RECURRENT PROSTATE CANCER: RESULTS OF A SINGLE INSTITUTION SERIES WITH A MINIMUM FOLLOW-UP OF 5 YEARS (2014) (5)
- Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma. (2021) (5)
- A Systematic Review and Scoping Analysis of Smoking Cessation after a Urologic Cancer Diagnosis. (2021) (5)
- Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy. (2017) (5)
- Response and Toxicity to the Second Course of 3 Cycles of 177Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer (2021) (5)
- Is adjunctive systemic chemotherapy after cystectomy for T2N+ disease of therapeutic benefit? (2012) (5)
- 544 Long-term impact of adjuvant versus early salvage radiation therapy on clinical recurrence in pT3N0 prostate cancer patients treated with radical prostatectomy: Results of a multi-institutional analysis (2016) (5)
- Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. (2021) (5)
- Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non-clear Cell Renal Cell Carcinoma Patients. (2020) (5)
- Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder (2020) (5)
- Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients. (2021) (5)
- Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy. (2020) (5)
- Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysis (2021) (5)
- Partial nephrectomy driven by cavitron ultrasonic surgical aspirator under zero ischemia: a pilot study (2015) (5)
- Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size. (2020) (5)
- Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis. (2021) (5)
- The effect of gender on nephrectomy perioperative outcomes: a national survey. (2012) (5)
- The value and limitations of urothelial bladder carcinoma molecular classifications to predict oncological outcomes and cancer treatment response: A systematic review and meta-analysis. (2020) (5)
- Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis. (2021) (5)
- Epigenetic alterations of testicular germ cell tumours. (2020) (5)
- Comprehensive handbook for developing a bladder cancer cystectomy database. (2013) (5)
- Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media? (2020) (5)
- An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population‐based analysis (2013) (5)
- Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis. (2018) (5)
- Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations. (2022) (5)
- Safety and Short-Term Oncological Outcomes of Thulium Fiber Laser En Bloc Resection of Non-Muscle-Invasive Bladder Cancer: A Prospective Non-Randomized Phase II Trial (2020) (5)
- 576 Prediction of cancer-specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: Development of an optimized post-operative nomogram using decision curve analysis (2013) (5)
- The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages (2020) (5)
- The Efficacy and Safety of Relugolix Compared with Degarelix in Advanced Prostate Cancer Patients: A Network Meta-analysis of Randomized Trials. (2021) (5)
- Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy (2022) (5)
- Re: Global effects of smoking, of quitting, and of taxing tobacco. (2014) (5)
- Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity (2022) (5)
- Oncologic outcomes after minimally invasive surgery for cT1 renal masses: a comprehensive review (2017) (5)
- Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy (2021) (5)
- Re: lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. (2008) (5)
- Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250]. (2020) (5)
- Demographic analysis of randomized controlled trials in bladder cancer (2013) (5)
- Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response (2021) (5)
- The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy (2020) (5)
- The prognostic value of sarcopenia in patients with prostate cancer: a systematic review (2021) (5)
- Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis (2021) (5)
- Bladder sparing landscape for bacillus Calmette-Guérin unresponsive bladder cancer. (2020) (5)
- Salvage Radical Prostatectomy: Baseline Prostate Cancer Characteristics and Survival Across SEER Registries. (2021) (5)
- Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma (2020) (5)
- Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy. (2019) (5)
- Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent (2019) (5)
- Long-term survival of patients aged 80 years or older treated with radical prostatectomy for prostate cancer. (2017) (5)
- Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer (2021) (5)
- Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients. (2016) (5)
- Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract (2017) (5)
- Bladder cancer incidence rates and trends in young adults aged 20-39 years. (2020) (4)
- Editorial comment on: Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. (2008) (4)
- [Surgical treatment of upper tract urothelial carcinomas by nephroureterectomy: state of the art review for the yearly scientific report of the French National Association of Urology]. (2014) (4)
- Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients. (2020) (4)
- 876 PREOPERATIVE DETECTION OF A SINGLE CIRCULATING TUMOUR CELL IS INDEPENDENTLY ASSOCIATED WITH INFERIOR OUTCOME IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER (2012) (4)
- Prognostic significance of perirenal fat invasion and tumor size in pT1 to pT3a renal cell carcinoma: Results of a comprehensive multicenter study of the CORONA project—Can we improve prognostic discrimination of patients with stage pT3a tumors? (2015) (4)
- Alternating Cystoscopy with Bladder EpiCheck® in the Surveillance of Low-Grade Intermediate-Risk NMIBC: A Cost Comparison Model (2021) (4)
- Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis. (2021) (4)
- The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC). (2020) (4)
- Association of Prostate Cancer with Nuts, Seeds, Alcohol and Processed Meats: A Worldwide Population-Based Study (2020) (4)
- Lower urinary tract symptoms in patients with liver cirrhosis (2015) (4)
- Comprehensive analysis of in-hospital delirium after major surgical oncology procedures. (2019) (4)
- The Use of Biomarkers for Bladder Cancer Diagnosis and Surveillance. (2016) (4)
- 897 Gender-specific differences in clinicopathologic outcomes following radical cystectomy: An international multi-institutional study of over 8,000 patients (2014) (4)
- The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer. (2020) (4)
- Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines. (2020) (4)
- Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration. (2021) (4)
- Association of Processed Meats and Alcohol Consumption with Renal Cell Carcinoma: A Worldwide Population-Based Study (2020) (4)
- Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy. (2022) (4)
- Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma. (2018) (4)
- 826 THE EFFECT OF RADICAL VERSUS PARTIAL NEPHRECTOMY ON OTHER-CAUSE MORTALITY IN PATIENTS WITH T1A RENAL CELL CARCINOMA: RESULTS FROM THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS DATABASE (2010) (4)
- Predictive tools for prostate cancer staging, treatment response and outcomes. (2012) (4)
- Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer. (2020) (4)
- 1597 GENDER DIFFERENCES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY A POPULATION-BASED ANALYSIS (2012) (4)
- 1062 SOCIOECONOMIC TRENDS AND UTILIZATION IN THE EMERGENCY DEPARTMENT TREATMENT OF URINARY TRACT INFECTIONS (2013) (4)
- OUTCOMES FOR PATIENTS WITH pT0 DISEASE AFTER RADICAL NEPHROURETERECTOMY FOR UPPER‐TRACT UROTHELIAL CARCINOMA (2009) (4)
- Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy (2022) (4)
- PI-LBA07 THE DEVELOPMENT AND CLINICAL VALIDATION OF A HIGH SENSITIVITY URINE BIOMARKER TEST FOR THE DETERMINATION OF RECURRENCE IN UROTHELIAL CARCINOMA PATIENTS (2016) (4)
- Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancer. (2018) (4)
- Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy. (2013) (4)
- Higher Cancer Mortality in Rural Upper Urinary Tract Urothelial Carcinoma Patients (2020) (4)
- Discharge patterns after radical cystectomy: contemporary trends in the United States. (2012) (4)
- Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review. (2020) (4)
- Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis. (2022) (4)
- Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets (2021) (4)
- Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study. (2019) (4)
- Prognostic impact of insulin‐like growth factor‐I and its binding proteins, insulin‐like growth factor‐I binding protein‐2 and ‐3, on adverse histopathological features and survival outcomes after radical cystectomy (2022) (4)
- Improvement in overall and cancer‐specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients (2021) (4)
- Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma. (2022) (4)
- Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study. (2021) (4)
- Risk stratification of upper tract urothelial carcinoma: A Review of the Current Literature (2019) (4)
- Contemporary rates and predictors of open conversion during minimally invasive radical prostatectomy for non-metastatic prostate cancer. (2020) (4)
- En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser (2021) (4)
- Rates of other‐cause mortality after radical cystectomy are decreasing over time—A population‐based analysis over two decades (2020) (4)
- Reply from Authors re: Mark S. Soloway, Michael Garcia-Roig, Michael A. Gorin and Rajinikanth Ayyathurai. How Can We Improve Outcomes for Upper Tract Urothelial Carcinoma? Eur Urol 2012;61:254–6 (2012) (4)
- Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence. (2021) (4)
- Impact of Age on Perioperative Outcomes at Radical Prostatectomy: A Population-Based Study. (2020) (4)
- Prostate cancer risk estimation tool use by members of the American Urological Association: a survey based study. (2015) (4)
- Re: Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Carcinoma (PURE-01): An Open-label, Single-arm, Phase II Study. (2019) (4)
- Regional differences in patient age and prostate cancer characteristics and rates of treatment modalities in favorable and unfavorable intermediate risk prostate cancer across United States SEER registries. (2021) (4)
- What is next in second- and later-line treatment of metastatic renal cell carcinoma? review of the recent literature (2021) (4)
- Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract (2018) (4)
- Editorial comment on: Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker. (2009) (4)
- The effect of race on survival after local therapy in metastatic prostate cancer patients. (2018) (4)
- A Cost Comparison of Open versus Robotic Cystectomy (2010) (4)
- Molecularly-driven precision medicine for advanced bladder cancer (2018) (4)
- Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy (2017) (4)
- Contemporary seminal vesicle invasion rates in NCCN high‐risk prostate cancer patients (2022) (4)
- Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer (2020) (4)
- A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis. (2020) (4)
- Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer (2021) (4)
- 742 FEATURES ASSOCIATED WITH RECURRENCE BEYOND 5 YEARS AFTER NEPHRECTOMY AND NEPHRON-SPARING SURGERY FOR RENAL CELL CARCINOMA: DEVELOPMENT AND INTERNAL VALIDATION OF A RISK-MODEL TO PREDICT LATE RECURRENCE BASED ON A LARGE MULTI-CENTER DATABASE (CORONA/SATURN-PROJECT) (2013) (4)
- Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (2021) (4)
- Assessment of the optimal number of positive biopsy cores to discriminate between cancer‐specific mortality in high‐risk versus very high‐risk prostate cancer patients (2021) (4)
- Fibroblast growth factor receptors across urothelial carcinoma landscape. (2020) (4)
- Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma (2021) (4)
- Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies. (2019) (4)
- Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: A populationbased assessment (2010) (4)
- Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis (2018) (4)
- Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis. (2008) (4)
- Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database-based Study. (2020) (4)
- Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients. (2021) (4)
- Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder (2022) (4)
- Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent (2016) (4)
- The search for better prognostic factors for men treated for localized prostate cancer continues. (2008) (4)
- 1907 LEVEL OF THROMBOUS ACCORDING TO MAYO CLINIC CLASSIFICATION IS AN INDEPENDENT PREDICTOR OF PERIOPERATIVE COMPLICATIONS AND CANCER-RELATED OUTCOME: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM (2013) (4)
- Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies (2022) (4)
- Regular Coffee Consumption Is Associated with Lower Regional Adiposity Measured by DXA among US Women. (2020) (3)
- 1426: Pre-Operative Plasma Endoglin Levels Predict Metastasis to Lymph Nodes and Disease Progression in Patients Treated with Radical Prostatectomy (2007) (3)
- Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis. (2022) (3)
- Surgical intervention in patients with urothelial carcinoma of the bladder and lymph node metastasis (2021) (3)
- Peripheral blood rt-PCR assays for detection and prognosis of prostate cancer. (2003) (3)
- Comparison between 1973 and 2004/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder (2021) (3)
- Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy. (2009) (3)
- 1701 ACCURACY OF THE EORTC RISK TABLES AND OF THE CUETO SCORING MODEL TO PREDICT OUTCOMES IN NON MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER (2013) (3)
- MP14-09 SURVIVAL AFTER CONSERVATIVE MANAGEMENT VERSUS EXTERNAL BEAM RADIOTHERAPY IN VERY ELDERLY PATIENTS WITH LOCALIZED PROSTATE CANCER (2016) (3)
- 1021 PROSPECTIVE VALIDATION OF MULTIPLE BIOMARKERS FOR IMPROVED CLINICAL DECISION-MAKING IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER (2010) (3)
- Medical practice and placebo response: an inseparable bond? (2020) (3)
- Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer (mCRPC). (2020) (3)
- Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer. (2022) (3)
- Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer (2021) (3)
- Intraoperative aerosol viral transmission in minimally invasive surgery: a scoping review and impact on clinical guidelines and practice during the onset of the coronavirus disease 2019 (COVID‐19) pandemic (2020) (3)
- Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer (2022) (3)
- Validation of bedside ultrasound to predict lumbar muscle area in the computed tomography in 200 non-critically ill patients: The USVALID prospective study. (2022) (3)
- Health-related quality of life in bladder cancer patients: general and cancer-specific instruments. Part 1 (2021) (3)
- TUMOR NECROSIS IS AN INDICATOR OF AGGRESSIVE BIOLOGY IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT (2009) (3)
- Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer. (2017) (3)
- Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review (2022) (3)
- Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy (2021) (3)
- The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. (2021) (3)
- Immuno-oncology therapy in metastatic bladder cancer: a systematic review and network meta-analysis. (2021) (3)
- [Prognostic factors of upper tract urothelial carcinomas and impact on survival: a systematic review for the yearly scientific report of the French National Association of Urology]. (2014) (3)
- Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails. (2019) (3)
- Bacillus Calmette-Guerin (BCG) with or without pembrolizumab (pembro) for high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) that is persistent or recurrent following BCG induction: Phase III KEYNOTE-676 study. (2019) (3)
- Dual immune check point blockade or immune check point-tyrosine kinase inhibitor combination: as a first-line treatment in metastatic renal cell carcinoma? (2021) (3)
- Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy (2021) (3)
- Integrative molecular profiling challenges robustness of prognostic signature scores in multifocal prostate cancer. (2018) (3)
- Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis. (2022) (3)
- Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study (2022) (3)
- Oncologic outcomes and survival in pT0 tumors after radical nephroureterectomy for upper tract urothelial carcinoma: results from of a large multicenter international collaborative study. (2013) (3)
- Stage and cancer‐specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population‐based study (2021) (3)
- The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy. (2021) (3)
- Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer. (2019) (3)
- 216 Discrepancy between guidelines and daily practice in the management of non-muscle-invasive bladder cancer (NMIBC): Results of a European survey (2016) (3)
- A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond (2022) (3)
- Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy. (2019) (3)
- 1366 ASSESSMENT OF MORTALITY FOR NON CANCER-RELATED MORTALITY IN PATIENTS WITH HISTOLOGICALLY PROVEN SMALL RENAL MASSES MANAGED NON-SURGICALLY (2010) (3)
- Notice of duplicate publication: "Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis" (arch intern med. 2008;168[2]:235-236). (2008) (3)
- 575 Segmental ureterectomy versus radical nephroureterectomy for urothelial cancer of the ureter: A matched-pair analysis (2013) (3)
- Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes. (2019) (3)
- Rebuttal from authors re: James W.F. Catto. More nomograms or better evidence of efficacy: what do we need in urologic oncology? Eur Urol 2008;54:11-12. (2008) (3)
- Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors (2021) (3)
- The role of taxane-based chemotherapy in the treatment of prostate cancer. (2020) (3)
- Impact of the preoperative modified glasgow prognostic score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder. (2021) (3)
- Functional Outcomes after Local Salvage Therapies for Radiation-Recurrent Prostate Cancer Patients: A Systematic Review (2021) (3)
- Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration (2022) (3)
- Die Verwendung von PubMed zur Verbesserung evidenzbasierter Medizin in der Urologie (2013) (3)
- Kaplan-Meier-Analysen in der urologischen Praxis (2013) (3)
- Kenntnisse von deutschsprachigen Urologen zur Häufigkeit der Assoziation des Peniskarzinoms mit dem Humanen Papillomavirus – Survey-Ergebnisse der European PROspective Penile Cancer Study (E-PROPS) (2019) (3)
- Benigne Prostatahyperplasie (BPH) und benignes Prostatasyndrom (BPS) (2016) (3)
- PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy. (2019) (3)
- The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta‐analysis (2020) (3)
- Risk stratification for upper tract urinary carcinoma (2020) (3)
- Molecular diagnosis of prostate cancer (2004) (3)
- The impact of cigarette smoking on adverse pathological features and survival in patients undergoing radical cystectomy for urinary bladder cancer - a prospective, European multicenter study of the EAU young academic urologists urothelial carcinoma group (2018) (3)
- Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. (2021) (3)
- Sarcopenic Obesity and Its Prognostic Impact on Urologic Cancers: A Systematic Review. (2021) (3)
- Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy (2021) (3)
- Can we rely on a negative multiparametric MRI to exclude significant prostate cancer at biopsy? Results from a regional cancer centre (2019) (3)
- Re: nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT. (2015) (3)
- Selecting patients for immediate cystectomy. (2007) (3)
- Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study (2022) (3)
- 4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study (2019) (3)
- Segmental ureterectomy for upper tract urothelial carcinoma: two procedures with different indications. (2013) (3)
- The Role of Urologist (2018) (3)
- Nocebo Response in the Pharmacological Management of Overactive Bladder: A Systematic Review and Meta-analysis. (2020) (3)
- Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study. (2022) (3)
- Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non-muscle-invasive Bladder Cancer. (2021) (3)
- Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. (2020) (3)
- The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder (2020) (3)
- MORE EXTENSIVE LYMPHADENECTOMY IMPROVES THE PROGNOSIS OF PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA WITHOUT NODAL METASTASES (2008) (3)
- Benefit and Harm of Active Surveillance for Biopsy-proven Renal Oncocytoma: A Systematic Review and Pooled Analysis (2022) (3)
- The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis. (2022) (3)
- Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial Carcinoma. (2022) (3)
- 639 PREOPERATIVE PREDICTORS OF RENAL FUNCTION DECLINE FOLLOWING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (2012) (3)
- Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis (2019) (3)
- Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder. (2021) (3)
- Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies (2019) (3)
- The microbiome in urinary tract infections in children - an update. (2021) (3)
- In Non-Metastatic pT1b Kidney Cancer Patients Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy. (2019) (3)
- Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial Carcinoma. (2021) (3)
- Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers (2018) (3)
- 1001 The impact of re-TUR on clinical outcomes in a large cohort of t1g3 patients treated with BCG (2014) (3)
- Oncological outcomes of radical nephroureterectomy versus kidney-sparing surgery for elective treatment of clinically organ-confined upper tract urothelial carcinoma of the distal ureter. (2015) (3)
- 21: Development of a Highly Accurate Nomogram for Prediction of the Need for Exploration in Patients with Renal Trauma (2007) (3)
- Non‐organ confined stage and upgrading rates in exclusive PSA high‐risk prostate cancer patients (2022) (3)
- Vaccine-based immunotherapy for prostate cancer. (2000) (3)
- Second line immune checkpoint inhibition in urothelial cancer. (2019) (3)
- Single-lesion Prostate-specific Membrane Antigen Protein Expression (PSMA) and Response to [177Lu]-PSMA-ligand Therapy in Patients with Castration-resistant Prostate Cancer (2021) (3)
- The promise and challenges of neoadjuvant immunotherapy in the management of non‐metastatic muscle‐invasive bladder cancer (2020) (3)
- Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium) (2022) (2)
- Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities. (2019) (2)
- PD10-01 DISEASE-FREE SURVIVAL WITH LONGER FOLLOW-UP FROM THE CHECKMATE 274 TRIAL OF ADJUVANT NIVOLUMAB IN PATIENTS AFTER SURGERY FOR HIGH-RISK MUSCLE-INVASIVE UROTHELIAL CARCINOMA (2022) (2)
- Survival benefit of local vs. no local treatment for metastatic prostate cancer - impact of baseline PSA and metastatic substages (2018) (2)
- Patient’s behavior and attitudes toward the management of benign prostatic hyperplasia among patients with the risk of disease progression: prospective study by “Prostate and Expectations of Treatment Epidemiology Research (PETER) study group” (2015) (2)
- A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery (2022) (2)
- Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists. (2022) (2)
- Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy. (2022) (2)
- Re: Timing of Androgen Deprivation Therapy and Its Impact on Survival after Radical Prostatectomy: A Matched Cohort Study (2009) (2)
- Lower urinary tract symptoms are associated with clinically relevant depression, anxiety, and stress symptoms (2022) (2)
- Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder (2021) (2)
- ADJUVANT CHEMOTHERAPY FOR UPPER TRACT TRANSITIONAL CELL CARCINOMA: RESULTS FROM THE UPPER TRACT UCC CONSORTIUM (2008) (2)
- Re: Radiation with or Without Antiandrogen Therapy in Recurrent Prostate Cancer. (2017) (2)
- Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy. (2022) (2)
- MORTALITY PREDICTIONS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA (2009) (2)
- DOES HYDRONEPHROSIS ON PREOPERATIVE AXIAL CT IMAGING PREDICT WORSE OUTCOMES FOR PATIENTS UNDERGOING NEPHROURETERECTOMY FOR UPPER-TRACT UROTHELIAL CARCINOMA? (2008) (2)
- Non-Muscle-Invasive Bladder Cancer in the Elderly Patient (2014) (2)
- Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patterns+ (2021) (2)
- Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups (2022) (2)
- Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy. (2019) (2)
- Primary lymphomas of the genitourinary tract: A population-based study (2019) (2)
- 998 Comparison of the EORTC tables and the newly introduced EAU categories for risk stratification of patients with non-muscle-invasive bladder cancer (2014) (2)
- ICUD guidelines for upper tract urothelial carcinoma: a state-of-the-art evidence-based guidance for clinical decisions regarding diagnosis, management and treatment (2017) (2)
- The consequences of inadvertent radical nephrectomy in the treatment of upper tract urothelial carcinoma. (2021) (2)
- A systematic review and meta-analysis of prognostic impact of different Gleason patterns in ISUP grade group 4 (2021) (2)
- Uptake of laparoscopic radical nephroureterectomy in France: a 2003-2011 national practice report. (2012) (2)
- 1697 PROGNOSTIC FACTORS AND RISK GROUPS IN T1G3 PATIENTS INITIALLY TREATED WITH BCG: RESULTS OF A MULTICENTER RETROSPECTIVE SERIES IN 2530 PATIENTS (2013) (2)
- 1521 LAPAROSCOPIC AND OPEN PARTIAL NEPHRECTOMY: COMPARISON OF COMPLICATIONS USING CLAVIEN GRADING SYSTEM (2011) (2)
- Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients (2021) (2)
- Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients (2022) (2)
- Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation‐recurrent Prostate Cancer (2017) (2)
- Prognostic and Predictive Markers, and Stratifications Tables, for the Detection and Treatment of Renal Cell Carcinoma (2019) (2)
- The role for surgeryin high-risk prostate cancer (2015) (2)
- Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients. (2022) (2)
- Cytoreductive Surgery in Patients with Urothelial Bladder Cancer. (2022) (2)
- Artificial intelligence in prostate histopathology: where are we in 2021? (2021) (2)
- Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis (2022) (2)
- Association between rs6152 polymorphism in the androgen receptor gene and disease aggressiveness in a prospective cohort of prostate cancer patients undergoing radical prostatectomy (2018) (2)
- Das Urothelkarzinom des oberen Harntraktes (2012) (2)
- Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy. (2021) (2)
- Survival after radical prostatectomy versus radiation therapy in clinical node‐positive prostate cancer (2022) (2)
- Multi-institutional validation of the predictive value of Ki-67 in patients with high-grade urothelial carcinoma of the upper urinary tract. (2015) (2)
- Langzeitergebnisse nach Vaporisation der Prostata (2016) (2)
- Predicting Clinical Outcome Following Post Prostatectomy Radiation Therapy: A Poisson-Based Tumor Control Probability (TCP) Model Based on a Large Multi-institutional Series (2015) (2)
- 1231: Delay in Radical Cystectomy Over 12 Weeks is Not Associated with Adverse Outcome: Results from the Bladder Cancer Research Consortium (2006) (2)
- Update on Prostate-Specific Antigen Testing for the Early Detection of Prostate Cancer (2008) (2)
- [Upper tract urothelial carcinoma. An update on clinical and pathological prognostic factors]. (2012) (2)
- Oncologic and Safety Outcomes for Retrograde and Antegrade Endoscopic Surgeries for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis. (2022) (2)
- THE EFFECT OF ANDROGEN DEPRIVATION THERAPY ON THE RATE OF SUBSEQUENT NON-CANCER MORBIDITIES (2008) (2)
- 13 OUTCOMES OF PATIENTS WITH CLINICAL T1 GRADE 3 BLADDER UROTHELIAL CELL CARCINOMA TREATED WITH RADICAL CYSTECTOMY (2007) (2)
- RISK FACTORS FOR RESIDUAL DISEASE AT RE‐TUR IN T1G3 BLADDER CANCER: PD48‐03 (2017) (2)
- MP51-15 TIME FROM SURGERY TO URINARY CONTINENCE SIGNIFICANTLY INFLUENCES THE SUBSEQUENT RECOVERY OF ERECTILE FUNCTION IN PATIENTS TREATED WITH BILATERAL NERVE-SPARING RADICAL PROSTATECTOMY (2014) (2)
- Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis. (2020) (2)
- En-Bloc Transurethral Resection of Non-Muscle-Invasive Bladder Cancer. Current Evidence and Glimpses into the Future (2019) (2)
- Impact of Intestinal Urinary Diversion on the Risk of Fracture and Loss of Bone Mass: A Systematic Review (2021) (2)
- Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]. (2015) (2)
- IMPACT OF TUMOR LOCATION ON PROGNOSIS FOR UPPER- TRACT UROTHELIAL CARCINOMA: OUTCOMES FROM OVER 1300 PATIENTS (2008) (2)
- A Plea for the Evaluation of the Carbon Footprint of New Mini-invasive Surgical Technologies in Urology. (2020) (2)
- Novel technologies that change the diagnostic and treatment paradigm in urology: En-bloc as the new treatment standard. (2020) (2)
- Erratum: Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy (BJU International (2010) 105: (1672-7) DOI: 10.1111/j.1464-410X.2009.09072.x) (2015) (2)
- Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer. (2020) (2)
- Re: Bevacizumab plus Interferon alfa-2a for Treatment of Metastatic Renal Cell Carcinoma: A Randomised, Double-Blind Phase III Trial (2008) (2)
- Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy? (2019) (2)
- Bladder Cancer: Invasive VMP72-01 RADICAL CYSTECTOMY VERSUS BLADDER-SPARING TREATMENT FOR PATIENTS WITH MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE URINARY BLADDER: A COMPARATIVE EFFECTIVENESS POPULATION-BASED STUDY. (2015) (2)
- Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients (2022) (2)
- Bladder cancer risk: Use of PLCO and NLST to identify a suitable screening cohort. (2014) (2)
- Adherence to guideline recommendations for multimodality treatment of patients with pT2–3 M0 non‐urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes (2020) (2)
- Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma (2020) (2)
- Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab (2021) (2)
- 647 The neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy: Validation and meta-analysis (2015) (2)
- PD10-03 ASSESSING THE UNDER-ESTIMATION OF NODAL TUMOUR BURDEN BY 68GA-PSMA AND 11C-CHOLINE PET/CT SCAN IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENCE OF PROSTATE CANCER: A LARGE MULTI-INSTITUTIONAL ANALYSIS (2018) (2)
- 948 The impact of different BCG strains on outcome in a large cohort of T1G3 patients treated with BCG (2015) (2)
- Cancer‐specific survival after radical prostatectomy versus external beam radiotherapy in high‐risk and very high‐risk African American prostate cancer patients (2021) (2)
- Trimodal therapy with high-dose-rate brachytherapy and hypofractionated external beam radiation combined with long-term androgen deprivation for unfavorable-risk prostate cancer (2021) (2)
- Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update (2022) (2)
- Bladder Cancer Screening and Future Directions in Urine-Based Markers for Bladder Urothelial Carcinoma (2007) (2)
- The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer (2021) (2)
- Influence of steep Trendelenburg position on postoperative complications: a systematic review and meta-analysis (2021) (2)
- The prostate biopsy. (2018) (2)
- Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion. (2019) (2)
- Building bridges in urothelial carcinoma to face common challenges (2016) (2)
- Oncological and safety profiles in patients undergoing simultaneous TURB and TURP. (2022) (2)
- The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspective. (2008) (2)
- Dual immune checkpoint inhibition in metastatic renal cell carcinoma: Editorial re.: Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced RCC: extended 4-year follow-up of the phase III CheckMate 214 trial. (2021) (2)
- Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL (2014) (2)
- Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis (2022) (2)
- Racial differences in the distribution of bladder cancer metastases: a population-based analysis (2020) (2)
- MP57-11 DOES THE USE OF CARDIOPULMONARY BY-PASS (CPB) IMPACT SURVIVAL IN PATIENTS UNDERGOING NEPHRECTOMY/LEVEL III-IV TUMOR THROMBECTOMY? A MULTI-INSTITUTIONAL ANALYSIS (2014) (2)
- Cytoreductive radical prostatectomy (cRP) is feasible in men with hormone-naive, metastatic prostate cancer (mPCA) (2017) (2)
- 1795 NUMBER OF METASTATIC SITES AND PERIOPERATIVE OUTCOMES AFTER CYTOREDUCTIVE NEPHRECTOMY: A POPULATION-BASED ANALYSES (2012) (2)
- Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy? (2022) (2)
- Comparison of short-term and long-term neoadjuvant hormone therapy prior to radical prostatectomy: a systematic review and meta-analysis (2022) (2)
- Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer (2021) (2)
- 601 Role of conventional cytology in the treatment of upper tract urothelial carcinoma (OSS-UTUC): Results from the multi-institutional organ-sparing-UTUC collaboration (2013) (2)
- Ischemic Priapism in a 12 Year Old Patient Associated With Coronavirus Disease 2019 (COVID-19): A Case Report (2022) (2)
- Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review (2022) (2)
- Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy. (2021) (2)
- Optimizing performance and interpretation of prostate biopsy: A critical analysis of the literature (2010) (2)
- Fighting the 'tobacco epidemic' - A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancer. (2021) (2)
- Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer (2020) (2)
- Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients (2019) (2)
- EXPRESSION OF MULTIPLE BIOMARKERS IS ASSOCIATED WITH LOCALLY ADVANCED UROTHELIAL CARCINOMA OF THE BLADDER IN A PROSPECTIVE EVALUATION (2009) (2)
- Electronic Cigarettes: A Wolf in Sheep's Clothing. (2017) (2)
- The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy. (2020) (2)
- Inflammatory bowel disease and prostate cancer risk: A systematic review (2020) (2)
- The impact of sex and age on distribution of metastases in patients with renal cell carcinoma (2021) (2)
- [Long-term results after prostate vaporisation : GreenLight™ laser vaporisation of the prostate and electrovaporisation]. (2016) (2)
- Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma (2021) (2)
- No gender diversities in outcomes in patients diagnosed with non-muscle invasive, highrisk bladder cancer treated with early second resection and BCG – a multicenter analysis (2019) (2)
- Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer (2021) (2)
- Metabolic syndrome predicts worse perioperative outcomes in patients treated with partial nephrectomy for renal cell carcinoma. (2020) (2)
- A systematic review and meta-analysis of prognostic impact of different Gleason patterns in ISUP grade group 4. (2020) (2)
- Adjuvant versus early salvage radiation therapy in node positive prostate cancer patients: A long-term survival analysis (2017) (2)
- Words of wisdom. Re: radical prostatectomy or watchful waiting in early prostate cancer. (2014) (2)
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update. (2023) (2)
- The surgical approach can be determined from the pathological specimen obtained after open or robot-assisted laparoscopic radical prostatectomy (2014) (2)
- Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate (2021) (2)
- Gender Differences in Bladder and Kidney Cancers (2017) (2)
- Surgical Metastasectomy for Visceral and Bone Prostate Cancer Metastases: A Mini-Review. (2022) (2)
- Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis (2022) (2)
- Focal therapy of prostate cancer (2018) (2)
- The placebo and nocebo effects in functional urology (2021) (2)
- Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: An European Association of Urology Guidelines systematic review (2018) (2)
- Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study. (2017) (2)
- Comparison of partial vs. radical nephrectomy effect on other cause mortality, cancer specific mortality and 30-day mortality in patients older than 75 years (2018) (2)
- Feasibility and Safety of Robotic Distal Ureterectomy (2013) (2)
- Association between CYP17A1 polymorphisms and response to abiraterone in patients with metastatic castration-resistant prostate cancer: a systematic review (2018) (2)
- Urological adverse drug reactions of psychotropic medication in psychiatric inpatients - A drug surveillance report from German-speaking countries. (2021) (2)
- The T309G murine double minute 2 gene polymorphism is an independent prognostic factor for patients with renal cell carcinoma. (2015) (2)
- Combination Therapy in Metastatic Renal Cell Carcinoma (2011) (1)
- The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. (2017) (1)
- ANDROGEN DEPRIVATION THERAPY DOES NOT PREDISPOSE TO OSTEOPENIA IN PROSTATE CANCER PATIENTS (2008) (1)
- Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab. (2022) (1)
- PREDICTIVE VALUE OF THE COMBINATION OF IMMUNOHISTOCHEMICAL MARKERS IN PATIENTS WITH PT1 DISEASE AT RADICAL CYSTECTOMY (2009) (1)
- 841 A SYSTEMATIC ANALYSIS OF THE DETRIMENTAL EFFECT OF ORCHIECTOMY ON 12 SYSTEMIC MORBIDITIES (2009) (1)
- PD41-10 ROBOTIC RADICAL CYSTECTOMY IS ASSOCIATED WITH SHORTER LENGTH OF STAY AND LESS BLOOD LOSS THAN OPEN RADICAL CYSTECTOMY: RESULTS FROM A LARGE MULTICENTER RETROSPECTIVE COHORT (2018) (1)
- Use of immunocytology to predict bladder cancer presence in patients with asymptomatic hematuria. (2011) (1)
- Does low-risk prostate cancer detection change with repeat biopsies? (2012) (1)
- PD13-01 COMPARATIVE EFFECTIVENESS OF INTRAVESICAL BCG-TICE AND BCG-MOREAU IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (2019) (1)
- Prospective evaluation of the performance of 68Ga-PSMA 11-PET CT/MRI imaging for lymph node staging in patients with biochemical recurrence after radical prostatectomy (2018) (1)
- External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population‐based Study (2017) (1)
- Feasibility and Optimal Time Point of [68Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of (2022) (1)
- [Rhabdomyosarcoma. Presentation of 67 cases]. (1976) (1)
- 1230: Evidence Based Gender Related Outcomes after Radical Cystectomy (2006) (1)
- Radical prostatectomy versus radiotherapy in M1a and low volume M1b prostate cancer patients: an indirect comparison with the STAMPEDE trial arm H (2020) (1)
- Prognostic impact of variant histologies in urothelial bladder cancer treated by radical cystectomy. (2023) (1)
- Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum. (2022) (1)
- PD35-12 PREOPERATIVE FACTORS ASSOCIATED WITH COMPLICATIONS FOLLOWING RADICAL NEPHROURETERECTOMY (2014) (1)
- DISCREPANCY BETWEEN CLINICAL AND PATHOLOGICAL STAGE: IMPACT ON PROGNOSIS FOLLOWING RADICAL CYSTECTOMY (2006) (1)
- 741 TIME TO RECURRENCE IS A SIGNIFICANT PREDICTOR OF CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RECURRENT RENAL CELL CARCINOMA - RESULTS FROM A COMPREHENSIVE MULTI-CENTER DATABASE (CORONA/SATURN-PROJECT) (2013) (1)
- Update on Flat and Papillary Urothelial Lesions: Genitourinary Pathology Society Consensus Recommendations. (2022) (1)
- Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer (2022) (1)
- Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations. (2016) (1)
- 1252: Impact of Concomitant Carcinoma in situ on Clinical Outcomes after Radical Cystectomy (2006) (1)
- Therapeutic management of Bacillus Calmette–Guerin refractory patients: a narrative review (2020) (1)
- Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer (2022) (1)
- [Biopsy techniques in the upper urinary tract for the diagnosis of urothelial carcinoma: systematic review]. (2019) (1)
- 350 OUTCOMES OF OPEN VERSUS ROBOTIC-ASSISTED RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A MULTI-INSTITUTION STUDY ON 13,567 MEN (2011) (1)
- Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinoma. (2020) (1)
- 199 CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH CLINICAL CARCINOMA IN SITU ONLY TREATED WITH RADICAL CYSTECTOMY: AN INTERNATIONAL STUDY OF 243 PATIENTS (2010) (1)
- 1023: The Role of Digital Rectal Examination in Prediction of Pathological Stage After Radical Prostatectomy in Contemporary Patients (2007) (1)
- Selection and evaluation of preoperative systemic inflammatory response biomarkers model prior to cytoreductive nephrectomy using a machine-learning approach (2021) (1)
- PROPOSAL FOR SUBCLASSIFICATION OF PT3 UROTHELIAL CANCER OF THE RENAL PELVIS (2009) (1)
- Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy. (2019) (1)
- Contemporary concepts and controversies in the diagnosis and management of urothelial carcinoma (2016) (1)
- IMPACT OF PREVIOUS RADIOTHERAPY FOR PROSTATE CANCER ON CLINICAL OUTCOMES OF BLADDER CANCER PATIENTS (2009) (1)
- Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration‐resistant prostate cancer (2021) (1)
- 1433: Association of Blood Levels of Components of the Urokinase System of Plasminogen Activation with Prostate Cancer Presence, Invasion, Progression, and Metastasis (2007) (1)
- Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity? (2022) (1)
- MP44-17 THE SIGNIFICANCE OF SYMPTOMATOLOGY: ANALYSIS FROM THE INTERNATIONAL RENAL CELL CARCINOMA-VENOUS THROMBUS CONSORTIUM (IRCC-VTC) (2015) (1)
- 650 COMPARATIVE OUTCOME ANALYSIS OF OPEN VERSUS ROBOTIC-ASSISTED RADICAL PROSTATECTOMY MATCHED BY D'AMICO RISK CATEGORY (2011) (1)
- MP53-16 THE MORE YOU SEE, THE MORE YOU MISS: ASSOCIATION BETWEEN PI-RADS SCORE OF THE INDEX LESION AND MULTI-FOCAL, CLINICALLY SIGNIFICANT PROSTATE CANCER (2018) (1)
- Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis (2020) (1)
- Reply to the Letter to the Editor from Fromont (2009) (1)
- The introduction of a surgical checklist for the transurethral resection of the bladder improves recurrence-free survival in non-muscle invasive bladder cancer patients (2018) (1)
- Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review (2021) (1)
- V12-03 SAFETY AND SHORT-TERM ONCOLOGICAL OUTCOMES OF THULIUM FIBER LASER EN-BLOC RESECTION OF NON-MUSCLE-INVASIVE BLADDER CANCER: A PROSPECTIVE NON-RANDOMIZED PHASE II TRIAL (2020) (1)
- 1844 ACCURACY OF THE CHARLSON COMORBIDITY INDEX (CCI) IN PREDICTING IN-HOSPITAL MORTALITY (IHM) IN PATIENTS TREATED WITH RADICAL CYSTECTOMY (RC) (2011) (1)
- Cytoreductive Radical Prostatectomy for Metastatic Hormone-sensitive Prostate Cancer-Evidence from Recent Prospective Reports. (2023) (1)
- 1661: Comparison of %FPSA, %BPSA, [-2]PPSA/FPSA, and [- 2]PPSA/BPSA for Prostate Cancer Detection in men With total Serum PSA Concentrations Between 4 and 10 NG/NL (2004) (1)
- 876 Comparative analyses of surgical modalities for the management of prostate cancer: A multi-institutional study of positive surgical margin rates on 22,403 patients operated on in the new millennium (2012) (1)
- 1427 IMPACT OF STATIN USE ON ONCOLOGICAL OUTCOMES OF PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER TREATED WITH RADICAL CYSTECTOMY (2013) (1)
- An up-to-date catalogue of urinary markers for the management of prostate cancer. (2020) (1)
- Sequential intravesical gemcitabine and docetaxel therapy in patients with nonmuscle invasive bladder cancer: a systematic review and meta-analysis (2022) (1)
- 1116: A Prognostic Tool to Identify Patients at High Risk of Relapse at 2, 5 and 8 Years after Cystectomy for Transitional Cell Carcinoma (TCC) of the Urinary Bladder: Nomogram Development and Internal Validation (2005) (1)
- 14 Radical nephroureterectomy versus endoscopic procedures for the treatment of upper urinary tract urothelial carcinoma: A meta-analysis of comparative studies (2014) (1)
- 765 THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER (2011) (1)
- Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations (2022) (1)
- 1977 TRENDS IN UTILIZATION AND OUTCOMES FOR PERCUTANEOUS NEPHROLITHOTOMY IN THE UNITED STATES (2013) (1)
- Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria (2021) (1)
- Author ' s Accepted Manuscript Prospective External Validation of Model for Bladder Cancer Detection (2014) (1)
- Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis. (2022) (1)
- Prognostic models to help predict patient responses to intravesical immunotherapy (2020) (1)
- Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer. (2022) (1)
- 670 HIGH RATES OF ADVANCED DISEASE, COMPLICATIONS, AND DECLINE OF RENAL FUNCTION AFTER RADICAL NEPHROURETERECTOMY: FURTHER EVIDENCE TO SUPPORT THE INCREASED USE OF NEOADJUVANT CHEMOTHERAPY? (2011) (1)
- Neoadjuvant therapy in urothelial cancer (2019) (1)
- Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates (2022) (1)
- Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer. (2021) (1)
- Bladder Cancer: Upper Tract TCC IMP2-06 MULTI-INSTITUTIONAL VALIDATION OF THE PREDICTIVE VALUE OF KI-67 IN PATIENTS WITH HIGH-GRADE UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT (2015) (1)
- Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity. (2022) (1)
- COMPETING RISKS NOMOGRAM PREDICTING THE PROBABILITY OF BLADDER CANCER RECURRENCE AFTER CYSTECTOMY CAN RELIABLY DISTINGUISH BETWEEN TUMOURS DESTINED TO RECUR AND PATIENTS WHO MAY DIE OF OTHER CAUSES BEFORE RECURRENCE (2006) (1)
- Surgical checklist adherence across urology expertise levels impacts TURBT quality indicators. (2022) (1)
- Oncology: Adrenal/Renal/Upper Tract/Bladder Preoperative Multivariable Prognostic Model for Prediction of Nonorgan Confined Urothelial Carcinoma of the Upper Urinary Tract (2010) (1)
- Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysis. (2021) (1)
- 194 COMPLICATIONS OF THE LAPAROSCOPIC VS. THE OPEN TECHNIQUES IN PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA (RCC) TREATED WITH PARTIAL OR RADICAL NEPHRECTOMY: A POPULATION-BASED ANALYSIS OF THE UNITED STATES (2011) (1)
- Editorial comment on: Prostate growth and prevalence of prostate diseases in early onset spinal cord injuries. (2009) (1)
- Radical Nephrectomy After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma. (2023) (1)
- Words of wisdom: Re: Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group trial. (2013) (1)
- Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis (2022) (1)
- Association of Negative Follow-Up Biopsy and Reclassification during Active Surveillance of Prostate Cancer: A Systematic Review and meta-Analysis. (2021) (1)
- IS THERE AN AGE LIMIT FOR THE INDICATION OF EXTENDED PELVIC LYMPH NODE DISSECTION DURING RADICAL PROSTATECTOMY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER?: MP64‐10 (2017) (1)
- 813 Time to disease recurrence is a strong predictor of cancer-specific mortality in upper tract urothelial carcinoma (2013) (1)
- Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort. (2023) (1)
- THE PERFORMANCE OF PSA, PSAD, AND TRANSITION ZONE PSAD IN 210 PATIENTS EVALUATED BY A SINGLE EXAMINER (1999) (1)
- Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method (2021) (1)
- Gender differences in acute stone admissions – should we have a lower threshold for treatment in female patients? (2021) (1)
- Lower Urinary Tract Symptoms (LUTS) (2016) (1)
- 1830 IMPACT OF HISTOLOGIC SUBTYPE ON TUMOR THROMBUS LEVEL AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND VENA CAVA THROMBUS (2013) (1)
- Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, non-invasive bladder tumors in 2019? (2019) (1)
- MP30-13 IMPACT OF MICROSCOPIC VEIN INVASION ON CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND TUMOR THROMBUS (2014) (1)
- MP55-08 PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN A MULTICENTRE COHORT OF PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER. (2014) (1)
- Peri-operative mortality and long-term survival after partial versus radical cystectomy for muscle invasive bladder cancer (2015) (1)
- 1511: Outcomes of Patients with Clinical T1 Grade 3 Bladder Urothelial Cell Bladder Carcinoma Treated with Radical Cystectomy (2007) (1)
- The importance of negative baseline multiparametric MRI to reduce the rate of early reclassification in low-risk prostate cancer patients managed with active surveillance (2018) (1)
- 118 REMOVAL OF AT LEAST 8 NODES IMPROVES BOTH STAGING AND OUTCOMES IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (2009) (1)
- 262: Nomograms for Bladder Cancer Recurrence According to Grade and Stage (2004) (1)
- Editorial comment on: Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy. (2009) (1)
- 540 PARTIAL NEPHRECTOMY VERSUS RADICAL NEPHRECTOMY FOR NON-METASTATIC RENAL CELL CARCINOMA: UTILIZATION TRENDS IN THE UNITED STATES (2011) (1)
- Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas (2020) (1)
- 845: Urinary Levels of Tumor-Associated Trypsin Inhibitor (TATI) in the Detection of Transitional Cell Carcinoma of the Urinary Bladder (2005) (1)
- Evaluation of sarcopenia in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A study from the Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology (2019) (1)
- Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group. (2022) (1)
- Evaluation of the Guidelines for Penile Cancer Treatment: Overview and Assessment (2021) (1)
- 299 ANDROGEN RECEPTOR (AR) AND BLADDER CANCER: A LARGE BI-INSTITUTIONAL STUDY ON 473 PATIENTS (2009) (1)
- Optimal results come from optimal surgery and optimal (neoadjuvant) systemic therapy (2014) (1)
- 892: Persistent Uroplakin Expression in Advanced Urothelial Carcinomas: Implications in Clinical Outcome (2007) (1)
- IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time. (2022) (1)
- Prognostic performance and reproducibility of the 1973 and 2004/2016 WHO grading classification systems in non-muscle-invasive bladder cancer: A European Association of Urology non-muscle invasive bladder cancer guidelines panel systematic review (2018) (1)
- PD40-07 CLINICAL OUTCOMES AND ADVERSE EVENTS AFTER FIRST-LINE TREATMENT IN METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (2021) (1)
- 301: Pelvic Lymph Nodes as a Prognostic Factor in Patients Undergoing Radical Cystectomy for Invasive Transitional Cell Carcinoma: A Multicenter Study (2004) (1)
- Prognostic value of PD-1 and PD-L1 expression in patients with high-grade urothelial carcinoma of the upper urinary tract. (2017) (1)
- Influence of preoperatively detected circulating tumor cells on the outcome of patients with urothelial carcinoma of the bladder treated with radical cystectomy. (2012) (1)
- PI-07 A TRANSPLANT-BASED SURGICAL APPROACH MAY IMPROVE POSTOPERATIVE COMPLICATIONS IN CASES OF RENAL CELL CARCINOMA AND TUMOR THROMBUS (2015) (1)
- MP22-07 BLADDER CANCER SCREENING: USE OF THE PLCO AND NLST TO IDENTIFY A SUITABLE SCREENING COHORT (2014) (1)
- Brief update of the new WHO classification for urothelial carcinoma (2022) (1)
- There Are Cooler Ways to Die Than Smoking: Urologists of the World, Unite Against This Health Care Tragedy. (2015) (1)
- Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival. (2022) (1)
- En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis. (2023) (1)
- The Future of Prostate Cancer Diagnosis: Biomarkers, Biopsy, Both, or Neither? (2015) (1)
- Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics (2022) (1)
- Frequent truncating mutations of the cohesin complex gene STAG2 in urothelial carcinoma of the bladder. (2014) (1)
- How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder? (2019) (1)
- Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables (2022) (1)
- Contemporary trends and survival outcomes after aborted radical prostatectomy in lymph node metastatic prostate cancer patients (2018) (1)
- 1008 PARTIAL CYSTECTOMY DOES NOT UNDERMINE CANCER CONTROL IN APPROPRIATELY SELECTED PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER: A POPULATION-BASED MATCHED ANALYSIS (2009) (1)
- Urothelial carcinoma (2011) (1)
- 1238 IMMUNOCYTOLOGY IS A STRONG PREDICTOR OF BLADDER CANCER PRESENCE IN PATIENTS WITH ASYMPTOMATIC HEMATURIA (2011) (1)
- Radical cystectomy in non-metastatic sarcomatoid bladder cancer: A direct comparison vs urothelial bladder cancer. (2022) (1)
- MRI as a screening tool for prostate cancer: current evidence and future challenges (2022) (1)
- Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond (2022) (1)
- The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 national comprehensive cancer network practice guidelines for bladder cancer treatment (2011) (1)
- MULTIPLE BIO-MARKERS FOR THE PREDICTION OF BLADDER CANCER RECURRENCE AND MORTALITY (2008) (1)
- 1155 EXPRESSION OF CYCLOOXYGENASE-2 IN SQUAMOUS CELL CARCINOMA OF THE URINARY BLADDER (2010) (1)
- 667 LYMPH NODE DISSECTION IS PERFORMED LESS FREQUENTLY IN PATIENTS TREATED WITH LAPAROSCOPIC VS. OPEN NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: A POPULATION-BASED STUDY (2011) (1)
- PREOPERATIVE PLASMA IGF-1 LEVELS DO NOT CORRELATE WITH FINAL PATHOLOGIC STAGE OR PROGRESSION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY (1999) (1)
- The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis (2022) (1)
- Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients (2021) (1)
- Association of statins use and mortality outcomes in prostate cancer patients who received androgen deprivation therapy: a systematic review and meta-analysis (2021) (1)
- 1400 EXPRESSION OF CELL CYCLE-RELATED MOLECULAR MARKERS IN PATIENTS TREATED WITH RADICAL CYSTECTOMY FOR SQUAMOUS CELL CARCINOMA OF THE BLADDER (2011) (1)
- 573 Prediction of intravesical recurrence after radical nephroureterectomy: Development of a clinical decision-making tool (2013) (1)
- pT3N0 PROSTATE CANCER PATIENTS WITH RT-PCR-hK2-L-POSITIVE LYMPH NODES ARE AT HIGHER RISK FOR RECURRENCE (1999) (1)
- 332 A systematic review and meta-analysis of clinicopathologic factors linked with intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma (2015) (1)
- Reducing Complications After Surgery: Still a Long Way To Go. (2016) (1)
- Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer (2022) (1)
- Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES–UTUC registry (2022) (1)
- Expression Analysis and Mutational Status of Histone Methyltransferase KMT2D at Different Upper Tract Urothelial Carcinoma Locations (2021) (1)
- MP7-01 PREOPERATIVE NOMOGRAM TO PREDICT PERIOPERATIVE COMPLICATIONS AFTER RADICAL NEPHROURETERECTOMY (2015) (1)
- Re: Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer (2009) (1)
- 792 COMPARISON BETWEEN COMPLICATION RATES LENGTH OF STAY AND COSTS OF MINIMAL INVASIVE VS. OPEN RADICAL PROSTATECTOMY (2010) (1)
- MP87-13 IMPACT OF PRE-TREATMENT PSA LEVEL ON CANCER CONTROL AFTER EARLY SALVAGE RADIATION THERAPY POST RADICAL PROSTATECTOMY: NEED FOR PATIENT STRATIFICATION ACCORDING TO PROSTATE CANCER FEATURES (2015) (1)
- PERIRENAL HEMATOMA SIZE IS PREDICTIVE OF NEED FOR ANGIOGRAPHIC EMBOLIZATION AFTER RENAL INJURY (2008) (1)
- Contemporary analysis of the effect of marital status on survival in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: A population-based study. (2021) (1)
- Blood-Based Tumor Markers for Prostate Cancer (2013) (1)
- 302: Lymphovascular Invasion Independently Predicts Increased Risk of Distant Recurrence and Decreased Overall Survival in Patients with Transitional Cell Carcinoma (TCC) (2004) (1)
- Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis (2022) (1)
- Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies (2021) (1)
- Incorporating biomarker research in a real-world setting: challenges of a prophecy. (2014) (1)
- [Knowledge of German-speaking urologists regarding the association between penile cancer and human papilloma virus: results of a survey of the European PROspective Penile Cancer Study (E-PROPS)]. (2019) (1)
- Nephroureterectomy at Memorial Sloan-Kettering Cancer Center (2010) (1)
- DENSE DOSE MVAC VERSUS GC IN PATIENTS WITH CT3‐4A BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A REAL WORLD EXPERIENCE: MP58‐04 (2017) (1)
- Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma. (2022) (1)
- Volume outcome relationship in penile cancer: a systematic review. (2020) (1)
- A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder Cancer. (2022) (1)
- 1415 LOSS OF SPINK1 EXPRESSION IN UROTHELIAL CARCINOMA OF THE BLADDER IS ASSOCIATED WITH UNFAVORABLE OUTCOME AFTER RADICAL CYSTECTOMY (2012) (1)
- Does low-risk prostate cancer detection change with repeat biopsies? (2012) (1)
- [Palliative surgery for metastatic urothelial cancer]. (2018) (1)
- PD07-06 COMPARISON OF PARTIAL VS. RADICAL NEPHRECTOMY EFFECT ON OTHER CAUSE MORTALITY, CANCER SPECIFIC MORTALITY AND 30-DAY MORTALITY IN PATIENTS OLDER THAN 75 YEARS (2018) (1)
- 38 LYMPHOVASCULAR INVASION IS A PATHOLOGIC FEATURE OF BIOLOGICALLY AGGRESSIVE DISEASE IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT: AN INTERNATIONAL EXTERNAL VALIDATION STUDY (2010) (1)
- Association between male infertility and prostate cancer: a systematic review and meta-analysis (2021) (1)
- Staging primary prostate cancer with 68Ga-PSMA HBED-CC/[18F]Fluorocholine-PET/MRI (2016) (1)
- Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core. (2022) (1)
- MP69-10 GLYCATED HEMOGLOBIN (HBA1C) LEVELS ARE INDEPENDENTLY ASSOCIATED WITH UNFAVOURABLE PROSTATE CANCER AND DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY (2014) (1)
- Impact of Adjuvant Radiotherapy on Survival of Patients with Pathological High-Risk Muscle Invasive Bladder Cancer: A Propensity Scored Match Paired Analysis (2019) (1)
- 33 VALIDATION OF THE AJCC TNM SUBSTAGING OF PT2 BLADDER CANCER: DEEP MUSCLE INVASION IS ASSOCIATED WITH SIGNIFICANTLY WORSE OUTCOME (2010) (1)
- 1378: Are Patients who are PT0 Following Radical Cystectomy Cured of Bladder Cancer? Results from the Bladder Cancer Research Consortium (BCRC) (2005) (1)
- Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literature (2021) (1)
- 481 ROBOTIC RADICAL CYSTECTOMY IS FEASIBLE AND SAFE IN THE TREATMENT OF ADEQUATELY SELECTED OCTOGENARIANS (2011) (1)
- Assays for Prostate Cancer (2013) (1)
- MP72-01 RADICAL CYSTECTOMY VERSUS BLADDER-SPARING TREATMENT FOR PATIENTS WITH MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE URINARY BLADDER: A COMPARATIVE EFFECTIVENESS POPULATION-BASED STUDY. (2015) (1)
- Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta‐analysis (2022) (1)
- Biopsietechniken im oberen Harntrakt zur Diagnostik des Urothelkarzinoms: systematische Übersicht (2019) (1)
- Effect of African-American race on cancer specific mortality differs according to clear-cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma (2018) (1)
- Collecting duct carcinoma: Epidemiology, clinical characteristics and survival. (2022) (1)
- Adult Urology Survivin Expression in Patients with Non- Muscle-Invasive Urothelial Cell Carcinoma of the Bladder (2007) (1)
- The Impact of Surgical Waiting Time on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: A Systematic Review (2022) (1)
- Incidence and risk factors for venous thromboembolism after transurethral resection of bladder tumor: A population-based analysis (2017) (1)
- Konfidenzintervalle und p-Werte in der Urologie (2013) (1)
- Cholecystectomy following gallstone pancreatitis: early surgery should be advocated nationwide (2014) (1)
- Words of wisdom. Re: Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Escudier B, Pluzanska A, Koralewski P, et al., for the AVOREN Trial investigators. (2008) (1)
- O9 TREATMENT OF ADVANCED STAGE BLADDER AND UPPER URINARY TRACT CANCERThursday, 27 March, 15.45-17.15, Gold HallMORE EXTENSIVE LYMPHADENECTOMY IMPROVES THE PROGNOSIS OF PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA WITHOUT NODAL METASTASES (2008) (1)
- PD60-10 IMPACT OF PREOPERATIVE CONTROLLING NUTRITIONAL STATUS (CONUT) SCORE ON PERIOPERATIVE MORBIDITY AND SURVIVAL OUTCOMES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A MULTICENTER ANALYSIS (2020) (1)
- The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer (2022) (1)
- 1532: Serum BPSA is A Better Predictor of Prostate Enlargement than Either Total PSA or Free PSA in Men without Prostate Cancer (2004) (1)
- Staging performance and clinical impact of 68Ga-PSMA 11 ligand PET/MRI for primary diagnosed prostate cancer (2018) (1)
- Urothelial Carcinoma In Situ and Treatment of Bacillus Calmette-Guérin Failures (2018) (1)
- Cancer Spectrum, Family History of Cancer and Overall Survival in Men with Germline BRCA1 or BRCA2 Mutations (2021) (1)
- ADJUVANT VERSUS EARLY SALVAGE RADIATION THERAPY IN NODE POSITIVE PROSTATE CANCER PATIENTS: A LONG‐TERM SURVIVAL ANALYSIS: PD72‐06 (2017) (1)
- Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials. (2021) (1)
- Comparison between small renal masses 0–2cm vs. 2.1–4 cm in size: a population-based study (2020) (1)
- 247 PT3 SUBSTAGING IS A PROGNOSTIC INDICATOR IN LYMPH NODE NEGATIVE UROTHELIAL CARCINOMA OF THE BLADDER (2011) (1)
- Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram (2018) (1)
- 106 Serum MMP-7, sFas and FasL levels in predicting therapy resistance and survival in castration-resistant prostate cancer patients treated with docetaxel (2014) (1)
- Risikomodell für krebsspezifisches Überleben nach radikaler Zystektomie (2016) (0)
- What doses are our patients receiving? The radiation dose associated with CT, RIRS and PCNL (2018) (0)
- Does Anterior Suspension Stitch improve early continence in Robotic assisted radical prostatectomy (RARP)? – A single surgeon Series (2018) (0)
- Concordance of clinical T stage as reported on multi-parametric magnetic resonance imaging to final pathological staging of radical prostatectomy specimen (2018) (0)
- 19. Parathyroidectomy in Pregnancy: A single centre 10-year experience (2015) (0)
- Short-term functional outcomes in severely obese patients (BMI >35 kg/m2) undergoing robotic assisted radical prostatectomy (2022) (0)
- Acute stone admissions – should we have a lower threshold for treatment in female patients (2019) (0)
- The diagnosis and management of men with low sperm motility (2019) (0)
- Is mp MRI enough (IMRIE) in prostate cancer diagnosis? (2019) (0)
- Optimising exposure in a tertiary referral robotic urological surgical centre: A template for successful fellowships (2018) (0)
- What is the negative predictive value of mpMRI in excluding significant prostate cancer at biopsy? Results from a robotic cancer centre (2018) (0)
- Systematic review and meta-analysis of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma (2018) (0)
- Words of wisdom. Re: Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V. (2009) (0)
- 904 DIAGNOSIS AND TREATMENT OF PROSTATE CANCER WITH RADICAL PROSTATECTOMY AT AN EARLIER AGE DOES NOT AFFECT THE PATHOLOGICAL STAGE (2007) (0)
- Pattern of positive node metastases in patients treated with extended and super extended pelvic lymph node dissection and radical cystectomy due to bladder cancer (2017) (0)
- 533 Impact on post-operative survival of the status of distal ureteral margin. Is it necessary to achieve a negative margins at the time of radical cystectomy? (2015) (0)
- 421 UPPER URINARY TRACT UROTHELICAL CARCINOMA WITH LOCOREGIONAL NODAL METASTASES: EXPERIENCE WITH AGGRESSIVE INTEGRATION OF SYSTEMIC THERAPY FOLLOWED BY RADICAL NEPHROURETERECTOMY (2010) (0)
- Oncologic outcomes in patients with residual invasive upper tract urothelial carcinoma following neoadjuvant chemotherapy. (2023) (0)
- MP59-18 COMPREHENSIVE ASSESSMENT OF CONTEMPORARY SHORT-, INTERMEDIATE-, AND LONG-TERM ENDPOINTS AFTER EITHER PARTIAL NEPHRECTOMY OR MINIMALLY-INVASIVE RADICAL NEPHRECTOMY (2015) (0)
- Assessing the optimal timing of salvage radiation therapy administration after radical prostatectomy: a stage-specific analysis from a large multi-institutional series (2020) (0)
- 1982 NODAL YIELD IS NOT INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITHOUT NODAL METASTASIS AT RADICAL CYSTECTOMY (2011) (0)
- Comprehensive molecular dissection of multi-focal prostate cancer and concomitant lymph node metastasis: Implications for tissue based prognostic biomarkers (2017) (0)
- 105 Comparison of long-term renal function outcomes after either partial or radical nephrectomy (2015) (0)
- Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages (2023) (0)
- 1678 PARTIAL NEPHRECTOMY IS NOT ASSOCIATED WITH AN OTHER-CAUSE MORTALITY BENEFIT IN PATIENTS AGED ≥75 YEARS AND/OR MULTIPLE COMORBIDITIES WITH SMALL RENAL MASSES (2012) (0)
- Abstract B21: PTRF promotes cell survival and predicts disease progression in upper tract urothelial carcinoma (2020) (0)
- RACE SPECIFIC DIFFERENCES IN HISTOPATHOLOGY OF PROSTATE CANCER IN AN EQUAL ACCESS HEALTH CARE SYSTEM (1999) (0)
- AN ASSESSMENT OF THE MOST SIGNIFICANT DETERMINANTS OF THE NATURAL HISTORY OF UPPER TRACT TRANSITIONAL CELL CARCINOMA AFTER NEPHROURETERECTOMY: A MULTI-INSTITUTIONAL RECURSIVE PARTITIONING MODEL (2009) (0)
- Evidence‐Based Urology (2011) (0)
- MP14-08 LONG-TERM IMPACT OF ADJUVANT VERSUS EARLY SALVAGE RADIATION THERAPY ON CLINICAL RECURRENCE IN PT3N0 PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS (2016) (0)
- PD16-04 RADICAL PROSTATECTOMY VERSUS RADIOTHERAPY IN M1A AND LOW VOLUME M1B PROSTATE CANCER PATIENTS: AN INDIRECT COMPARISON WITH THE STAMPEDE TRIAL ARM H (2020) (0)
- MP7-18 EXTERNAL VALIDATION OF TALL SCORE FOR PREDICTION OF ONCOLOGICAL OUTCOMES OF HIGH GRADE UPPER TRACT UROTHELIAL CARCINOMA AFTER RADICAL NEPHROURETERECTOMY (2015) (0)
- PD60-04 SURVIVAL AFTER RADICAL PROSTATECTOMY VS. RADIATION THERAPY IN CLINICAL NODE-POSITIVE PROSTATE CANCER (2022) (0)
- Selective cytology in detection of high grade upper urinary tract urothelial cancer: A systematic review and meta-analysis (2019) (0)
- 124 External validation of the pathological nodal staging score in bladder cancer: A population-based study (2014) (0)
- 456 Patterns of clinical recurrence and impact of site of metastasis on mortality of patients with node positive prostate cancer after radical prostatectomy and extended pelvic lymph node dissection (2015) (0)
- Bladder cancer: the curious case of a not so rare disease. (2014) (0)
- Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities (2023) (0)
- Re: Enzalutamide and Survival in Nonmetastatic Castration-Resistant Prostate Cancer. (2020) (0)
- Association between inflammatory potential in diet and bladder cancer risk: Results from three US prospective cohort studies (2018) (0)
- 944 RISK AND PREDICTORS OF FRACTURES AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION (2010) (0)
- MP17-07 INCREASING RATE OF NON-INTERVENTIONAL TREATMENT MANAGEMENT IN LOCALIZED PROSTATE CANCER CANDIDATES FOR ACTIVE SURVEILLANCE (2018) (0)
- PD58-10 IMPLEMENTING THE FOLLOW-UP SCHEDULE AFTER RADICAL NEPHROURETRECTOMY FOR LOW RISK UPPER TRACT UROTHELIAL CARCINOMA (2022) (0)
- Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries (2022) (0)
- MP57-04 ASSOCIATION BETWEEN FAMILY HISTORY AND ONCOLOGIC OUTCOMES AFTER RADICAL PROSTATECTOMY FOR CLINICALLY NONMETASTATIC PROSTATE CANCER (2022) (0)
- Prognostic differences in patients with T1a renal cell carcinoma according to clinical size (2020) (0)
- Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines. (2022) (0)
- PD63-11 RADICAL SALVAGE PROSTATECTOMY (RSP) FOR RADIORECURRENT PROSTATE CANCER (RPCA): ONOLOGICAL AND FUNCTIONAL OUTCOME OF A LARGE CONTEMPORARY SERIES (2020) (0)
- Recurrence and progression according to stage at re-TUR in t1g3 bladder cancer patients treated with BCG: Not as bad as previously thought (2017) (0)
- Increasing trend of non-interventional treatment management in patients candidate to active surveillance with localized prostate cancer (2018) (0)
- 271 Lymph nodes in prostate cancer patients treated with radical prostatectomy: Oncological outcomes of patients with positive nodes and complications of an extended pelvic lymphadenectomy with robotic assisted approach: Results from a single tertiary care center (2014) (0)
- – Urothelial Cancer Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma : A Systematic Review by the European Association of Urology Guidelines Panel on Non – muscle-invasive Bladder Cancer (2017) (0)
- Reply by Authors. (2021) (0)
- Reply by Authors. (2020) (0)
- 686 THE RATE OF TRANSFUSIONS, COMPLICATIONS, LENGTH OF STAY, AND IN-HOSPITAL MORTALITY IN PATIENTS TREATED WITH CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA PATIENTS (2011) (0)
- Effect of race on prostate cancer survival The effect of race on survival after local therapy in metastatic prostate cancer patients (2018) (0)
- Integrated Systems and Technologies Metabolomic Pro fi ling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression (2011) (0)
- A Review of How Lasers Are Used in UTUC Surgery: Can the Choice of Laser Affect Outcomes? (2023) (0)
- 250 THE ADDED VALUE OF DIFFERENT NODAL CODING SCHEMES IN BLADDER CANCER PATIENTS FOLLOWING RADICAL CYSTECTOMY (RC): A POPULATION-BASED ANALYSIS (2011) (0)
- 426 DISPARITIES IN THE UTILIZATION OF PARTIAL NEPHRECTOMY IN THE UNITED STATES A CASE FOR CONCERN (2012) (0)
- Evaluation of a panel of preoperative blood-based systemic inflammatory response biomarkers for outcome prediction in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma (2021) (0)
- 1671 COST-EFFECTIVENESS (CE) OF DIFFERENT MANAGEMENT STRATEGIES FOR LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER(NMIBC) (2012) (0)
- 170 Hypogonadism independently predicts pathological Gleason pattern 5 at the time of radical prostatectomy (2016) (0)
- Clinical Impact and Statistical Significance of Multiparametric Magnetic Resonance Imaging for Local Staging of Prostate Cancer. (2020) (0)
- 1716 HER-2 EXPRESSION STATUS PROVIDES INDEPENDENT PROGNOSTIC INFORMATION IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER (2010) (0)
- Comparison of salvage radiation therapy delivered for PSA persistence versus PSA relapse after radical prostatectomy: How is the outcome changing? (2021) (0)
- Comprehensive molecular profiling of multi-focal prostate cancer and concomitant lymph node metastasis: Implications for tissue-based prognostic biomarkers. (2017) (0)
- 1032 VALIDATION OF RESIDUAL PATHOLOGIC STAGE AT RADICAL CYSTECTOMY AS A PROGNOSTIC FACTOR IN PATIENTS WITH CT2N0 BLADDER CANCER (2010) (0)
- 721 IT'S THE WEEKEND! INCREASED MORTALITY IN METASTATIC PROSTATE CANCER PATIENTS VISITING THE EMERGENCY DEPARTMENT IN THE WEEKEND VS. WEEKDAY (2013) (0)
- IMPACT OF INTRA‐ AND POST‐OPERATIVE BLOOD TRANSFUSION ON THE INCIDENCE, TIMING AND PATTERN OF DISEASE RECURRENCE AFTER RADICAL CYSTECTOMY: MP58‐11 (2017) (0)
- 754 Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non muscle-invasive urothelial carcinoma of the bladder (2013) (0)
- 926 EXPRESSION OF TUMOUR-ASSOCIATED TRYPSIN INHIBITOR (TATI) AND ITS CORRELATION WITH MOLECULAR MARKERS, PATHOLOGIC FEATURES AND CLINICAL OUTCOMES OF UROTHELIAL BLADDER CANCER (2010) (0)
- Clinical experience and critical evaluation of the role of everolimus in advanced renal cell carcinoma (2011) (0)
- 1483 THE RATES OF PARTIAL NEPHRECTOMY IN PATIENTS WITH SMALL RENAL MASSES ARE INCREASING: A POPULATION-BASED STUDY (2010) (0)
- Predictive models for improved prognostication and selection of neoadjuvant and adjuvant systemic chemotherapy in upper tract urothelial cell carcinoma. (2016) (0)
- Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy (2022) (0)
- UP-02.160 Prognostic Value of Insulin-like Growth Factor II mRNA Binding Protein 3 (IMP3) in Prostate Cancer (2011) (0)
- PD15-07 ASSESSING THE OPTIMAL EXTENT OF SALVAGE LYMPH NODE DISSECTION IN PATIENTS WITH SINGLE PELVIC NODAL UPTAKE AT [11C]-CHOLINE PET/CT SCAN FROM RECURRING PROSTATE CANCER (2014) (0)
- MP23-17 PROGNOSTIC AND PREDICTIVE VALUE OF PREOPERATIVE VASCULAR CELL ADHESION MOLECULE-1 PLASMA LEVELS IN UROTHELIAL CARCINOMA OF THE BLADDER TREATED WITH RADICAL CYSTECTOMY (2022) (0)
- Residual pathologic stage at radical cystectomy and risk stratification of patients with pT2N0 bladder cancer. (2009) (0)
- A preoperative nomogram to predict major complications after robot assisted partial nephrectomy (2019) (0)
- Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies (2019) (0)
- 24 THE EUROPEAN NETWORK FOR THE STUDY OF ADRENAL TUMORS STAGING SYSTEM IS PROGNOSTICALLY SUPERIOR TO THE INTERNATIONAL UNION AGAINST CANCER STAGING SYSTEM: A NORTH AMERICAN VALIDATION (2010) (0)
- The natural history of sarcomatoid renal-cell carcinoma, a stage-by-stage analysis (2021) (0)
- MP41-19 ADVERSE EVENTS OF THE SECOND-LINE TREATMENT STRATEGIES FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA OF THE BLADDER: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2021) (0)
- Bladder cancer: Is contrast-enhanced CT necessary for following up NMIBC? (2013) (0)
- MP28-12 MOLECULAR MARKERS (FGFR3 MUTATION; P53 & KI-67 EXPRESSION) AND CLINICAL OUTCOME OF RADICAL CYSTECTOMY FOR BLADDER CANCER: A MULTICENTER, MULTILAB STUDY (2014) (0)
- MP60-18 THE NUMBER OF TRANSURETHRAL RESECTIONS IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH MUSCLE- INVASIVE BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY (2014) (0)
- What is the best definition of biochemical response to salvage radiation therapy in prostate cancer patients treated for PSA rising after radical prostatectomy? Results from a multi-institutional series (2019) (0)
- PD27-08 PREDICTORS OF EARLY FAILURE AFTER TIMELY ADMINISTERED SALVAGE RADIOTHERAPY FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2014) (0)
- 1065 PREDICTORS OF ONCOLOGIC OUTCOMES AFTER SALVAGE RADICAL PROSTATECTOMY FOR RADIO-RECURRENT PROSTATE CANCER: A MULTI-INSTITUTIONAL COLLABORATION (2010) (0)
- 327 HER-2 EXPRESSION STATUS PROVIDES INDEPENDENT PROGNOSTIC INFORMATION IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER: A RATIONALE FOR TARGETED THERAPY (2010) (0)
- Comprehensive molecular profiling of multifocal prostate cancer challenges the robustness of prostate cancer prognostic signatures (2018) (0)
- 1400 CLINICAL NODAL STAGING SCORES FOR BLADDER CANCER A NEW PREOPERATIVELY NODAL ASSESSMENT TOOL (2012) (0)
- LBA02-08 RESULTS FROM THE EXTENDED FOLLOW-UP IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER IN THE CHeckMATE 274 TRIAL (2023) (0)
- Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer (2022) (0)
- 541 IS HOSPITAL VOLUME A DETERMINANT OF TYPE OF SURGERY, COMPLICATIONS, LENGTH OF STAY, AND IN-HOSPITAL MORTALITY IN NON-METASTATIC RENAL CELL CARCINOMA? (2011) (0)
- When should salvage radiation therapy be associated with concomitant hormonal therapy in patients affected by prostate cancer? The key role of PSA doubling time (2018) (0)
- Oncologic Impact of Cystoscopic Findings in Non-Muscle Invasive Bladder Cancer: A Meta-analysis. (2022) (0)
- 1401 THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER (2011) (0)
- Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. (2023) (0)
- 838 INCREASING RATES OF METASTATIC SEMINOMA AND NONSEMINOMA TESTICULAR CANCER: A CAUSE FOR CONCERN? (2010) (0)
- Comparison of survival outcomes between laparoscopic versus open radical nephroureterectomy in upper tract urothelial cancer patients: Experiences of a tertiary care single-center (2022) (0)
- PD34-02 THE KEY ROLE OF PSA DOUBLING TIME IN PATIENTS TREATED WITH SALVAGE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY: IMPLICATIONS FOR THE EXTENT OF RADIATION AND THE CONCOMITANT USE OF HORMONAL THERAPY (2021) (0)
- MP61-08 PROGRESSION OF T1 HIGH RISK INTO MUSCLE-INVASIVE BLADDER CANCER IS AN INDEPENDENT PROGNOSTIC FACTOR OF MORTALITY AFTER RADICAL CYSTECTOMY (2014) (0)
- Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration resistant prostate cancer (2019) (0)
- MP72-04 IMPACT OF THE SITE OF RECURRENCE AFTER RADICAL CYSTECTOMY ON SURVIVAL: DIFFERENT SITES FOR DIFFERENT OUTCOMES. (2015) (0)
- 912 High volume of lymph node invasion at radical prostatectomy: A proxy for systemic disease. Analyses on metastatic progression and patient survival (2015) (0)
- – Bladder Cancer Repeat Transurethral Resection in Non – muscle-invasive Bladder Cancer : A Systematic Review (2018) (0)
- 513 THE RATES OF METASTATIC RENAL CELL CARCINOMA ARE DECREASING OVER TIME: A POPULATION-BASED ANALYSIS (2010) (0)
- Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis (2022) (0)
- Inherited mutations in Chinese patients with upper tract urothelial carcinoma (2022) (0)
- 166 External validation of the pathological nodal staging score for prostate cancer in a contemporary cohort: A population-based study (2014) (0)
- MP18-13 VALIDATION OF EAU GUIDELINE’S PRETREATMENT RISK STRATIFICATION PARAMETERS IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC) (2018) (0)
- Prognostic factors and risk groups in T1G3 patients initially treated with BCG: Results of a multicenter retrospective series in 1743 patients (2013) (0)
- PD24-02 SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA PATIENTS: A POPULATION-BASED STUDY (2018) (0)
- Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly –An International Multicenter Study (2021) (0)
- Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification (2022) (0)
- 1981 TRENDS IN SURGERY FOR UPPER URINARY TRACT STONES IN THE UNITED STATES: 1999-2009 (2013) (0)
- Prediction o f R esponse t o S alvage R adiation T herapy i n Patients W ith P rostrate C ancer R ecurrence A fter R adical Prostatectomy (2001) (0)
- MP78-01 CONTEMPORARY MANAGEMENT OF PROSTATE CANCER PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: A POPULATION-BASED STUDY. (2015) (0)
- 21 Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma (2014) (0)
- The knowledge and practices of urologists in the United States (US) about standardization of PSA assays. (2011) (0)
- 724 Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma (2015) (0)
- PD40-04 EVALUATION OF A PANEL OF PREOPERATIVE BLOOD-BASED SYSTEMIC INFLAMMATORY RESPONSE BIOMARKERS FOR OUTCOME PREDICTION IN PATIENTS TREATED WITH CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA (2021) (0)
- 538 AGE IS AN IMPORTANT PREDICTOR OF CANCER-SPECIFIC SURVIVAL IN PATIENT WITH TRANSITIONAL CELL CARCINOMA AFTER RADICAL CYSTECTOMY (2009) (0)
- Prognostic impact of primary tumor location in advanced urothelial carcinoma: The EORTC series. (2017) (0)
- MP35-18 NEUTROPHIL TO LYMPHOCYTE RATIO IS ASSOCIATED WITH LYMPH NODE INVASION AND HIGHER NODAL BURDEN IN CONTEMPORARY HIGH RISK PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION (2018) (0)
- Does low-risk prostate cancer detection change with repeat biopsies? (2012) (0)
- MP54-16 IMMEDIATE RADICAL CYSTECTOMY VS. BCG IMMUNOTHERAPY FOR T1 HIGH GRADE NON-MUSCLE-INVASIVE BLADDER CANCER: AN INTERNATIONAL MULTICENTRE COLLABORATION (2022) (0)
- A CONDITIONAL NOMOGRAM FOR PREDICTION OF EARLY RECURRENCE OF BLADDER CANCER AFTER RADICAL CYSTECTOMY (2008) (0)
- PROGNOSTIC VALUE OF PD‐1 AND PD‐L1 EXPRESSION IN PATIENTS WITH HIGH‐GRADE UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT: MP71‐03 (2017) (0)
- Microbiome in Lower Urinary Tract Symptoms (LUTSs): Mapping the State of the Art with Bibliometric Analysis (2023) (0)
- Intravesical chemohyperthermia versus bacillus calmette-guerin instillation for intermediate- and high-risk non-muscle invasive bladder cancer: A systematic review and meta-analysis (2021) (0)
- PD55-08 SELECTING THE BEST CANDIDATES FOR CISPLATIN-BASED ADJUVANT CHEMOTHERAPY AFTER RADICAL CYSTECTOMY IN PN+ BLADDER CANCER PATIENTS (2021) (0)
- Impact of preoperative Controlling nutritional status (CONUT) score on perioperative morbidity and survival outcomes in patients with bladder cancer treated with radical cystectomy (2020) (0)
- MP22-03 LONG-TERM ONCOLOGIC OUTCOMES OF PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENCE OF PROSTATE CANCER: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES (2019) (0)
- MP15-19 CAN LOW RISK DISEASE OUTSIDE THE INDEX LESION BE LEFT UNTREATED IN MEN SUITABLE FOR FOCAL THERAPY? DEVELOPMENT OF NOVEL CRITERIA TO IDENTIFY POTENTIAL CANDIDATES FOR FOCAL THERAPY AMONG PATIENTS WITH INTERMEDIATE RISK PROSTATE CANCER AND POSITIVE MULTI-PARAMETRIC MRI (2022) (0)
- PROGNOSTIC SIGNIFICANCE OF BAP1 EXPRESSION IN UPPER TRACT UROTHELIAL CARCINOMA: MP71‐05 (2017) (0)
- 976 A multi-institutional study comparing biochemical recurrence rates on 20,614 patients operated on in the new millennium (2012) (0)
- Surgical management of locally advanced bladder cancer: Is radical cystectomy a valid option for clinical T4 bladder cancer? (2016) (0)
- 2217 HIGH DETECTION RATES OF SIGNIFICANT PROSTATE CANCER OCCUR WITH REPEAT BIOPSIES (2012) (0)
- Words of Wisdom. Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. (2016) (0)
- Molecular markers for screening, detection and prognosis of bladder cancer (2015) (0)
- MP28-20 PATHOLOGICAL VALIDATION OF ADJUVANT ANTI - FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR PERSONALIZED TREATMENT OF BLADDER CANCER (2014) (0)
- Perioperative allogenic blood transfusion in renal cell carcinoma: Risk factors and impact on long-term outcomes (2016) (0)
- Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling (2019) (0)
- The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: A network meta-analysis. (2023) (0)
- Assessing online crowdfunding for urologic cancer care using automated data extraction (2021) (0)
- MP77-02 INSULIN-LIKE GROWTH FACTOR MRNA-BINDING PROTEIN 3 (IMP3) EXPRESSION HELPS PROGNOSTICATION IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (2014) (0)
- Extended follow-up results from the CheckMate 274 trial. (2023) (0)
- MP14-09 DIFFERENTIAL RISK STRATIFICATION OF MEMORIAL SLOAN KETTERING CANCER CENTER (MSKCC) AND THE INTERNATIONAL METASTATIC RCC DATABASE CONSORTIUM (IMDC) PROGNOSTIC SCORE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) TREATED WITH TYROSINE-KINASE INHIBITORS (TKI) (2020) (0)
- 78 Impact of renal function on eligibility for chemotherapy and survival in patients who underwent radical nephroureterectomy (2013) (0)
- MP18-02 EFFICACY OF PREOPERATIVE CHEMOTHERAPY ON OUTCOMES OF HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA (UTUC) (2018) (0)
- Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity (2022) (0)
- Reply by Authors. (2020) (0)
- The impact of HER2 status on oncological outcomes of patients with invasive bladder cancer (2016) (0)
- PD57-12 THE IMPACT OF PERSISTENTLY ELEVATED PSA LEVELS ON PROGRESSION AND SURVIVAL OF PATIENTS UNDERGOING CYTOREDUCTIVE RADICAL PROSTATECTOMY FOR OLIGOMETASTATIC PROSTATE CANCER (2020) (0)
- Influence of preoperatively detected circulating tumor cells on the outcome of patients with urothelial carcinoma of the bladder treated with radical cystectomy. (2012) (0)
- MP48-12 ONCOLOGIC SURVEILLANCE FOR SURGICALLY-TREATED HIGH RISK UPPER TRACT UROTHELIAL CARCINOMA (2021) (0)
- MP32-17 CLINICAL RECURRENCE AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER, DEFINING OPTIMAL SURVEILLANCE AFTER SURGERY (2019) (0)
- PD30-03 PREDICTING UNFAVORABLE PROSTATE CANCER IN ACTIVE SURVEILLANCE CANDIDATES TREATED WITH RADICAL PROSTATECTOMY: A POPULATION-BASED STUDY (2015) (0)
- 627 Preoperative favourable characteristics in bladder cancer patients cannot substitute the necessity of extended lymphadenectomy during radical cystectomy: A sensitivity curve and a survival analysis (2016) (0)
- PROGNOSTIC SIGNIFICANCE OF EZH2 EXPRESSION IN UPPER TRACT UROTHELIAL CARCINOMA: MP71‐06 (2017) (0)
- The impact of disagreement between prognostic risk scores on oncologic outcomes of metastatic renal cell carcinoma (mRCC) patients in the tyrosine-kinase inhibitor (TKI) era (2020) (0)
- Reply to Pascal Mouracade's Letter to the Editor re: Thomas F. Chromecki, Eugene K. Cha, Harun Fajkovic, et al. The Impact of Tumor Multifocality on Outcomes in Patients Treated with Radical Nephroureterectomy. Eur Urol 2012;61;245–53 (2012) (0)
- 737 The interval between diagnosis and radical cystectomy does not impact the outcomes of patients treated with neoadjuvant chemotherapy (2015) (0)
- PO-0870: Fitting data of relapse-free survival after postprostatectomy RT with a comprehensive TCP model (2016) (0)
- A Tribute to John P. Stein (1962–2008): Surgeon, scientist, teacher, and humanist (2008) (0)
- Distribution of histological subtypes and tumor grade according to tumor size in T1-T2 surgically treated renal cell carcinoma (2020) (0)
- 1015 Collecting system invasion and Fuhrman grading but not tumour size facilitate prognostic stratification of patients with pT2 renal cell carcinoma – can the current 7th edition of TNM classification be improved? (2012) (0)
- Urological Oncology : Bladder , Penis and Urethral Cancer , and Basic Principles of Oncology Re : Factors Influencing the Length of Stay after Radical Cystectomy : Implications for Cancer Care and Perioperative Management (2016) (0)
- 391 CLINICAL UTILITY OF NMP22 FOR BLADDER CANCER SURVEILLANCE A MULTI-CENTER CROSS-SECTIONAL STUDY (2012) (0)
- 1289 ACUTE IMAGING FOR HEMATURIA IN THE UNITED STATES: COSTS AND PREDICTORS FROM THE NATIONWIDE EMERGENCY DEPARTMENT SAMPLE (2013) (0)
- Reaction Assay for Human Glandular Kallikrein Variant-specific Reverse Transcriptase-Polymerase Chain Detection of Metastatic Prostate Cancer Using a Splice (2013) (0)
- 12 Impact of institution volume on outcomes after robot-assisted radical cystectomy: An analysis of 1,118 patients from the International Robotic Cystectomy Consortium (2011) (0)
- Comparing oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity match analysis (2017) (0)
- ASO Visual Abstract: Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy (2022) (0)
- MP53-04 RATES OF UPGRADING AND UPSTAGING IN PROSTATE CANCER PATIENTS WITH SINGLE GGG1 POSITIVE BIOPSY CORE (2022) (0)
- 1119 A RE-ASSESSMENT OF 30-, 60- AND 90-DAY MORTALITY AFTER RADICAL PROSTATECTOMY (2012) (0)
- Recent pharmacological approaches for the treatment of renal cell carcinoma (2022) (0)
- POD-05.04 Stage pT0 After Radical Cystectomy: Are All Patients Equal? (2011) (0)
- Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histological subtype matter? (2019) (0)
- MP48-17 URETERAL STENTING DOES NOT INCREASE THE RISK OF METACHRONOUS UPPER TRACT UROTHELIAL CARCINOMA IN PATIENTS WITH BLADDER CANCER PRESENTING WITH HYDRONEPHROSIS IN COMPARISON WITH PERCUTANEOUS NEPHROSTOMY (2021) (0)
- ORIGINAL RESEARCH—EJACULATORY DISORDERS Impact of Medical Treatments for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia on Ejaculatory Function: A Systematic Review and Meta-Analysis (2014) (0)
- MP15-20 SURVIVAL AFTER RADICAL PROSTATECTOMY VS. RADIATION THERAPY IN DUCTAL CARCINOMA OF THE PROSTATE (2022) (0)
- Reply to Huseyin Besiroglu's Letter to the editor regarding the article 'Do we need repeat transurethral resection after en-bloc resection for pathological T1 bladder cancer?' (2023) (0)
- 773PMULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE II STUDY OF SORAFENIB COMPARED TO PLACEBO WITH BEST SUPPORTIVE CARE AFTER FAILURE OF DOCETAXEL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER. (2014) (0)
- MP08-13 PROGNOSTIC VALUE OF MICROMETRIC SUBSTAGING IN pT1 BLADDER CANCER PATIENTS TREATED WITH EN BLOC TRANSURETHRAL RESECTION (2023) (0)
- PET in bladder cancer imaging (2023) (0)
- Elevated preoperative neutrophil–lymphocyte ratio predicts upgrading at radical prostatectomy (2017) (0)
- MULTI-INSTITUTIONAL EVALUATION OF THE PREDICTIVE VALUE OF P53 IMMUNOHISTOCHEMICAL STAINING IN PATIENTS WITH PT1-2 N0 DISEASE AT RADICAL CYSTECTOMY (2008) (0)
- Assessing the impact and predictors of other-cause mortality in patients treated with post-prostatectomy salvage radiation therapy in order to avoid possible overtreatment: Results from a large, multi-institutional study (2019) (0)
- PD14-08 COMPARATIVE OUTCOMES OF PRIMARY AND RECURRENT HIGH GRADE NON-MUSCLE INVASIVE AND PRIMARY AND PROGRESSIVE MUSCLE-INVASIVE BLADDER CANCER AFTER RADICAL CYSTECTOMY: RESULTS FROM A RETROSPECTIVE MULTICENTER STUDY (2022) (0)
- Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study (2018) (0)
- MP14-11 WHEN IS THE OPTIMAL TIMING FOR SALVAGE RADIATION THERAPY IN PATIENTS WITH INCREASING PSA AFTER RADICAL PROSTATECTOMY? A PATIENT RISK STRATIFICATION MODEL BASED ON PROSTATE CANCER AGGRESSIVENESS (2016) (0)
- Re: The Role of Surgery in High-risk Localized Prostate Cancer (2014) (0)
- The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy (2022) (0)
- Prognostic value of SPINK1 expression in bladder cancer after radical cystectomy. (2012) (0)
- Association of sex with oncologic outcomes in pTa bladder cancer (2021) (0)
- MP82-14 SINGLE NUCLEOTIDE POLYMORPHISMS AND RISK OF PROSTATE CANCER: DEVELOPMENT AND VALIDATION OF A NOVEL GENETIC RISK SCORE FOR INDIVIDUALIZED SCREENING AND DIAGNOSTIC PROGRAMMES (2018) (0)
- Diagnosis and treatment of upper tract urothelial carcinoma (2012) (0)
- MP37-09 MORE EXTENSIVE PELVIC LYMPH NODE DISSECTIONS DURING ROBOTIC ASSISTED RADICAL PROSTATECTOMY ARE ASSOCIATED WITH HIGHER RATES OF PERI-OPERATIVE COMPLICATIONS. RESULTS OF A SINGLE INSTITUTION SERIES (2014) (0)
- Importance of magnetic resonance imaging and prostate‐specific membrane antigen PET‐CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancer (2022) (0)
- ASSESSEMENT OF THE MINIMUM NUMBER OF LYMPH NODES NEEDED AT RADICAL CYSTECTOMY IN BLADDER CANCER PATIENTS (2008) (0)
- 238 SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY VS. NO SURGERY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (2009) (0)
- Differential impact of radiation therapy after radical prostatectomy on recurrence patterns: an assessment using [68Ga]Ga-PSMA ligand PET/CT(MRI) (2020) (0)
- MP37-19 IMPACT OF PRIOR PELVIC RADIATION ON COMPLICATIONS AFTER ROBOTIC ASSISTED RADICAL CYSTECTOMY (2014) (0)
- Single-lesion PSMA protein expression and response to Lu-177 PSMA therapy in patients with castration-resistant prostate cancer. (2021) (0)
- Very long-term outcomes, time patterns of recurrence and other-cause mortality in patients treated with salvage radiation therapy for recurrent prostate cancer after radical prostatectomy: Implications for risk tailored follow-up strategies (2021) (0)
- Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: An updated systematic review and meta-analysis (2022) (0)
- Re: Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial. (2018) (0)
- The prognostic impact of intraductal carcinoma of the prostate: A systematic review and meta-analysis (2020) (0)
- Evaluating safety and efficacy of INCB054828 as adjuvant therapy for molecularly-selected, high-risk patients with urothelial carcinoma (UC): A phase 2 study of the European Association of Urology Research Foundation (EAU-RF) (2018) (0)
- Reply from Authors re: Evangelos Liatsikos, Panagiotis Kallidonis. Laparoscopic or Open Nephroureterectomy? Which is the More Efficient Way to go? Eur Urol 2009;56:10–12 (2009) (0)
- Urothelial Cancer Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma (2012) (0)
- Impact of family history on pathologic outcome and biochemical recurrence after radical prostatectomy (2016) (0)
- PD03-08 THE NECESSITY OF A SECOND TRANSURETHRAL RESECTION FOR PATIENTS DIAGNOSED WITH PTAHG TUMOR AT FIRST TUR: A MULTICENTER COLLABORATION OF EAU YOUNG ACADEMIC UROLOGISTS UROTHELIAL CARCINOMA GROUP (2020) (0)
- 1804 Development of Accurate Models for Individualized Prediction of Survival at 6 and 12 Months After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (2012) (0)
- Reply from Authors re: Evangelos Liatsikos, Panagiotis Kallidonis. Laparoscopic or Open Nephroureterectomy? Which is the More Efficient Way to go? Eur Urol 2009;56:10–12 (2009) (0)
- MP22-10 WHICH POSITIVE SURGICAL MARGINS FEATURES IMPACT ON THE RISK OF PROSTATE CANCER SPECIFIC MORTALITY? A DISEASE-TAILORED, COMPETING-RISK, LONG-TERM ANALYSIS (2019) (0)
- The placebo effect and the future direction in management of overactive bladder: A systematic review and meta-analysis (2020) (0)
- MP27-03 DELAYING POST-OPERATIVE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY IS ASSOCIATED WITH INCREASED FUNCTIONAL OUTCOMES: RESULTS FROM A LARGE SINGLE, REFERRAL CENTER SERIES (2022) (0)
- PD62-05 THE IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN IN UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS TREATED WITH NEPHROURETERECTOMY: A MULTICENTER COLLABORATION (2019) (0)
- Abstract 1292: Validation study on quantitative analysis method of interrelationships between immune cells and prostate epithelial and cancer cells (2015) (0)
- 1797 THE RISK OF IN-HOSPITAL MORTALITY AFTER CYTOREDUCTIVE NEPHRECTOMY: AN ASSESSMENT BASED ON PATIENT CHARACTERISTICS AND POSTOPERATIVE OUTCOMES DURING HOSPITALIZATION (2012) (0)
- 910 CAVEOLIN-1 OVEREXPRESSION IS ASSOCIATED WITH AGGRESSIVE PROSTATE CANCER RECURRENCE (2007) (0)
- Young men with low risk prostate cancer can be safely candidate to active surveillance regardless of the extent of biopsy involvement: Results from a single center series with pathological confirmation (2019) (0)
- Frontiers in combining immune checkpoint inhibitors for advanced urothelial cancer management. (2020) (0)
- Radiographic predictors of need for angiographic embolization after traumatic renal injury (2009) (0)
- Should the follow-up schedule after radical nephroureterectomy be revised? An analysis on the timing and location of recurrences (2021) (0)
- MP22-01 WHAT IS THE BEST DEFINITION OF BIOCHEMICAL RESPONSE TO SALVAGE RADIATION THERAPY IN PROSTATE CANCER PATIENTS TREATED FOR PSA RISING AFTER RADICAL PROSTATECTOMY? RESULTS FROM A MULTI-INSTITUTIONAL SERIES (2019) (0)
- Contemporary conditional cancer‐specific survival rates in surgically treated adrenocortical carcinoma patients: A stage‐specific analysis (2022) (0)
- Re: Cabazitaxel Versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer. (2020) (0)
- Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. the importance of an extensive, multi-modal approach (2020) (0)
- Natural history of patients treated with salvage radiation therapy for rising PSA after radical prostatectomy: A long-term survival analysis (2017) (0)
- The microbiome of kidney stones and urine of patients with nephrolithiasis (2023) (0)
- Molecular and therapeutic aspects of advanced urachal cancer (2017) (0)
- 403 Apparent diffusion coefficient values obtained by unenhanced MRI predicts disease-specific survival in bladder cancer (2016) (0)
- HIGH-ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY (TUMT) VERSUS alpha-BLOCKER TREATMENT FOR BEING PROSTATIC HYPERPLASIA(BPH): A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL (1999) (0)
- 1037: Percent Free PSA is Associated with Clinical Outcomes in Patients with Total PSA Levels Below 10 ng/mL (2005) (0)
- The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma (2011) (0)
- Radical cystectomy and urinary diversion in women: techniques, outcomes, and challenges—a narrative review (2021) (0)
- MP23-16 CIRCULATING TUMOR DNA IS A STRONG PREDICTOR IN PATIENTS TREATED WITH SYSTEMIC THERAPY FOR UROTHELIAL CARCINOMA (2022) (0)
- Comparative effectiveness of radiotherapy and radical cystectomy in unfit patients with resectable urinary bladder cancer (2018) (0)
- Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]. (2023) (0)
- 376 Urine detection of survivin is a powerful marker for the non-invasive diagnosis of bladder cancer (2004) (0)
- Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. (2017) (0)
- MP61-12 DO PREOPERATIVE PATIENT CHARACTERISTICS INFLUENCE URINARY DIVERSION AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER? – RESULTS OF THE GERMAN PROMETRICS 2011 STUDY (2014) (0)
- MP22-20 ASSESSING THE IMPACT AND PREDICTORS OF OTHER-CAUSE MORTALITY IN PATIENTS TREATED WITH POST-PROSTATECTOMY SALVAGE RADIATION THERAPY IN ORDER TO AVOID POSSIBLE OVERTREATMENT: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL STUDY (2019) (0)
- Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer (2023) (0)
- 1892 PT2 SUBSTAGING IN UROTHELIAL CARCINOMA OF THE BLADDER: DEEP MUSCLE INVASION IS ASSOCIATED WITH WORSE OUTCOME (2011) (0)
- Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma (2022) (0)
- 1681 A NON-CANCER RELATED SURVIVAL BENEFIT IS ASSOCIATED WITH PARTIAL NEPHRECTOMY (2012) (0)
- MP25-10 PREVENTION AND DETECTION OF IATROGENIC URETERAL INJURY DURING ABDOMINAL OR PELVIC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS (2022) (0)
- Selecting the best candidates for platinum-based adjuvant chemotherapy after radical cystectomy in pN+ bladder cancer patients (2021) (0)
- MP38-04 IMPACT OF ADJUVANT CHEMOTHERAPY IN PATIENTS WITH ADVERSE FEATURES AND VARIANT HISTOLOGY AT RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE CARCINOMA OF THE BLADDER: DOES HISTOLOGICAL SUBTYPE MATTER? (2019) (0)
- A systematic review on the management of primary urethral carcinoma (2019) (0)
- MP7-09 INCREASED EZH2 EXPRESSION IS ASSOCIATED WITH ADVERSE ONCOLOGIC OUTCOMES FOLLOWING RADICAL NEPHROURETERECTOMY (2015) (0)
- Assessing the effect of concomitant hormonal therapy on severe toxicity in patients treated with post-prostatectomy radiation therapy: Results from a large, multi-institutional study (2021) (0)
- Overall survival in patients with disease recurrence after renal cell carcinoma (2018) (0)
- 1796 AN ASSESSMENT OF LYMPHADENECTOMY OMISSION AT CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: A POPULATION-BASED ANALYSIS (2012) (0)
- 418 PROGNOSTIC SIGNIFICANCE OF TUMOR LOCATION IN UPPER TRACT UROTHELIAL CARCINOMA (2010) (0)
- 701 Statin use is not associated with prognosis or BCG-response in patients with non-muscle invasive bladder cancer (2013) (0)
- Identifying the optimal candidates for radiation therapy after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: Results from a multi-institutional collaboration (2021) (0)
- Re: Enzalutamide with Standard First-line Therapy in Metastatic Prostate Cancer. (2020) (0)
- Androgen receptor inhibitors for non-metastatic castration-resistant prostate cancer: network meta-analysis (2020) (0)
- Non-neurogenic Male Lower Urinary Tract Symptoms (incl. Benign Prostatic Hyperplasia) (2014) (0)
- 1259: Prognostic Significance of Deep Muscular Invasion and Extravesical Extension in Pathological Staging of Bladder Cancer after Radical Cystectomy (2006) (0)
- 1670 NON-CANCER RELATED MORTALITY IN PARTIAL VERSUS RADICAL NEPHRECTOMY FOR T1A RENAL CELL CARCINOMA: A PROPENSITY-BASED MATCHED ANALYSIS (2011) (0)
- Preoperative P lasma L evels o f T ransforming G rowth F actor Beta 1 (TGF- b 1 ) S trongly P redict P rogression i n P atients Undergoing R adical P rostatectomy (2001) (0)
- REPLY (2008) (0)
- 537 Early, intermediate and late recurrence after radical cystectomy due to bladder cancer: The necessity of a tailored follow up (2015) (0)
- The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy. (2022) (0)
- POD-05.05 Risk Stratification of Patients Who Are pT0N0 after Radical Cystectomy (2011) (0)
- MP7-06 MULTICENTER EXTERNAL VALIDATION OF A POST-OPERATIVE NOMOGRAM FOR PREDICTING THE RISK OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (2015) (0)
- Prostate Cancer in Lymph Nodes Transcription-PCR for the Detection of Micrometastatic Comparison of Immunohistochemistry with Reverse Updated Version (2003) (0)
- 643 PROPENSITY-SCORE MATCHED COMPARISON OF PERIOPERATIVE OUTCOMES BETWEEN OPEN AND LAPAROSCOPIC NEPHROURETERECTOMY: A NATIONAL SERIES (2012) (0)
- RECURRENCE AND PROGRESSION ACCORDING TO STAGE AT RE‐TUR IN T1G3 BLADDER CANCER PATIENTS TREATED WITH BCG: NOT AS BAD AS PREVIOUSLY THOUGHT: PD48‐07 (2017) (0)
- Stage-migration and survival of lymph node positive prostate cancer patients: A comprhensive trend analyses of surgically treated men over the last two decades (2018) (0)
- 131Development and internal validation of a nomogram predicting 2,5 and 8-year bladder cancer-specific survival (BCA-NED) after radical cystectomy (2005) (0)
- There is no way to compensate for a non-timely use of salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy (2019) (0)
- Editorial: Lower urinary tract symptoms, benign prostate hyperplasia and beyond. (2021) (0)
- 508 Association of cigarette smoking and smoking cessation with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer (2015) (0)
- Central prostate biopsy revision at referral center is key for correct patient management: Results from a prospective, single center series (2018) (0)
- Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapy (2023) (0)
- LAPAROSCOPIC NEPHROURETERECTOMY DOES NOT UNDERMINE CANCER CONTROL OUTCOMES IN SELECTED PATIENTS WITH NON-METASTATIC UPPER TRACT UROTHELIAL CARCINOMA (2009) (0)
- PATIENTS WITH RENAL PELVIS UPPER TRACT TRANSITIONAL CELL CARCINOMA HAVE SIGNIFICANTLY WORSE CANCER-SPECIFIC SURVIVAL THAN PATIENTS WITH URETERAL PRIMARIES (2009) (0)
- Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy (2022) (0)
- Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk level (2022) (0)
- 238: Combined Effect of Apoptotic Biomarkers on Bladder Cancer Recurrence and Mortality after Radical Cystectomy (2007) (0)
- Author reply (0)
- OUTCOMES OF RADICAL NEPHROURETERECTOMY FOR UROTHELIAL CARCINOMA: A CONTEMPORARY SERIES FROM THE UPPER TRACT UROTHELIAL CARCINOMA COLLABORATION (2008) (0)
- Molecular uropathology and cancer genetics for the urologist: key findings for classification and diagnosis (2022) (0)
- MP32-10 COMPARATIVE EFFECTIVENESS OF ROBOTIC ASSISTED AND OPEN RADICAL CYSTECTOMY IN CONTEMPORARY COHORTS OF BLADDER CANCER PATIENTS: AN INTERNATIONAL MULTICENTER COLLABORATION (2019) (0)
- Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations (2023) (0)
- Temporal Stage and Grade Migration in Surgically-Treated Patients with Upper Urinary Tract Transitional Cell Carcinoma (2009) (0)
- MP62-05 SYSTEMATIC ASSESSMENT OF POSITIVE SURGICAL MARGINS FEATURES IN OPEN VS. ROBOT ASSISTED RADICAL PROSTATECTOMY: IS THERE A DIFFERENCE? (2015) (0)
- How Well Does the PCA3-incorporated Chun Nomogram Perform in Predicting Prostate Biopsy (2013) (0)
- 852 HIGHLY PREDICTIVE NOMOGRAM ON SURVIVAL AFTER IN PATIENTS TREATED WITH SURGERY FOR PRIMARY PENILE SQUAMOUS CELL CARCINOMA, BASED ON THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS DATABASE (2010) (0)
- 639: Predictors of Prostate Cancer Detection Using an Extended Biopsy Regimen in Patients with a Total PSA Between 2.5 and 4.0NG/ML (2004) (0)
- 1799 IN-HOSPITAL MORTALITY AFTER CYTOREDUCTIVE NEPHRECTOMY: A POPULATION-BASED ANALYSIS ACCORDING TO DISTRIBUTION OF METASTATIC SITES (2012) (0)
- Assessment of other‐cause mortality in localized renal cell carcinoma patients within 15 years: A population‐based analysis (2020) (0)
- The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy (2022) (0)
- PD60-11 IMPACT OF THE TIME ELAPSED BETWEEN PROSTATE BIOPSY AND SURGERY ON THE ACCURACY OF THE BRIGANTI NOMOGRAM PREDICTING LYMPH NODE INVASION IN MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER (2022) (0)
- 870 CEACAM1 EXPRESSION DISTINGUISHES INDOLENT FROM LETHAL PROSTATE CANCER (2010) (0)
- 845: Extended Biopsy Schemes are Associated with Similar Pathological Characteristics but Lower Biochemical Recurrence than Sextant Biopsy (2007) (0)
- NEOADJUVANT AND ADJUVANT alpha-BLOCKADE TO IMPROVE EARLY RESULTS OF HIGH-ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY (TUMT): RESULTS OF A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL (1999) (0)
- 1074 IMPACT OF CLINICAL AND HISTOPATHOLOGICAL PARAMETERS ON DISEASE-SPECIFIC SURVIVAL IN PATIENTS WITH COLLECTING DUCT RENAL CELL CARCINOMA (2013) (0)
- The impact of persistently elevated PSA levels on progression and survival of patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate cancer (2020) (0)
- PROGNOSTIC VALUE OF LYMPH NODE DENSITY IN A MULTI-CENTER, INTERNATIONAL COHORT OF PATIENTS WITH NODE POSITIVE UROTHELIAL CARCINOMA OF THE BLADDER (2009) (0)
- 373 PATHOLOGICAL NODAL STAGING SCORE FOR PROSTATE CANCER: A TOOL TO ADDRESS ADEQUATE NODAL DISSECTION IN MEN TREATED WITH RADICAL PROSTATECTOMY (2013) (0)
- 358 DOES INCREASING THE NODAL YIELD IMPROVE OUTCOMES IN PATIENTS WITHOUT NODAL METASTASIS AT RADICAL PROSTATECTOMY (2013) (0)
- Re: Lymph Node Colonization Induces Tumor-immune Tolerance To Promote Distant Metastasis. (2022) (0)
- Adjuvant chemotherapy improves survival outcomes in patients treated with neoadjuvant chemotherapy and radical cystectomy for bladder cancer: Results of a multi-institutional collaboration (2019) (0)
- 686 ONCOLOGIC OUTCOMES AND SURVIVAL IN PT0 TUMORS AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: RESULTS FROM OF A LARGE MULTICENTER INTERNATIONAL COLLABORATIVE STUDY (2013) (0)
- A novel nomogram to identify patients with lymph node metastases in the extended lymph node dissection area at radical cystectomy (2019) (0)
- 1797 TUMOR SIZE IS ASSOCIATED WITH THE RATE OF SYNCHRONOUS METASTASES IN PATIENTS WITH SMALL RENAL CELL TUMORS (2010) (0)
- TUMOR ARCHITECTURE IS AN INDEPENDENT PROGNOSTIC FACTOR FOR DISEASE RELAPSE AND CANCERSPECIFIC SURVIVAL IN PATIENTS TREATED WITH NEPHROURETERECTOMY: A MULTI-INSTITUTIONAL ANALYSIS OF 1363 PATIENTS FROM THE UPPER TRACT UROTHELIAL CARCINOMA COLLABORATION (2008) (0)
- 37 VALIDATION OF TUMOUR ARCHITECTURE IS AN INDEPENDENT PREDICTOR OF OUTCOMES AFTER RADICAL NEPHROURETERECTOMY (2010) (0)
- Does associated CIS with MIBC impact on neoadjuvant chemotherapy? Results of an International consortium (2017) (0)
- [Surgery only? Multimodal treatment for urothelial carcinoma of the bladder]. (2020) (0)
- 1132 HUMAN MISMATCH REPAIR PROTEIN EXPRESSION IN BLADDER CANCER (2013) (0)
- 801 The impact of insurance status on tumor characteristics and treatment selection in contemporary prostate cancer patients (2015) (0)
- PD55-12 INCREMENTAL UTILITY OF MP-MRI PERFORMED BEFORE CONFIRMATORY BIOPSY IN REDUCING THE RISK OF PROGRESSION DURING ACTIVE SURVEILLANCE FOR MEN WITH LOW RISK PROSTATE CANCER: IS IMAGING ALWAYS USEFUL? (2019) (0)
- 1488 CARDIOVASCULAR DISEASE AND PROSTATE CANCER: A COMPETING-RISKS ANALYSIS (2013) (0)
- What Specimen Urologists Should Be Most Concerned About ? A Systematic Review and Meta-Analysis (2020) (0)
- Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages (2023) (0)
- Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis. (2021) (0)
- Response to Re: External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients (2021) (0)
- Pilot study on the correlation of multiphoton microscopy of human testicular tumors with histology. (2012) (0)
- PD12-07 PREOPERATIVE FRAILTY PREDICTS ADVERSE SHORT-TERM POST-OPERATIVE OUTCOMES IN PATIENTS TREATED WITH PARTIAL NEPHRECTOMY (2021) (0)
- Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials (2021) (0)
- LYMPHOVASCULAR INVASION IS INDEPENDENTLY ASSOCIATED WITH CANCER RECURRENCE AND SURVIVAL IN PATIENTS WITH NEGATIVE LYMPH NODES AT RADICAL NEPHROURETERECTOMY (2008) (0)
- Prognostics Factors, Molecular Markers, and Predictive Tools in Upper Tract Urothelial Carcinoma (2015) (0)
- 1043 Impact of synchronous metastasis distribution on survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy (2014) (0)
- Radical cystectomy in pathological T4a and T4b patients: Is there any space for sub stratification? (2018) (0)
- Partial nephrectomy in frail patients: Effect of surgical approach on complications and health-care expenditures (2021) (0)
- Urothelial Cancer: Upper Tract TumorsModerated Poster638 INTERNATIONAL VALIDATION OF THE PROGNOSTIC VALUE OF SUBCLASSIFICATION FOR AJCC STAGE PT3 UPPER TRACT UROTHELIAL CARCINOMA OF THE RENAL PELVIS (2012) (0)
- 1015 Cardiovascular disease and prostate cancer: A competing-risks analysis (2013) (0)
- TIMING OF SALVAGE RADIATION THERAPY AND USE OF CONCOMITANT HORMONAL THERAPY FOR PATIENTS WITH PSA RISING AFTER RADICAL PROSTATECTOMY: A LONG‐TERM SURVIVAL ANALYSIS: PD72‐03 (2017) (0)
- ASO Visual Abstract: En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis. (2023) (0)
- Robot-assisted partial nephrectomy: systematic review of functional results (2017) (0)
- MP48-19 STAGE AND CANCER SPECIFIC MORTALITY DIFFERS WITHIN SPECIFIC ASIAN ETHNIC GROUPS IN UPPER TRACT UROTHELIAL CARCINOMA (2021) (0)
- PD10-10 IMPROVING PREDICTION OF LOCAL STAGE BY PSMA-PET. DEVELOPMENT OF A NOVEL INTEGRATED TOOL FOR EXTRACAPSULAR EXTENSION AND SEMINAL VESICLE INVASION COMBINING CLINICAL AND IMAGING FEATURES IN LOCALIZED PROSTATE CANCER (2023) (0)
- 567 LYMPH NODE YIELD AND NUMBER OF POSITIVE LYMPH NODES AFTER RPLND DOES NOT PREDICT CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH NONSEMINOMATOUS GERM CELL TUMORS OF THE TESTIS (2010) (0)
- MP50-06 SURVIVAL OF TESTICULAR PURE TERATOMA VS. MIXED GERM CELL TUMOR PATIENTS ACROSS ALL STAGES (2023) (0)
- Which patients should be still considered for late salvage radiotherapy for rising or persistently elevated PSA after radical prostatectomy: Results from a large multi-institutional study (2018) (0)
- ANDROGEN DEPRIVATION THERAPY VERSUS SKELETAL FRACTURES. THE EFFECT OF TIME DEPENDENT VARIABLES ON OBSERVED RISK (2008) (0)
- MORE EXTENSIVE LYMPH NODE DISSECTION AT RADICAL PROSTATECTOMY IS ASSOCIATED WITH IMPROVED OUTCOMES AFTER SALVAGE RADIOTHERAPY FOR RISING PSA AFTER SURGERY: A LONG‐TERM, MULTI‐INSTITUTIONAL ANALYSIS: PD15‐11 (2017) (0)
- Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients. (2021) (0)
- 1207 BIOCHEMICAL FAILURE IN D'AMICO LOW RISK PATIENTS WITH GLEASON SUM UPGRADING FOLLOWING RADICAL PROSTATECTOMY: AN INTERNATIONAL, MULTI-INSTITUTIONAL STUDY (2011) (0)
- Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. the importance of patient stratification for tailored post-operative treatments (2020) (0)
- Management of upper tract urothelial carcinoma (2018) (0)
- IMPROVED PREDICTION OF DISEASE RELAPSE AFTER RADICAL PROSTATECTOMY USING A PANEL OF PREOPERATIVE BLOOD-BASED BIOMARKERS (2008) (0)
- Radical Salvage Prostatectomy (RSP) for Radiorecurrent Prostate Cancer (rPCA): Onological and functional outcome of a large contemporary series (2020) (0)
- Editorial introductions. (2019) (0)
- MP59-16 COMPARATIVE EFFECTIVENESS OF LOCAL TUMOR DESTRUCTION VERSUS NEPHRECTOMY IN PATIENTS OLDER THAN 75 YEARS OLD FOR SMALL RENAL MASSES. (2015) (0)
- The key role of PSA doubling time in patients treated with salvage radiation therapy after radical prostatectomy: Implications for the extent of radiation and the concomitant use of hormonal therapy (2021) (0)
- MP66-13 THE PROGNOSTIC ROLE OF THE PREOPERATIVE SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS TREATED WITH RADICAL CYSTECTOMY (2021) (0)
- Re: Pathologic Stage T2a and T2b Prostate Cancer in the Recent Prostate-Specific Antigen Era: Implications for Unilateral Ablative Therapy (2009) (0)
- Role of lymphadenectomy during primary surgery for kidney cancer. (2023) (0)
- MP15-10 THE ROLE OF LYMPH NODE DISSECTION IN PATIENTS UNDERGOING SALVAGE RADICAL PROSTATECTOMY (2021) (0)
- 552 Predicting the 5-year risk of biochemical relapse after post-prostatectomy radiotherapy in ≥pT2 patients with a comprehensive radiobiological model (2016) (0)
- 451 Biochemical recurrence after radical prostatectomy: Who is at risk of dying from prostate cancer? (2015) (0)
- 340 Independent validation of the 2010 TNM staging system for renal cell carcinoma: Does it improves predictive accuracy in cancer-specific mortality compared to 2002 TNM? (2013) (0)
- MP60-04 IMPACT OF PRE-OPERATIVE HEMOGLOBIN VALUES AND PERI-OPERATIVE BLOOD TRANSFUSION ON CANCER SPECIFIC AND OVERALL MORTALITY AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: RESULTS FROM A SINGLE INSTITUTION COHORT (2014) (0)
- Localized Prostate Cancer Factor / Scatter Factor Levels in Patients with Clinically Predictive Value of Plasma Hepatocyte Growth (2008) (0)
- CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IS FEASIBLE IN MEN WITH HORMONE‐NAIVE, METASTATIC PROSTATE CANCER (MPCA).: MP53‐19 (2017) (0)
- The impact of smoking on genomic alterations in muscle-invasive bladder cancer (2018) (0)
- MP16-18 SURVIVAL OUTCOMES AFTER RADICAL CYSTECTOMY VERSUS CONSERVATIVE MANAGEMENT FOR T1 HIGH GRADE NON-MUSCLE INVASIVE MICROPAPILLARY BLADDER CANCER: A MULTICENTER COLLABORATION BY THE EUROPEAN ASSOCIATION OF UROLOGY - YOUNG ACADEMIC UROLOGISTS (2021) (0)
- Prostate Cancer: Localized: Surgical Therapy VIPD43-10 HYPOGONADISM INDEPENDENTLY PREDICTS PATHOLOGICAL GLEASON PATTERN 5 AT THE TIME OF RADICAL PROSTATECTOMY (2016) (0)
- 508 The impact of cigarette smoking and smoking cessation on oncological aggressiveness at radical cystectomy – a prospective, European, multicenter study of the EAU Young Academic Urologists (YAU) bladder cancer working group (2016) (0)
- Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma (2023) (0)
- En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference? (2023) (0)
- 394 CONCORDANCE IN MOLECULAR MARKER STATUS BETWEEN BLADDER TUMORS AT TIME OF TRANSURETHRAL RESECTION AND SUBSEQUENT RADICAL CYSTECTOMY: RESULTS OF A 5-YEAR PROSPECTIVE STUDY (2013) (0)
- 912 CIRCULATING LEVELS OF PLASMINOGEN ACTIVATION INHIBITOR-1 IMPROVE THE ACCURACY OF PRE-AND POST-OPERATIVE NOMOGRAMS FOR PREDICTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY (2007) (0)
- Assessing the risk of early and late toxicity of post-prostatectomy radiation therapy: A long-term multi-institutional analysis (2017) (0)
- 668 LYMPH NODE DISSECTION IS OMITTED IN THE VAST MAJORITY OF PATIENTS TREATED WITH NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (2011) (0)
- NATURAL HISTORY OF PATIENTS TREATED WITH SALVAGE RADIATION THERAPY FOR RISING PSA AFTER RADICAL PROSTATECTOMY: A LONG‐TERM SURVIVAL ANALYSIS: PD72‐05 (2017) (0)
- Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder. (2022) (0)
- Novel classification for upper tract urothelial carcinoma to better risk-stratify patients eligible for kidney sparing strategies: an international collaborative study (2021) (0)
- 69 THE BURDEN OF HEMATURIA IN THE UNITED STATES: ESTIMATES FROM THE NATIONWIDE EMERGENCY DEPARTMENT SAMPLE (2013) (0)
- MP69-01 CAN WE CONSIDER PATIENTS WITH LIMITED BIOPSY GLEASON SCORE 3+4 ELIGIBLE FOR ACTIVE SURVEILLANCE? (2014) (0)
- Oncologic surveillance for surgically-treated high risk upper tract urothelial carcinoma (2021) (0)
- 1382: Bladder Cancer-Specific Survival Following Radical Cystectomy for Primary Non-Transitional Cell Carcinoma (Non-TCC) of the Bladder: Results from the Bladder Cancer Research Consortium (BCRC) (2005) (0)
- Do we really need detailed biopsy assessment of patients with low-risk prostate cancer candidate to active surveillance? A prospective validation of the ISUP recommendations (2019) (0)
- MP14-04 ADJUVANT THERAPY WITH TYROSINE KINASE INHIBITORS FOR RENAL CELL CARCINOMA: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS (2021) (0)
- 214 Prognostic significance of markers of systemic inflammatory response in patients with non-muscle invasive bladder cancer (2016) (0)
- Prognostic value of variant histology in bladder carcinoma treated with radical cystectomy: A systematic review and meta-analysis (2020) (0)
- Value of repeated ureterorenoscopy within the first 3 months after endoscopic treatment in upper tract urothelial carcinoma (UTUC) (2018) (0)
- 331 Multicenter external validation of a post-operative nomogram for predicting the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (2015) (0)
- Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients (2022) (0)
- DNA damage repair gene alteration status as a predictive marker for response to neoadjuvant chemotherapy in muscle invasive bladder cancer (2020) (0)
- 1601 ONCOFETAL PROTEIN IMP3 A POTENTIAL BIOMARKER FOR INVASIVE BLADDER CANCER (2012) (0)
- 579 SIZE OF TUMOR METASTASIS AND EXTRANODAL EXTENSION STRATIFY LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS INTO PROGNOSTICALLY DIFFERENT RISK GROUPS (2010) (0)
- Letter to the EditorReply by the Authors (2008) (0)
- 1338 PERIOPERATIVE OUTCOMES OF ROBOT-ASSISTED RADICAL PROSTATECTOMY VS. OPEN RADICAL PROSTATECTOMY (2012) (0)
- PD59-06 PEMBROLIZUMAB OUTPERFORMS TYROSINE KINASE INHIBITORS IN THE ADJUVANT THERAPY OF PATIENTS WITH HIGH-RISK RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (2022) (0)
- Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies (2022) (0)
- Serum Cholinesterase in patients treated with salvage radical prostatectomy for radiation recurrence (2018) (0)
- Evaluation of dualtracer multiparametric PET/MRI parameters in primary prostate cancer (2016) (0)
- Cigarette smoking is adversely associated with pathological response to platinum-based neoadjuvant chemotherapy in patients undergoing treatment for urinary bladder cancer (2018) (0)
- MP2-07 A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICOPATHOLOGIC FACTORS LINKED WITH INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY TO TREAT UPPER TRACT UROTHELIAL CARCINOMA (2015) (0)
- Re: Effect of Bipolar Androgen Therapy for Asympto- matic Men with Castration-resistant Prostate Cancer: Results from a Pilot Clinical Study (2015) (0)
- Multimodal treatment for urothelial carcinoma of the bladder (2020) (0)
- 1828 SURVIVAL AFTER RADICAL CYSTECTOMY OF NON-BILHARZIAL SQUAMOUS CELL CARCINOMA VS. UROTHELIAL CARCINOMA: A NORTH-AMERICAN POPULATION-BASED STUDY (2010) (0)
- MP37-20 INDIVIDUAL SURGEON COMMITMENT TO PELVIC LYMPH NODE DISSECTION RATHER THAN SURGICAL VOLUME IS A MAJOR DETERMINANT OF THE EXTENT OF NODAL DISSECTION DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY (2014) (0)
- MP59-11 EN BLOC RESECTION FOR BLADDER TUMORS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSES OF ITS DIFFERENTIAL EFFECT ON ITS SAFETY, HISTOPATHOLOGY AND, RECURRENCE (2022) (0)
- MP2-09 NOMOGRAM FOR PREDICTION OF RECURRENCE-FREE SURVIVAL IN PATIENTS WITH HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA AFTER EXTIRPATIVE THERAPY (2015) (0)
- PD29-12 COMPARISON OF ONCOLOGICAL OUTCOMES OF DISTAL URETERAL ≤PT2 UROTHELIAL CARCINOMA MANAGED BY NEPHROURETERECTOMY, SEGMENTAL URETERECTOMY OR ENDOSCOPIC SURGERY (2015) (0)
- 1016 Are continent urinary diversions feasible at the time of radical cystectomy after pelvic radiotherapy? Analysis of a large retrospective multicenter series (2016) (0)
- There is no way to compensate a non-timely use of early salvage radiation therapy in men with recurrent Prostate Cancer after Radical Prostatectomy. A retrospective, multi-centre analyses on oncological and toxicity outcomes (2021) (0)
- Discrepancy between clinical and nephroureterectomy tumors stage as well as grade in upper tract urothelial carcinoma (2021) (0)
- 709 OLDER AND SICKER RENAL CELL CARCINOMA PATIENTS ARE OPERATED AT LOW VOLUME HOSPITALS (2012) (0)
- 645 ONCOLOGIC OUTCOMES AFTER RADICAL NEPHROURETERCTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: COMPARISON OVER THE THREE DECADES (2012) (0)
- MP69-15 OUTCOME OF RADICAL PROSTATECTOMY FOR MISCLASSIFIED ACTIVE SURVEILLANCE CANDIDATES (2014) (0)
- Individualized treatment schedule and investigator 's defined time to resistance (TTRi) may prolong survival in patients with metastatic renal cell carcinoma (mRCC) (2015) (0)
- MP08-10 THE INTRODUCTION OF A SURGICAL CHECKLIST FOR THE TRANSURETHRAL RESECTION OF THE BLADDER IMPROVES RECURRENCE-FREE SURVIVAL IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS (2018) (0)
- REMOVAL OF AT LEAST 8 NODES IMPROVES CANCER-SPECIFIC SURVIVAL IN NON METASTATIC PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (2009) (0)
- CONDITIONAL SURVIVAL IN ONCOLOGY: A REVIEW. (2017) (0)
- Validation of preoperative thrombocytosis as adverse prognostic factor in advanced bladder cancer (BCA) after radical cystectomy (RC) (2017) (0)
- IMPACT OF SAMPLING DENSITY ON INITIAL 10 OR MORE (+) CORE PROSTATE BIOPSY: DEVELOPMENT AND INTERNAL VALIDATION OF A 10+ CORES BIOPSY NOMOGRAM (2006) (0)
- PD5-12 PREDICTORS OF CANCER-SPECIFIC MORTALITY AFTER DISEASE RECURRENCE IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE PENIS (2014) (0)
- PD15-05 WHAT IS THE RISK OF LATE RECURRENCE AND MORTALITY AFTER SALVAGE RADIATION THERAPY FOR POST-PROSTATECTOMY PSA RISING? A LONG-TERM, MULTI-INSTITUTIONAL ANALYSIS (2019) (0)
- MP25-04 OUTCOMES OF METASTATIC RENAL CELL CARCINOMA PATIENTS WITH SARCOMATOID HISTOLOGY - A SINGLE TERTIARY CARE CENTER STUDY IN THE TKI ERA (2019) (0)
- Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary. (2023) (0)
- 603 Clinical nodal staging scores for bladder cancer: A proposal for preoperative risk-assessment (2012) (0)
- Do we really need detailed biopsy assessment of patients with low-risk prostate cancer candidate to active surveillance? A prospective validation of the ISUP recommendation (2019) (0)
- PURE BUT NOT MIXED HISTOLOGICAL VARIANTS ARE ASSOCIATED WITH POOR SURVIVAL AT RADICAL CYSTECTOMY IN BLADDER CANCER PATIENTS: MP54‐15 (2017) (0)
- 1256: Survivin Expression is Associated with Bladder Cancer Presence, Stage, Progression, and Mortality (2006) (0)
- Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial. (2020) (0)
- 430 MULTI-INSTITUTIONAL VALIDATION OF THE PREDICTIVE VALUE OF PREOPERATIVE HYDRONEPHROSIS FOR ADVANCED STAGE UPPER-TRACT UROTHELIAL CARCINOMA (2010) (0)
- THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER (2011) (0)
- PD44-12 RISK FACTORS OF CHRONIC KIDNEY DISEASE DETERIORATION FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS (2023) (0)
- MP03-10 LIFE EXPECTANCY IN METASTATIC UROTHELIAL BLADDER CANCER PATIENTS ACCORDING TO RACE/ETHNICITY (2022) (0)
- 157 High rates of significant prostate cancer are detectable in repeat biopsies (2012) (0)
- PATTERN OF POSITIVE NODE METASTASES IN PATIENTS TREATED WITH EXTENDED AND SUPER EXTENDED PELVIC LYMPH NODE DISSECTION AND RADICAL CYSTECOTMY DUE TO BLADDER CANCER: MP58‐20 (2017) (0)
- 1287 DEGREE OF VASCULAR SCLEROSIS IN BENIGN PARENCHYMA PREDICTS DEVELOPMENT OF CHRONIC KIDNEY DISEASE AFTER NEPHRECTOMY (2012) (0)
- PD15-09 PELVIC LYMPH NODE DISSECTION CAN BE SAFELY OMITTED IN MEN WITH A RISK OF NODAL METASTASES ≤5% BASED ON THE BRIGANTI NOMOGRAM: VALIDATION OF THE EAU GUIDELINS RECCOMENDATIONS FOR NODAL DISSECTION BASED ON PATIENT OUTCOME (2014) (0)
- 327 Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy (2015) (0)
- Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guérin: Implications for Decision-making? (2023) (0)
- 1888 PROSPECTIVE VALIDATION OF PROGNOSTIC BIOMARKER PANEL FOR BLADDER CANCER MANAGEMENT AT TIME OF TRANSURETHRAL RESECTION OF BLADDER TUMORS (2011) (0)
- 1659 A POPULATION-BASED ANALYSIS OF PERIOPERATIVE COMPLICATIONS AND MORTALITY ASSOCIATED WITH CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA (2010) (0)
- 903 Circulating tumour cells can not predict clinical or nodal stage, but survival after radical cystectomy for urothelial carcinoma of the bladder (2012) (0)
- Robot-Assisted Partial Nephrectomy Mid-Term Oncologic Outcomes: A Systematic Review (2022) (0)
- 889: Predictive Accuracy, Sensitivity, and Specificity of Nuclear Matrix Protein 22 and Urine Cytology for Prediction of Recurrence of Non-Transitional Cell Carcinoma of the Bladder (2006) (0)
- Oncologic impact of cumulative smoking exposure in patients treated with salvage radical prostatectomy for radiation-recurrent prostate cancer (2017) (0)
- MP75-20 THE RATE OF PIRADS 3 IS NOT A PROXY OF THE QUALITY OF MRI OF THE PROSTATE. RESULTS OF A SINGLE HIGH VOLUME RADIOLOGIST SERIES (2020) (0)
- 1764 COMPARATIVE ONCOLOGIC EFFECTIVENESS BETWEEN ROBOT-ASSISTED AND OPEN RADICAL CYSTECTOMY (2013) (0)
- What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? results from a large, multi-institutional series (2020) (0)
- MP12-17 IMMUNOTHERAPY-BASED COMBINATIONS IN THE FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH SARCOMATOID FEATURES: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (2022) (0)
- MP50-14 THE IMPACT OF RACE/ETHNICITY ON UPSTAGING AND/OR UPGRADING RATES AMONG INTEREDIATE RISK PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY (2021) (0)
- MP15-05 TOPOGRAPHIC DESCRIPTION OF THE SITE OF POSITIVE MPMRI AND IMPACT ON THE RISK OF POSITIVE SURGICAL MARGINS AT ROBOT-ASSISTED NERVE SPARING RADICAL PROSTATECTOMY. IMPLICATIONS FOR ACCURATE SURGICAL APPROACHES (2022) (0)
- Predictive factors for the absence of residual disease at repeated TURBT: Can we avoid a repeat TURBT in selected patients? (2019) (0)
- Characterization of late recurrence after radical cystectomy in a large multicenter cohort of bladder cancer patients (2016) (0)
- CHANGES OVER TIME IN NODE POSITIVE PROSTATE CANCER RATES AND FEATURES AMONG MEN TREATED WITH RADICAL PROSTATECTOMY AND EXTENTED PELVIC LYMPH NODE DISSECTION AT A SINGLE REFERRAL CENTER: MP97‐12 (2017) (0)
- Prognostic Factors and Predictive Tools in Upper Tract Urothelial Carcinoma (2018) (0)
- 1545 TRENDS IN UTILIZATION AND COMPARATIVE OUTCOMES FOR INFECTED UPPER URINARY TRACT STONES IN THE UNITED STATES: PCN VS. STENT (2013) (0)
- 552 Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma (2012) (0)
- PD57-12 WHICH PATIENTS WITH OLIGOMETASTATIC PROSTATE CANCER SHOULD BE CONSIDERED FOR CYTOREDUCTIVE RADICAL PROSTATECTOMY AS PART OF A MULTIMODAL TREATMENT? RESULTS FROM A LARGE, MULTI-INSTITUTIONAL COLLABORATION (2021) (0)
- 1821 ADVANCED AGE IS AN INDEPENDENT PREDICTOR OF CANCER-SPECIFIC MORTALITY AFTER RADICAL CYSTECTOMY FOR TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER (2010) (0)
- Regional differences in total hospital costs for radical cystectomy in the United States. (2023) (0)
- Identification of predictive serum biomarkers for chemotherapy resistance in prostate cancer using mass spectrometric proteome analysis (2018) (0)
- PD17-03 COMPARATIVE ANALYSES OF MICRO-ULTRASOUND VERSUS MRI-TARGETED BIOPSY FOR THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER. PRELIMINARY RESULTS FROM THE PROSPECTIVE US-MIRROR TRIAL (2022) (0)
- What is the optimal duration of hormonal treatment during salvage radiotherapy in men with pN1 Prostate Cancer? Results form a large Multi-Institutional series (2021) (0)
- Cure without toxicity: development of a novel model predicting trifecta outcomes after salvage radiation therapy for recurrent prostate cancer after radical prostatectomy (2020) (0)
- Which patients with Oligometastatic Prostate Cancer should be considered for Cytoreductive Radical Prostatectomy as part of a multimodal treatment? Results from a large, multi-institutional collaboration (2021) (0)
- 231 POST-TREATMENT NOMOGRAM FOR PREDICTION OF CONDITIONAL SURVIVAL AFTER NEPHRECTOMY (2009) (0)
- 1868 PROGNOSTIC VALUE OF BAJORIN CRITERIA FOR CANCER-SPECIFIC SURVIVAL IN PATIENTS WHO HAVE DISEASE RECURRENCE AFTER RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER (2013) (0)
- 1602 A POPULATION-BASED ASSESSMENT OF OUTCOMES AFTER RADICAL CYSTECTOMY IN OCTOGENARIANS (2012) (0)
- PD28-07 ASSESSMENT OF THE RATE OF ADHERENCE TO INTERNATIONAL GUIDELINES OF ANDROGEN DEPRIVATION THERAPY WITH EXTERNAL BEAM RADIATION THERAPY- A POPULATION-BASED STUDY (2016) (0)
- 253 PROGNOSTIC FACTORS OF CANCER RECURRENCE AND PROGRESSION IN PATIENTS WITH NON-MUSCLE-INVASIVE UROTHELIAL CARCINOMA (2011) (0)
- Implications of inadvertent radical nephrectomy instead of nephroureterectomy in the treatment of upper tract urothelial carcinoma (2020) (0)
- MP2-12 PROGNOSTIC IMPACT OF TUMOR STAGE ON POSITIVE LYMPH NODE STATUS IN UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING RADICAL NEPHROURETERECTOMY (2015) (0)
- 896 PREDICTION OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY: DEVELOPMENT OF A CLINICAL DECISION-MAKING TOOL (2013) (0)
- [BCG maintenance treatment: an optimal scheme?]. (2014) (0)
- Pembrolizumab (pembro) plus chemoradiotherapy (CRT) versus placebo plus CRT for patients (pts) with muscle-invasive bladder cancer (MIBC): The phase III KEYNOTE-992 study. (2021) (0)
- 1263: Competing Risks Nomogram Predicting the Probability of Bladder Cancer Recurrence after Cystectomy can Reliably Distinguish between those Destined to Recur and those who May Die of Other Causes before Recurrence (2006) (0)
- 839 DECREASED SURVIVAL OF BLACK AMERICANS WITH TESTICULAR CANCER: A CONTEMPORARY POPULATION-BASED ANALYSIS (2010) (0)
- MP78-15 BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: WHO IS AT RISK OF DYING FROM PROSTATE CANCER? (2015) (0)
- MP14-07 PATTERNS AND PREDICTORS OF CLINICAL RECURRENCE FOLLOWING EARLY SALVAGE RADIATION THERAPY IN PATIENTS WITH PSA RISE AFTER RADICAL PROSTATECTOMY: A LONG TERM MULTI-INSTITUTIONAL ANALYSIS (2016) (0)
- Hospitalization before surgery and subsequent risk of infective complications after radical cystectomy: A population-based analysis. (2017) (0)
- MP79-02 PERFORMANCE CHARACTERISTICS OF PET/CT SCAN IN MEN TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER: A PER PATIENT ANALYSIS WITH PATHOLOGICAL CONFIRMATION ACCORDING TO EACH AREA OF DISSECTION (2020) (0)
- MP40-14 PREDICTORS OF CANCER-SPECIFIC SURVIVAL AFTER DISEASE RECURRENCE IN PATIENTS WITH RENAL CELL CARCINOMA: THE EFFECT OF TIME TO RECURRENCE (2014) (0)
- PREDICTING LOCAL FAILURE AFTER RADICAL CYSTECTOMY IN BLADDER CANCER PATIENTS: IMPLICATIONS FOR THE SELECTION OF CANDIDATES AT ADJUVANT RADIATION THERAPY: MP58‐09 (2017) (0)
- Adrenal Lesions: Progress on All Fronts. (2016) (0)
- Corrigendum to < Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer>, urologic oncology: Seminars and original investigations volume 35, issue 6, June 2017, pages 356-362. (2022) (0)
- MP57-12 CANCER-SPECIFIC SURVIVAL AND PREDICTORS IN PATIENTS WITH CT3B KIDNEY CANCER: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM (2014) (0)
- Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy (2018) (0)
- The association of type and number of high‐risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapy (2022) (0)
- 474 Pathologic nodal staging scores (pNSS) for prostate cancer: A decision tool for adjuvant therapy after radical prostatectomy (2013) (0)
- MP63-20 DEVELOPMENT AND EXTERNAL VALIDATION OF A PATHOLOGICAL NODAL STAGING SCORE FOR PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA (2015) (0)
- MP74-03 GLEASON SCORE AT POSITIVE SURGICAL MARGIN IN PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS (2020) (0)
- Association between the extent of lymph node dissection and severe toxicity in men with prostate cancer treated with post-prostatectomy radiation therapy: results from a large multi-institutional series (2020) (0)
- Nonmuscle-invasive bladder cancer, old problems, new insights (2022) (0)
- MP43-19 DROP-OUT RATES FROM ACTIVE SURVEILLANCE FOR DISEASE PROGRESSION REMAIN CONSISTENT AND NOT NEGLIGIBLE OVER TIME. A PLEA FOR LONG-TERM ASSESSMENT BASED ON A LARGE, PROSPECTIVELY COLLECTED ACTIVE SURVEILLANCE COHORT (2022) (0)
- MP4-16 PATTERNS OF CLINICAL RECURRENCE AND IMPACT OF SITE OF METASTASIS ON MORTALITY OF PATIENTS WITH NODE POSITIVE PROSTATE CANCER AFTER RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION (2015) (0)
- MP78-12 ASSOCIATION OF CIGARETTE SMOKING AND SMOKING CESSATION WITH BIOCHEMICAL RECURRENCE IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER (2015) (0)
- 621 Diffusion weighted MRI of the bladder: A biomarker for prediction of bladder cancer aggressiveness (2014) (0)
- MP37-17 CHANGING PATTERNS AND PREDICTORS OF SALVAGE RADIATION THERAPY USE OVER TIME IN PATIENTS TREATED FOR POST-PROSTATECTOMY BIOCHEMICAL RECURRENCE: A TREND ANALYSIS OVER A 20-YEAR PERIOD FROM A MULTI-INSTITUTIONAL SERIES (2020) (0)
- 532 Final pathologic stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer: Does pT0 predict better survival than pTa/pTis/pT1? (2015) (0)
- 438 PREDICTORS OF EARLY OR LATE RECURRENCE AFTER PARTIAL OR RADICAL NEPHRECTOMIES FOR RENAL CELL CARCINOMA (2010) (0)
- 561 MAGE expression is associated with features of biologically aggressive urothelial carcinoma of the bladder (2012) (0)
- Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma. (2022) (0)
- 1031: Comparison of Stage Migration Patterns Between North America and Europe: An Analysis of 11350 Men (2007) (0)
- PD66-09 ACCURATE PREDICTION OF PROGRESSION TO MUSCLE INVASIVE DISEASE IN PATIENTS WITH T1G3 BLADDER CANCER: A CLINICAL DECISION-MAKING TOOL (2018) (0)
- Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States. (2023) (0)
- 396 Impact of stage migration on bladder cancer: A slow but steady improvement in the long term survival rates after radical cystectomy in the last 25 years (2016) (0)
- 655 IMPORTANT RACIAL DISPARITY EXISTS WITH RESPECT TO THE USE OF MINIMALLY INVASIVE RADICAL PROSTATECTOMY IN THE UNITED STATES (2011) (0)
- Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy. (2023) (0)
- Editorial comment on: Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. (2009) (0)
- More extensive lymph node dissection at radical prostatectomy is associated with improved outcomes after salvage radiotherapy for rising PSA after surgery: A long-term, multi-institutional analysis (2017) (0)
- ASSESSING THE RISK OF EARLY AND LATE TOXICITY OF POST‐PROSTATECTOMY RADIATION THERAPY: A LONG‐TERM MULTI‐INSTITUTIONAL ANALYSIS: PD72‐10 (2017) (0)
- IDENTIFYING THE OPTIMAL CANDIDATE FOR EARLY SALVAGE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: A LONG‐TERM MULTI‐INSTITUTIONAL ANALYSIS: PD51‐02 (2017) (0)
- MP68-11 IMPLICATIONS OF INADVERTENT RADICAL NEPHRECTOMY INSTEAD OF NEPHROURETERECTOMY IN THE TREATMENT OF UPPER TRACT UROTHELIAL CARCINOMA (2020) (0)
- 1367 SURGICAL MANAGEMENT OF T1A LESIONS IN THE 21ST CENTURY: A POPULATION-BASED STUDY (2010) (0)
- PD63-07 INTRAVESICAL THERAPY IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE-INVASIVE BLADDER CANCER: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF ONCOLOGIC OUTCOMES (2021) (0)
- No impact on disease recurrence or progression of the stage at re-TUR in Ta high-grade bladder cancer patients treated with BCG: A multi-center collaboration of EAU Young Academic Urologists Urothelial Carcinoma Group (2020) (0)
- 648 TUMOR GRADE IMPROVES THE ABILITY OF THE PROGNOSTIC ABILITY OF AJCC STAGES IN PATIENTS WITH PENILE CARCINOMA (2010) (0)
- Conditional survival for non-metastatic muscle-invasive adenocarcinoma of the urinary bladder after radical cystectomy. (2023) (0)
- Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review. (2023) (0)
- 1324: Survivin Expression is Associated With Characteristics of Benign Prostatic Hyperplasia (2004) (0)
- MP25-05 THE IMPACT OF CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA – A REAL-WORLD INVESTIGATION IN THE TKI ERA (2019) (0)
- MP24-06 THE IMPACT OF INSURANCE STATUS ON TUMOR CHARACTERISTICS AND TREATMENT SELECTION IN CONTEMPORARY PROSTATE CANCER PATIENTS (2015) (0)
- PD17-08 COMPARING THE DIAGNOSTIC ACCURACY OF 68GA-PSMA AND 11C-CHOLINE PET/CTSCAN ACCORDING TO PSA LEVEL: A LARGE MULTI-INSTITUTIONAL ANALYSIS WITH HISTOLOGICAL VERIFICATION IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER (2019) (0)
- Which positive surgical margins features impact on the risk of prostate cancer specific mortality? A disease-tailored, competing-risk, long-term analysis (2019) (0)
- PD12-12 COMPLICATION RATES AFTER RADICAL CYSTECTOMY AFTER RADIOTHERAPY: AN INTERNATIONAL, MULTICENTER RETROSPECTIVE STUDY ON 609 CASES (2016) (0)
- 113 IMPACT OF HOSPITAL AND SURGEONS VOLUME ON COMPLICATION RATES AFTER RADICAL CYSTECTOMY: POPULATION BASED STUDY (2010) (0)
- 643 STAGE SPECIFIC POPULATION-BASED TRENDS OF RPLND USE (2010) (0)
- Re: Failure-Free Survival and Radiotherapy in Patients with Newly Diagnosed Nonmetastatic Prostate Cancer: Data from Patients in the Control Arm of the STAMPEDE Trial. (2016) (0)
- Exploring the molecular basis of sexual dimorphism in bladder cancer (2020) (0)
- 650 A multi-institutional analysis of pathological and survival outcomes in patients with clinically node positive urothelial bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy (2015) (0)
- Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancer (2023) (0)
- A competing risk analysis of survival after radical cystectomy for bladder cancer patients: The impact of age at the time of surgery (2019) (0)
- Abstract 1193: Prospective validation of multiple biomarkers for improved clinical decision-making in patients with urothelial carcinoma of the bladder (2010) (0)
- Blood-Based Biomarkers as Prognostic Factors of Recurrent Disease after Radical Cystectomy: A Systematic Review and Meta-Analysis (2023) (0)
- 675 A COMPARATIVE SURVIVAL ANALYSIS OF NON BILHARZIAL SQUAMOUS CELL CARCINOMA VS. TRANSITIONAL CELL CARCINOMA AFTER CYSTECTOMY (2009) (0)
- Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: results from a large multicenter cohort study (2020) (0)
- Inclusion of prostate cancer foci outside imaging detected index lesion improves the ability to predict final pathological stage: Implications for a correct patient staging (2018) (0)
- Radical prostatectomy in metastatic prostate cancer: a systematic review (2017) (0)
- AUAP-3 Urothelial carcinoma at the uretero-enteric junction : multi-center evaluation of oncologic outcomes after radical nephroureterctomy (2011) (0)
- 1401 IS THE NODAL YIELD ASSOCIATED WITH OUTCOMES IN BLADDER CANCER PATIENTS WITHOUT NODAL METASTASIS AT RADICAL CYSTECTOMY (2012) (0)
- Comparing the diagnostic accuracy of 68Ga-PSMA and 11C-Choline PET/CT scan according to PSA level: A large multi-institutional analysis with histological verification in patients treated with salvage lymph node dissection for recurrent prostate cancer (2019) (0)
- 735 Nomogram predicting cancer specific mortality (CSM) after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer (BC): Results of an international consortium (2015) (0)
- EARLY POST-OPERATIVE PLASMA TGF-β1 IS A STRONG PREDICTOR OF BIOCHEMICAL PROGRESSION AFTER RADICAL PROSTATECTOMY (2008) (0)
- Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer. (2023) (0)
- Bladder-preserving strategies for Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer; where are we and what will be expected?: Erratum. (2020) (0)
- Prognostic value of concomitant carcinoma in situ in radical cystectomy specimens on patients with bladder cancer: A meta-analysis of 24,136 patients (2018) (0)
- Evaluation of Patterns of Presentation, Practice, and Outcomes of Upper Tract Urothelial Cancer: Protocol for an Observational, International, Multicenter, Cohort Study by the Clinical Research Office of the Endourology Society (Preprint) (2019) (0)
- Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis. (2022) (0)
- 1898 CLINICAL CARCINOMA IN SITU ONLY DISEASE: OUTCOMES OF PATIENTS TREATED WITH RADICAL CYSTECTOMY (2011) (0)
- Prevalence and trends in kidney stone among adults in the United States, 2007-2014 (2019) (0)
- 1249: Internal Validation of a Competing-Risks Survival Nomogram for Patients Treated with Cystectomy for Bladder Cancer (2006) (0)
- Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype (2022) (0)
- PD42-07 RADICAL VS PARTIAL CYSTECTOMY FOR URACHAL CARCINOMA: A POPULATION-BASED ANALYSIS (2022) (0)
- North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients (2018) (0)
- 907 Post-operative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with pT1-T3 N0/Nx upper tract urothelial carcinoma without metastasis (2014) (0)
- MP41-13 TIME FROM BIOCHEMICAL TO CLINICAL RECURRENCE SHOULD BE CONSIDERED AS A PROXY OF OVERALL SURVIVAL IN PATIENTS WITH CLINICALLY-LOCALIZED PROSTATE CANCER WHO EXPERIENCE RECURRENCE AFTER RADICAL PROSTATECTOMY (2019) (0)
- Clinical Cancer esearch cer Therapy : Clinical Effectiveness of Off-Protocol Adjuvant Chemotherapy for R ients with Urothelial Carcinoma of the Urinary Bladder (2010) (0)
- Can radical cystectomy be performed safely in the metastatic setting? Location of metastatic bladder cancer as a determinant of in-hospital mortality (2017) (0)
- MP7-05 PROGNOSTIC VALUE OF THE PT3 SUBCLASSIFICATION FOR UPPER TRACT UROTHELIAL CARCINOMAS OF THE RENAL PELVICALYCEAL SYSTEM (2016) (0)
- 733 MORTALITY PREDICTIONS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA (2009) (0)
- 1076 INDEPENDENT VALIDATION OF THE 2010 TNM STAGING SYSTEM FOR RENAL CELL CARCINOMA: DOES IT IMPROVES PREDICTIVE ACCURACY IN CANCER-SPECIFIC MORTALITY COMPARED TO 2002 TNM? (2013) (0)
- 688 THE EFFECT OF HOSPITAL VS. SURGICAL VOLUME ON OUTCOMES AFTER RADICAL PROSTATECTOMY A HEAD-TO-HEAD COMPARISON USING DECISION-CURVE ANALYSES (2012) (0)
- MP78-19 CIGARETTE SMOKING IS ADVERSELY ASSOCIATED WITH PATHOLOGICAL RESPONSE TO PLATINUM-BASED NEOADJUVANT CHEMOTHERAPY IN PATIENTS UNDERGOING TREATMENT FOR URINARY BLADDER CANCER - A PROSPECTIVE EUROPEAN MULTICENTER STUDY OF THE EAU YOUNG ACADEMIC UROLOGISTS (YAU) UROTHELIAL CARCINOMA GROUP (2018) (0)
- [What are the differences between American and French urologists?]. (2007) (0)
- Single nucleotide polymorphisms and risk of prostate cancer: Development and validation of a novel genetic risk score for individualized screening and diagnostic programmes (2018) (0)
- MP08-08 EN BLOC RESECTION VERSUS CONVENTIONAL TURBT FOR T1HG BLADDER CANCER: A PROPENSITY SCORE-MATCHED ANALYSIS (2023) (0)
- Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity (2023) (0)
- Performance characteristics of PET/CT scan in men treated with salvage lymph node dissection for recurrent prostate cancer: a per patient analysis with pathological confirmation according to each area of dissection (2020) (0)
- 1027 A POPULATION-BASED COMPETING-RISKS ANALYSIS OF THE SURVIVAL OF PATIENTS TREATED WITH RADICAL CYSTECTOMY FOR BLADDER CANCER (2010) (0)
- Neutrophil to lymphocyte ratio is associated with lymph node invasion and higher nodal burden in contemporary high risk patients treated with radical prostatectomy and extended pelvic lymph node dissection (2018) (0)
- 514 Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for non-metastatic bladder cancer: Results from a single high-volume institution (2016) (0)
- THE EFFECT OF COMPETING MORTALITY ON THE RISK OF BLADDER-CANCER RECURRENCE AND BLADDER CANCER SPECIFIC SURVIVAL (2006) (0)
- Systemic therapy for metastatic renal cell carcinoma in the first-line setting: Network meta-analysis (2020) (0)
- 35 CONCOMITANT CARCINOMA IN SITU IS NOT ASSOCIATED WITH CLINICAL OUTCOMES AFTER RADICAL CYSTECTOMY (2010) (0)
- PREDICTIVE VALUE OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER (2008) (0)
- 323 BLADDER CANCER (BCA) CONTROL OUTCOMES HAVE NOT IMPROVED WITHIN THE LAST THIRTY YEARS: A TREND ANALYSIS IN THE UNITED STATES (2011) (0)
- 1086 A systematic review and meta-analysis on the ejaculatory dysfunction after medical treatment for BPH: Data from 30 thousand patients enrolled in 23 RCTs (2014) (0)
- RACE AND GENDER DO NOT AFFECT THE CANCER-SPECIFIC SURVIAL AFTER SURGERY IN PATIENTS WITH UPPER TRACT TRANSITIONAL CELL CARCINOMA (2009) (0)
- 1452: Defining the Characteristics of Locally Recurrent Prostate Cancer After Radical Prostatectomy Based on the Results of Salvage Radiotherapy: a Multi-Center Analysis (2004) (0)
- Gene therapy for prostate cancer. (2000) (0)
- MP12-20 FIRST-LINE IMMUNOTHERAPY-BASED COMBINATIONS FOR METASTATIC RENAL CELL CARCINOMA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (2022) (0)
- The number of positive mpMRI-targeted cores is linearly associated with the risk of multifocal clinically significant prostate cancer: Implications for correct patient staging and counselling (2018) (0)
- MP67-18 IMPACT OF PERSISTENT PSA IN SALVAGE RADICAL PROSTATECTOMY PATIENTS - A MULTICENTER STUDY (2023) (0)
- 454 Impact of pre-treatment PSA level on cancer control after early salvage radiation therapy post-radical prostatectomy: Need for patient stratification according to prostate cancer features (2015) (0)
- 1433 FIVE YEAR PROSPECTIVE EVALUATION OF A MOLECULAR MARKER PANEL FOR PREDICTION OF RECURRENCE AFTER RADICAL CYSTECTOMY (2013) (0)
- The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer (2023) (0)
- Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients. (2021) (0)
- 1103 ROBOT-ASSISTED VS. LAPAROSCOPIC PARTIAL NEPHRECTOMY UTILIZATION PATTERNS AND PERIOPERATIVE OUTCOMES IN THE UNITED STATES (2012) (0)
- Validation externe d’un nomogramme de prédiction des complications après néphro-urétérectomie totale (2017) (0)
- What is the role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma? (2023) (0)
- Predictors of undetectable disease after radical cystectomy: Results from a single, large single-institution series (2019) (0)
- MP48-13 THE KEY ROLE OF CONCOMITANT ANDROGEN-DEPRIVATION THERAPY ON THE EFFICACY OF IMAGING GUIDED TREATMENTS IN MEN WITH BIOCHEMICAL RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY AND POSITIVE 68GA-PSMA PET/CT SCAN (2022) (0)
- PREOPERATIVE FACTORS PREDICTING LYMPH NODE INVASION IN PATIENTS WITH UPPER TRACT TRANSITIONAL CELL CARCINOMA (2008) (0)
- Correlation of disease-free survival at 2 to 3 years and 5-year overall survival in patients with muscle-invasive bladder cancer undergoing radical cystectomy. (2010) (0)
- Urinary Diversion (2019) (0)
- 1997 NATURAL HISTORY OF PATIENTS WITH DISEASE RECURRENCE AFTER NEPHRECTOMY FOR LOCALIZED RENAL CELL CARCINOMA (2011) (0)
- Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis (2023) (0)
- 1336 THE IMPACT OF HOSPITAL VOLUME, RESIDENCY AND FELLOWSHIP TRAINING ON COMPLICATIONS AFTER RADICAL PROSTATECTOMY (2012) (0)
- MP56-02 HEAD TO HEAD COMPARISON OF CONDITIONAL ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH INTERMEDIATE AND HIGH RISK PROSTATE CANCER (2015) (0)
- MP48-09 TOXICITY PROFILE OF IMMEDIATE POST-PROSTATECTOMY RADIATION THERAPY: RESULTS FROM A LARGE MULTI-INSTITUTIONAL SERIES (2022) (0)
- PRE-OPERATIVE PLASMA HER2 AND EGFR FOR STAGING AND PROGNOSTICATION IN PATIENTS WITH CLINICALLY LOCALISED PROSTATE CANCER (2008) (0)
- MP14-12 DISAGREEMENTS BETWEEN MEMORIAL SLOAN KETTERING CANCER CENTER (MSKCC) AND THE INTERNATIONAL METASTATIC RCC DATABASE CONSORTIUM (IMDC) PROGNOSTIC SCORE AND THEIR IMPACT ON SURVIVAL OUTCOMES IN CLEAR-CELL METASTATIC RENAL CELL CARCINOMA (mRCC) PATIENTS TREATED WITH TYROSINE-KINASE INHIBITORS (T (2021) (0)
- 1825 CLINICAL OUTCOME IN PATIENTS WITH PT4 UROTHELIAL CARCINOMA AT RADICAL CYSTECTOMY (2010) (0)
- 146 Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder (2014) (0)
- 685 COMPLICATIONS OF OPEN RADICAL NEPHRECTOMY VERSUS LAPAROSCOPIC RADICAL NEPHRECTOMY FOR NON-METASTATIC RENAL CELL CARCINOMA: A POPULATION-BASED ANALYSIS OF THE UNITED STATES (2011) (0)
- Multiparametric MRI increases clinically significant prostate cancer detection relative to standard clinical predictors: Results of a risk adapted analysis in a non-screened population (2018) (0)
- High-dose-rate brachytherapy and hypo-fractionated external beam radiation combined with long-term androgen deprivation for very-high-risk prostate cancer (2021) (0)
- PD33-02 VARIANT HISTOLOGIC DIFFERENTIATION IN BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: INCIDENCE AND LONG TERM SURVIVAL IN A SINGLE INSTITUTION STUDY. (2016) (0)
- PD60-10 A MORE EXTENDED PELVIC LYMPH NODE DISSECTION DECREASES RECURRENCE RATES IN SELECTED PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY (2022) (0)
- Multi-institutional evaluation of the prognostic significance of altered mammalian target of rapamycin (mTOR) pathway biomarkers in upper-tract urothelial carcinoma (UTUC). (2014) (0)
- Stage-migration and survival of lymph node positive prostate cancer patients: A comprehensive trend analyses of surgically treated men over the last two decades (2018) (0)
- MP56-18 NON-SURGICALLY RELATED CAUSES OF ERECTILE DYSFUNCTION AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: RESULTS FROM A SINGLE INSTITUTION SERIES (2015) (0)
- Early Vienna sources on the history of urology, sexual medicine and sexology (2021) (0)
- Development of a preoperative nomogram incorporating biomarkers of systemic inflammatory response to predict non-organ-confined urothelial carcinoma of the bladder at radical cystectomy (2016) (0)
- OP3-06 IMPACT OF TIME TO BIOCHEMICAL RECURRENCE ON CANCER-SPECIFIC MORTALITY IN PATIENTS WITH HIGH-RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: A COMPETING-RISKS REGRESSION ANALYSIS (2014) (0)
- Assessing the impact of salvage radiation therapy field after radical prostatectomy: a long-term analysis from a large multi-institutional series (2020) (0)
- MP47-20 THE IMPACT OF CIGARETTE SMOKING ON ADVERSE PATHOLOGICAL FEATURES AND SURVIVAL IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER - A PROSPECTIVE, EUROPEAN MULTICENTER STUDY OF THE EAU YOUNG ACADEMIC UROLOGISTS (YAU) UROTHELIAL CARCINOMA GROUP (2018) (0)
- 1017 Systematic assessment of positive surgical margins features in open vs. robot-assisted radical prostatectomy: Is there a difference? (2015) (0)
- The clinical value of the urokinase-plasminogen activator system (uPA) in patients with radical cystectomy (RC) for bladder cancer (2020) (0)
- Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients (2022) (0)
- MP58-13 OUTCOME REPORTING AFTER RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER USING ONCOLOGICAL TRIFECTA AND PENTAFECTA (2015) (0)
- IMPACT OF PROSTATE INVOLVEMENT ON OUTCOMES IN PATIENTS TREATED WITH RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER: MP54‐19 (2017) (0)
- Words of wisdom. Re: Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML. J Urol 2008;179:1830-7; discussion 1837. (2009) (0)
- Time from biochemical to clinical recurrence should be considered as a proxy of overall survival in patients with clinically-localized prostate cancer who experience recurrence after radical prostatectomy (2019) (0)
- Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort (2023) (0)
- Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysis. (2023) (0)
- Assessing the association between the template of pelvic salvage lymph node dissection for node-only recurrent prostate cancer and oncological outcomes. Results of a multi-institutional series (2021) (0)
- Preoperative anemia is a predictor of disease recurrence, cancer-specific survival and overall survival in bladder cancer patients: A retrospective study on 4335 radical cystectomies (2016) (0)
- From Avoiding Overtreatment and Undertreatment to Delivering the Right Therapy at the Right Time for the Right Tumor in the Right Patient: The Age of the Thoughtful Urologic Oncologic Surgeon Has Begun. (2023) (0)
- Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract: adapting new technologies for the diagnosis and management of upper tract urothelial carcinoma (2012) (0)
- Pure histological variants are associated with poor survival at radical cystectomy in patients with bladder cancer (2017) (0)
- 647 IMPACT OF LYMPHADENECTOMY AND SYSTEMIC CHEMOTHERAPY ON SURVIVAL OF PATIENTS WITH T4 UPPER TRACT UROTHELIAL CANCER (2012) (0)
- 2335 SOLUBLE GP130 PROMOTES PROSTATE CANCER INVASION AND PROGRESSION IN AN IL-6 INDEPENDENT FASHION (2011) (0)
- 151 Association of the expression of T-cell coregulatory proteins with clinical outcomes in patients with urothelial carcinoma of the bladder (2013) (0)
- 524 Preoperative renal artery embolization in renal carcinoma with venous thrombus: Preliminary results of a multicenter study (2016) (0)
- MP72-15 THE INTERVAL BETWEEN DIAGNOSIS AND RADICAL CYSTECTOMY DOES NOT IMPACT THE OUTCOMES OF PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY (2015) (0)
- IMPAIRED BASELINE PERFORMANCE STATUS AND CHRONIC KIDNEY DISEASE ARE SIGNIFICANTLY ASSOCIATED WITH MAJOR COMPLICATIONS FOLLOWING RADICAL NEPHROURETERECTOMY: MP78‐13 (2017) (0)
- MP77-05 ASSOCIATION OF PERIOPERATIVE BLOOD TRANSFUSION WITH ONCOLOGIC OUTCOMES AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (2014) (0)
- Risk stratification of high‐grade Ta, CIS, and T1 urothelial carcinoma of the bladder (2015) (0)
- No overt in X uence of lymphadenectomy on cancer-speci W c survival in organ-con W ned versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy : a retrospective international , multi-institutional study (2011) (0)
- Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia (2019) (0)
- European Urology: serving our readership through systematic peer review, use of reporting standards, and encouragement of postpublication review. (2015) (0)
- 620 Complication rates after radical cystectomy following any previous abdominal-pelvic-perineal radiotherapy: An international, multicenter retrospective study on 609 cases (2016) (0)
- Does castration status affect docetaxel‐related adverse events? :Identification of risk factors for docetaxel‐related adverse events in metastatic prostate cancer (2022) (0)
- PD10-07 CAN WE RELY ON AVAILABLE MODELS TO IDENTIFY CANDIDATES FOR EXTENDED PELVIC LYMPH NODE DISSECTION (EPLND) IN MEN STAGED WITH PSMA-PET? EXTERNAL VALIDATION OF THE BRIGANTI NOMOGRAMS AND DEVELOPMENT OF A NOVEL TOOL TO IDENTIFY OPTIMAL CANDIDATES FOR EPLND (2023) (0)
- 362 ROBOT-ASSISTED VS. OPEN RADICAL PROSTATECTOMY: A COMPARISON OF OUTCOMES ACROSS PROCEDURE TYPE AND VOLUME QUARTILE (2013) (0)
- PD34-05 IMPACT OF PREVIOUS WHOLE PELVIS RADIATION THERAPY IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR PROSTATE CANCER NODE-ONLY RECURRENCE: EVALUATION OF SURGICAL, PATHOLOGICAL, AND ONCOLOGICAL OUTCOMES (2021) (0)
- 1804 VASCULAR SCLEROSIS IN NEPHRECTOMY SPECIMENS IS ASSOCIATED WITH FUTURE DEVELOPMENT OF CHRONIC KIDNEY DISEASE (2013) (0)
- Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients. (2023) (0)
- External validation of two mpMRI-risk calculators predicting risk of prostate cancer before biopsy (2022) (0)
- Long-term impact of adjuvant versus early salvage radiation therapy on clinical recurrence in PT3N0 prostate cancer patients treated with radical prostatectomy: results of amulti-institutional series (2016) (0)
- MP37-02 IMPACT OF SURGICAL VOLUME ON SURGICAL MARGIN STATUS IN PATIENTS TREATED WITH ROBOT-ASSISTED RADICAL PROSTATECTOMY (2014) (0)
- Risk Stratification of Upper Tract Urothelial Carcinoma for Kidney-Sparing Surgery (2021) (0)
- Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer? (2022) (0)
- Changing patterns and predictors of salvage radiation therapy use over time in patients treated for post-prostatectomy biochemical recurrence: a trend analysis over a 20-year period from a multi institutional series (2020) (0)
- Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. (2012) (0)
- 671 PREDICTIVE VALUE OF THE COMBINATION OF IMMUNOSTOCHEMICAL MARKERS IN PATIENTS WITH PT1 DISEASE AT RADICAL CYSTECTOMY (2009) (0)
- 323 INTERNATIONAL VALIDATION OF THE PROGNOSTIC VALUE OF LYMPHOVASCULAR INVASION IN RADICAL CYSTECTOMY PATIENTS (2010) (0)
- 570 AN ANALYSIS OF PATIENTS WITH T2 RENAL CELL CARCINOMA ACCORDING TO TUMOR SIZE: A POPULATION-BASED ANALYSIS (2012) (0)
- ASSOCIATION BETWEEN RS6152 POLYMORPHISM IN THE ANDROGEN RECEPTOR GENE AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY: MP29‐17 (2018) (0)
- 1427: Circulating Levels of Plasminogen Activation Inhibitor-1 Improve the Accuracy of Pre- and Post-Operative Nomograms for Prediction of Prostate Cancer Recurrence after Radical Prostatectomy (2007) (0)
- PD35-06 POST-OPERATIVE NOMOGRAM TO PREDICT CANCER-SPECIFIC SURVIVAL AFTER RADICAL NEPHROURETERECTOMY IN PATIENTS WITH PT1-T3 N0/NX UPPER TRACT UROTHELIAL CARCINOMA WITHOUT METASTASIS (2014) (0)
- Urinary level of urokinase-type plasminogen activator and its receptor in the detection of bladder cancer (2003) (0)
- SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY VS. NO SURGERY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (2009) (0)
- Northeastern Section AUA 62nd Annual Meeting • Pittsburgh, PA • September 22-26, 2010. (2010) (0)
- A phase III study of INCB054828 as adjuvant therapy in patients (pts) with high-risk urothelial carcinoma (UC) harboring fibroblast growth factor receptor 3 (FGFR3) genomic alterations. (2018) (0)
- High prevalence and negative impact of sarcopenia on oncological outcomes in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy (2020) (0)
- The ef fi cacy of BCG TICE and BCG Connaught in a cohort of 2 , 099 patients with T 1 G 3 non – muscle-invasive bladder cancer (2016) (0)
- Comment on: "Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society". (2022) (0)
- 865PAdjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: A joint study of the EAU-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration (2017) (0)
- PD35-03 THE SIGNIFICANCE OF DE-RITIS RATIO IN PATIENTS WITH RADIATION-RECURRENT PROSTATE CANCER UNDERGOING SALVAGE RADICAL PROSTATECTOMY (2021) (0)
- 401 MRI-based spatially resolved quantitative diffusivity measurements reflect proliferative activity of bladder cancer (2016) (0)
- Role of Pelvic Drain and Timing of Urethral Catheter Removal Following RARP: A Systematic Review and Meta-analysis. (2023) (0)
- 1717 BILHARZIAL RELATED BLADDER CANCER: PATHOLOGICAL CHARACTERISTICS AND VALUE OF CYCLOOXYGENASE-2 EXPRESSION (2010) (0)
- PD57-09 SYSTEMATIC REVIEW AND META-ANALYSIS OF ADJUVANT THERAPY AFTER NEPHRECTOMY FOR HIGH-RISK, NON-METASTATIC RENAL CELL CARCINOMA (2018) (0)
- 394 VALIDATION OF VISCERAL METASTASES AND KARNOFSKY PERFORMANCE STATUS SCORE AS PREDICTORS OF ALL CAUSE MORTALITY AND CANCER-SPECIFIC SURVIVAL (2012) (0)
- MP46-05 IMPACT OF MINIMALLY INVASIVE APPROACH ON THE PROBABILITY OF EARLY COMPLETE FUNCTIONAL RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY (2014) (0)
- Development and split-sample validation of the first nomogram to identify the candidates for extended pelvic lymph node dissection among men staged with multi-parametric MRI for clinically localized prostate cancer (2018) (0)
- An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer (2023) (0)
- 1011 COMPARISON OF STAGE MIGRATION PATTERNS BETWEEN NORTH AMERICA AND EUROPE: AN ANALYSIS OF 11350 MEN (2007) (0)
- MOLECULAR PROFILING OF MULTI‐FOCAL PROSTATE CANCER AND CONCOMITANT LYMPH NODE METASTASIS: IMPLICATIONS FOR TISSUE‐BASED PROGNOSTIC BIOMARKERS: PD07‐12 (2017) (0)
- MP46-07 PROGNOSTIC VALUE OF PREOPERATIVE VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR CELL ADHESION MOLECULE-1 IN BLADDER CARCINOMA TREATED WITH RADICAL CYSTECTOMY (2023) (0)
- Comparison of DNA methylation profiles between BCG responders and failures (2018) (0)
- A Comparative Survival Analysis of Nonbilharzial Squamous Cell Carcinoma vs. Transitional Cell Carcinoma After Radical Cystectomy (2009) (0)
- Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis (2019) (0)
- 276 Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy (2013) (0)
- 770 Propensity-score matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: A national series (2012) (0)
- Skeletal muscle loss predicts oncological outcomes in T1HG patients treated with adjuvant intravesical BCG: Implications for decision-making? (2020) (0)
- Dissection of primary prostate cancer to determine the clonal origin of synchronous lymph node metastasis. (2020) (0)
- MP48-05 NEOADJUVANT CHEMOTHERAPY IN ELDERLY PATIENTS WITH UPPER TRACT UROTHELIAL CANCER: ONCOLOGIC OUTCOMES FROM A MULTICENTER STUDY (2021) (0)
- Seminar article Bladder cancer in the elderly (2009) (0)
- 132A multi-institutional pre-operative prognostic model to predict the risk of locally advanced pathologic stage (PT3+) and of lymph node metastases (PN+) at radical cystectomy: Development and internal validation (2005) (0)
- MP56-03 NUMBER OF LYMPH NODES REMOVED AT RADICAL PROSTATECTOMY FOR NODE NEGATIVE PROSTATE CANCER: A POTENTIAL MARKER OF DISEASE PERSISTENCE IN PATIENTS WITH EARLY BIOCHEMICAL FAILURE (2015) (0)
- PD10-08 THE PROGNOSTIC IMPACT OF PREOPERATIVE PSMA-PET ON EARLY ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: RESULTS OF A MULTI-CENTER ANALYSIS (2023) (0)
- Effect of positive surgical margins at radical prostatectomy on cancer‐specific mortality in high/very high‐risk prostate cancer patients with Gleason Grade Group 4–5 (2022) (0)
- MP61-01 THE EXTENT OF PELVIC LYMPH NODE DISSECTION DOES NOT IMPACT ON CANCER SPECIFIC SURVIVAL FOR PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER (2014) (0)
- IMPROVED PREDICTION OF CLINICAL OUTCOMES IN PATIENTS WITH ADVANCED BLADDER CANCER USING A PANEL OF FOUR CELL CYCLE REGULATORS (2009) (0)
- PD13-01 LOSS OF FOXA1 EXPRESSION IS ASSOCIATED WITH ADVERSE PATHOLOGIC FEATURES AND INFERIOR ONCOLOGIC OUTCOMES FOLLOWING RADICAL NEPHROURETERECTOMY (2016) (0)
- 41 PERSONALIZED MANAGEMENT OF UPPER URINARY TRACT UROTHELIAL CARCINOMA: THE EFFECT OF AGE ON CANCER-SPECIFIC MORTALITY (2010) (0)
- 542 IMPROVED PREDICTION OF CLINICAL OUTCOMES IN PATIENTS WITH ADVANCED BLADDER CANCER USING A PANEL OF FOUR CELL CYCLE REGULATORS (2009) (0)
- IS TRANSURETHRAL RESECTION ALONE ENOUGH FOR DIAGNOSIS HISTOLOGICAL VARIANTS? A SINGLE CENTER STUDY: MP58‐13 (2017) (0)
- MP22-06 IMAGING TARGETED TREATMENTS VERSUS EXTENDED SALVAGE LYMPH NODE DISSECTION FOR PATIENTS WITH A SINGLE NODAL RECURRENCE OF PROSTATE CANCER: A COMPARATIVE ANALYSIS FROM A LARGE MULTI-INSTITUTIONAL SERIES (2019) (0)
- Difference in Incontinence Pad Use between Patients after Radical Prostatectomy and Cancer-Free Population with Subgroup Analysis for Open vs. Minimally Invasive Radical Prostatectomy: A Descriptive Analysis of Insurance Claims-Based Data (2021) (0)
- North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy (2018) (0)
- Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node Involvement. (2017) (0)
- 423 EMERGENCY ROOM VISITS IN PATIENTS WITH METASTATIC PROSTATE CANCER (2013) (0)
- MP06-02 THE IMPACT OF SMOKING ON GENOMIC ALTERATIONS IN MUSCLE-INVASIVE BLADDER CANCER (2018) (0)
- Increase and Plateauing of Testicular Cancer Incidence in Austria—A Time Trend Analysis of the Past Four Decades (2023) (0)
- EXTERNAL VALIDATION OF A PREOPERATIVE NOMOGRAM TO PREDICT LIKELIHOOD OF ALL COMPLICATIONS FOLLOWING RADICAL NEPHROURETERECTOMY: MP78‐09 (2017) (0)
- 1041 Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for selection of active surveillance candidates (2015) (0)
- A SYSTEMATIC ANALYSIS OF THE PROGNOSTIC ABILITY OF VARIOUS NODAL CODING SCHEMES IN BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY (2008) (0)
- Detection o f C linically S ignificant, O ccult P rostate C ancer Metastases i n L ymph N odes U sing a S plice V ariant-Specific RT-PCR A ssay f or H uman G landular K allikrein (2003) (0)
- 322 CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH PT4 UROTHELIAL CARCINOMA AT RADICAL CYSTECTOMY: A RETROSPECTIVE INTERNATIONAL STUDY OF 583 PATIENTS (2010) (0)
- [Granting of venia legendi as an indicator of specialization : Victor von Ivánchich de Margita (1812-1892) "Lecturer for surgery of the urogenital organs" in Vienna in 1851]. (2022) (0)
- 908 ASSOCIATION OF BLOOD LEVELS OF UROKINASE PLASMINOGEN ACTIVATOR AND ITS SOLUBLE RECEPTOR WITH PROSTATE CANCER PRESENCE, INVASION, PROGRESSION, AND METASTASIS (2007) (0)
- PD35-09 TALL SCORE FOR PREDICTION OF ONCOLOGICAL OUTCOMES AFTER RADICAL NEPHROURETERECTOMY FOR HIGH GRADE UPPER TRACT UROTHELIAL CARCINOMA (2014) (0)
- Initial experience with aggressive treatment of metastastic prostate cancer using 3 cycles of 7.4 GBq [177Lu]-PSMA every 4 weeks (2016) (0)
- Online Crowdfunding for Urologic Cancer Care (2022) (0)
- Abstract 4130: Frequency and prognostic value of PTEN loss in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy (2014) (0)
- The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy (2023) (0)
- 1841 THE IMPORTANCE OF PELVIC LYMPH NODE DISSECTION IN THE ELDERLY: IMPLICATIONS FOR INTERPRETATION OF THE 2010 NATIONAL COMPREHENSIVE CANCER NETWORK PRACTICE GUIDELINES FOR BLADDER CANCER TREATMENT (2011) (0)
- POPULATION‐BASED VALIDATION OF THE 2014 ISUP GLEASON GRADING GROUPING IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY, BRACHYTHERAPY, EXTERNAL BEAM RADIATION OR NO LOCAL TREATMENT: MP20‐03 (2017) (0)
- Local treatment of metastasis improves oncological outcome in men with prostate cancer undergoing cytoreductive radical prostatectomy (cRP) for metastatic prostate cancer (mPCA) (2018) (0)
- MP37-11 ASSOCIATION BETWEEN THE EXTENT OF LYMPH NODE DISSECTION AND SEVERE TOXICITY IN MEN WITH PROSTATE CANCER TREATED WITH POST-PROSTATECTOMY RADIATION THERAPY: RESULTS FROM A LARGE MULTI-INSTITUTIONAL SERIES (2020) (0)
- NOMOGRAM PREDICTING RENAL CANCER-SPECIFIC SURVIVAL IN SURGICALLY TREATED PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (2008) (0)
- Biomarkers for screening and early detection of prostate cancer (2013) (0)
- Advances in Bladder Cancer Management (2015) (0)
- MP23-11 PERIOPERATIVE COMPLICATIONS AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: AN INTERNATIONAL MULTICENTER COLLABORATION (2022) (0)
- Epidemiology and Sociocultural Differences for Bladder Cancer (2018) (0)
- 615 PARTIAL NEPHRECTOMY (PN) VERSUS RADICAL NEPHRECTOMY (RN) FOR NON-METASTATIC RENAL CELL CARCINOMA (RCC): UTILIZATION TRENDS IN THE UNITED STATES (2011) (0)
- 17 Frequency and prognostic value of PTEN loss in patients with upper tract urothelial carcinoma (2014) (0)
- Renal cancer therapy: going forward by going backward? (2013) (0)
- T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum. (2022) (0)
- Psychological Distress in Patients Treated for Renal Cell Carcinoma: A Systematic Literature Review (2022) (0)
- The more you see, the more you miss: Association between PI-RADS score of the index lesion and multifocal, clinically significant prostate cancer (2018) (0)
- Highlights Bladder Cancer AUA 2010 (2010) (0)
- Atezolizumab (atezo) therapy for locally advanced/metastatic urinary tract carcinoma (mUTC) in patients (pts) with poor performance status (PS): Analysis of the prospective global SAUL study. (2020) (0)
- MP82-06 NEW CLASSIFICATION FOR UPPER TRACT UROTHELIAL CARCINOMA TO ENHANCE RISK STRATIFICATION OF PATIENTS ELIGIBLE TO ENDOSCOPIC MANAGEMENT: AN INTERNATIONAL COLLABORATIVE STUDY (2020) (0)
- 1906 POSITIVE SURGICAL MARGINS CONTRIBUTE TO DELAYED FAILURES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER (2012) (0)
- MP48-10 THE ROLE OF PRIOR BLADDER CANCER ON ANY RECURRENCE AND DISTANT METASTASIS IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY (2021) (0)
- Survival outcomes after radical cystectomy versus conservative management for clinical T1 high grade non-muscle invasive micropapillary bladder cancer: A multicenter collaboration by the European Association of Urology–Young Academic Urologists (2021) (0)
- Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023. (2023) (0)
- The relative drop of PSA values after androgen deprivation therapy is a useful parameter to select the best candidate for cytoreductive radical prostatectomy among patients with oligometastatic prostate cancer: an external validation study (2020) (0)
- 651 COMPARATIVE ONCOLOGIC EFFECTIVENESS OF OPEN VERSUS ROBOTIC-ASSISTED RADICAL PROSTATECTOMY IN PATIENTS WITH EXTRACAPSULAR EXTENSION AND/OR SEMINAL VESICLE INVASION (2011) (0)
- 1418 PROGNOSTIC TOOL TO HELP IDENTIFY PT1-3N0 PATIENTS LIKELY TO BENEFIT FROM ADJUVANT CHEMOTHERAPY AFTER RADICAL CYSTECTOMY (2011) (0)
- 265 TREATMENT MANAGEMENT OF T1A RENAL CELL CARCINOMA IN THE 21ST CENTURY: A POPULATION-BASED ANALYSIS (2011) (0)
- PD27-07 IMPACT OF SURGICAL TECHNIQUE ON THE RISK OF BIOCHEMICAL RECURRENCE IN PATIENTS WITH INTERMEDIATE AND HIGH-RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY (2014) (0)
- MP40-11 RENAL FUNCTION VARIATION AFTER NEPHROURETERECTOMY FOR UPPER URINARY TRACT CARCINOMA: EVALUATION IN A LARGE MULTICENTER COHORT (RADICAL NEPHROURETERECTOMY OUTCOMES (RANEO) RESEARCH CONSORTIUM) (2022) (0)
- PD15-04 THERE IS NO WAY TO COMPENSATE FOR A NON-TIMELY USE OF SALVAGE RADIATION THERAPY IN MEN WITH RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY (2019) (0)
- The prognostic role of early PSA response after salvage radiation therapy: Long-term results from a multi-institutional study (2018) (0)
- PD35-01 WHICH PATIENTS WITH CN1 DISEASE AT PET/CT ARE AFFECTED BY SYSTEMIC DISEASE? IMPLICATIONS FOR TAILORED TREATMENT APPROACHES BASED ON A LARGE MULTI-INSTITUTIONAL SERIES (2021) (0)
- 929 Obesity heads to worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder (2013) (0)
- A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis (2012) (0)
- 1780 FEMALE GENDER IS ASSOCIATED WITH HIGHER RISK OF DISEASE RECURRENCE IN PATIENTS WITH PRIMARY T1 HIGH GRADE UROTHELIAL CARCINOMA OF THE BLADDER (2013) (0)
- Aggressive Urologic Malignancy in Heart Transplant Recipients (2010) (0)
- MP48-08 METASTASIS WITHIN THREE YEARS FROM RADICAL NEPHROURETERECTOMY AS A BRIDGE TO OVERALL SURVIVAL: IMPLICATIONS FOR PATIENT COUNSELING, CURRENT, AND FUTURE STUDIES (2021) (0)
- 473 Pathological nodal staging score for prostate cancer: A tool to address adequate nodal dissection in men treated with radical prostatectomy (2013) (0)
- LYMPHOVASCULAR INVASION (LVI) IS INDEPENDENTLY ASSOCIATED WITH BLADDER CANCER RECURRENCE AND SURVIVAL IN PATIENTS WITH T1 AND NEGATIVE LYMPH NODES AT RADICAL CYSTECTOMY (2008) (0)
- Neutrophil–lymphocyte ratio predicts pathological features and biochemical recurrence after radical prostatectomy (2016) (0)
- 313 ADJUVANT CHEMOTHERAPY FOR UROTHELIAL CARCINOMA OF THE URINARY BLADDER (2010) (0)
- MP77-07 IMPACT OF SMOKING STATUS AND CUMULATIVE EXPOSURE ON INTRAVESICAL RECURRENCE OF UPPER TRACT UROTHELIAL CARCINOMA AFTER RADICAL NEPHROURETERECTOMY (2015) (0)
- The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm. (2023) (0)
- Genome-wide DNA methylation profiling of upper tract urothelial carcinoma (2018) (0)
- PD11-03 ASSESSMENT OF OTHER-CAUSE MORTALITY IN T1AN0M0 RENAL CELL CARCINOMA PATIENTS WITH 15 YEARS OF FOLLOW-UP: A SEER-BASED ANALYSIS (2020) (0)
- Single or Multiple Positive Nodes at Lymphadenectomy have Similar Cancer-specific Survival in Patients Treatedf Penile Squamous Cell Carcinoma (2010) (0)
- 909 Impact of the extent of lymph node dissection on survival of patients with locally advanced prostate cancer treated with radical prostatectomy (2015) (0)
- 1486 COMPARATIVE ANALYSES OF SURGICAL MODALITIES FOR THE MANAGEMENT OF PROSTATE CANCER: A MULTI-INSTITUTIONAL STUDY OF POSITIVE SURGICAL MARGIN RATES ON 22,403 PATIENTS (2013) (0)
- CEACAM1 IS A NEW URINARY MARKER FOR BLADDER CANCER (2009) (0)
- The efficacy and safety of relugolix compared to degarelix in advanced prostate cancer patients: A network meta-analysis of randomized trials (2021) (0)
- MP24-08 SMOKING EXPOSURE MIGHT CORRELATE WITH POOR NEOADJUVANT CHEMOTHERAPY RESPONSE AND SURVIVAL OUTCOMES FOLLOWING RADICAL CYSTECTOMY: SYSTEMATIC REVIEW AND PROGNOSTIC META-ANALYSIS (2020) (0)
- 87 PARTIAL NEPHRECTOMY FOR RENAL TUMORS IN SOLITARY KIDNEYS: AN UPDATE OF THE MEMORIAL SLOAN-KETTERING CANCER EXPERIENCE (2011) (0)
- MP12-13 THE ROLE OF NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA IN THE ERA OF IMMUNE-COMBINATION THERAPIES: A META-ANALYSIS (2022) (0)
- PD13-08 STRATIFICATION OF INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS: IMPLICATIONS FOR ADJUVANT THERAPIES. (2019) (0)
- MP51-20 THE ASSOCIATION OF TYPE AND NUMBER OF D’AMICO HIGH-RISK CRITERIA WITH RATES OF PATHOLOGICALLY NON ORGAN CONFINED PROSTATE CANCER (2022) (0)
- How to deal with steroids use in the management of metastatic prostate cancer during pandemic (2020) (0)
- MP69-18 HOW TO EXPAND INDICATIONS FOR ACTIVE SURVEILLANCE WITHOUT COMPROMISING CANCER CONTROL: A SYSTEMATIC ASSESSMENT OF THE CURRENTLY USED CRITERIA FOR PROSTATE CANCER PATIENTS (2014) (0)
- Prevalence and prognostic impact of prostate cancer histological variants at radical prostatectomy: A long-term, single center analysis (2018) (0)
- 126 Prognostic model for predicting survival in patients with disease recurrence following radical cystectomy (2014) (0)
- MP64-11 PROGNOSTIC IMPACT OF GLEASON GRADE AT THE MARGIN IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY (2021) (0)
- 1901 ADVANCED AGE IS AN INDEPENDENT PREDICTOR OF CANCER-SPECIFIC MORTALITY AFTER RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE URINARY BLADDER: A COMPETING-RISKS REGRESSION ANALYSIS (2011) (0)
- Emerging systemic treatment for metastatic castration-resistant prostate cancer: a review of recent randomized controlled trials (2023) (0)
- MP63-11 PREOPERATIVE PLATELET TO LYMPHOCYTE RATIO AS A PREDICTOR OF SURVIVAL AFTER RADICAL CYSTECTOMY DUE TO BLADDER CANCER (2016) (0)
- Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma. (2022) (0)
- The role of prior bladder cancer on any recurrence and distant metastasis in patients treated with radical nephroureterectomy (2021) (0)
- What is the optimal field of post-prostatectomy radiation therapy? Long-term results from a multi-institutional study (2018) (0)
- CAN RADICAL CYSTECTOMY BE PERFORMED SAFELY IN THE METASTATIC SETTING? LOCATION OF METASTATIC BLADDER CANCER AS A DETERMINANT OF IN‐HOSPITAL MORTALITY: MP34‐20 (2017) (0)
- 156 Prediction and reversibility of cisplatin-resistance in bladder cancer: HOXA9 a novel epigenetic biomarker (2013) (0)
- MP41-12 RADICAL CYSTECTOMY IN PATHOLOGICAL T4A AND T4B PATIENTS: IS THERE ANY SPACE FOR SUB STRATIFICATION? (2018) (0)
- 1646: PSA Represents a Highly Accurate Predictor of Pathologic Stage and Surgical Outcomes (2006) (0)
- BCG-Unresponsive Bladder Cancer: New Frontiers in the Treatment Landscape (2019) (0)
- 316: Risk Factors for Distant vs. Local Recurrence in Patients Undergoing Radical Cystectomy for Transitional Cell Cancer (2004) (0)
- 130Prognostic utility of the 1997 TNM bladder cancer substaging classification system for PT2 and PT3 disease: Results from the bladder cancer research consortium (BCRC) (2005) (0)
- 44 BLADDER CANCER CONTROL OUTCOMES HAVE NOT IMPROVED WITHIN THE LAST THIRTY YEARS: A TREND ANALYSIS IN THE UNITED STATES (2011) (0)
- Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data (2021) (0)
- 874 COMBINING IMAGING AND URETEROSCOPY VARIABLES IN A PREOPERATIVE MULTIVARIABLE MODEL FOR PREDICTION OF MUSCLE-INVASIVE AND NON-ORGAN CONFINED DISEASE IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (2011) (0)
- Not All Adverse Pathology Features Are Equal: Identifying Optimal Candidates for Adjuvant Radiotherapy Among Patients With Adverse Pathology at Radical Prostatectomy (2022) (0)
- 640 Head-to-head comparison of conditional oncological outcomes after radical prostatectomy in patients with intermediate and high risk prostate cancer (2015) (0)
- MP56-16 THE IMPACT OF RE-TUR ON CLINICAL OUTCOMES IN A LARGE COHORT OF T1G3 PATIENTS TREATED WITH BCG. (2014) (0)
- MP15-03 PROGNOSTIC VALUE OF LYMPHOVASCULAR INVASION IN PATIENTS TREATED WITH SALVAGE RADICAL PROSTATECTOMY FOR RADIATION-RECURRENT PROSTATE CANCER (2022) (0)
- Global Trends of Prostate Cancer by Age, and Their Associations With Gross Domestic Product (GDP), Human Development Index (HDI), Smoking, and Alcohol Drinking. (2023) (0)
- ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder? (2022) (0)
- Cytoreductive nephrectomy does not improve survival of metastatic renal cell carcinoma in the TKI era (2019) (0)
- Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities (2020) (0)
- ASO Author Reflections: Is T1HG Bladder Cancer a Good Candidate for En Bloc Resection? (2023) (0)
- BLOOD‐BASED BIOMARKERS AS PREDICTORS OF ONCOLOGIC OUTCOMES FOR NON‐MUSCLE‐INVASIVE UROTHELIAL BLADDER CARCINOMA: MP04‐17 (2017) (0)
- 40 THE RATES OF METASTATIC BLADDER CANCER ARE INCREASING OVER TIME: A POPULATION-BASED ANALYSIS (2010) (0)
- Molecular characterization to delineate the clonal evolution of primary prostate cancer with synchronous lymph node metastasis. (2022) (0)
- Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer (2022) (0)
- The role of cytoreductive radical prostatectomy (cRP) in men with hormone-sensitive, metastatic prostate cancer (mPCA). (2017) (0)
- PD26-09 PRIMARY TA HIGH GRADE BLADDER TUMORS: DETERMINATION OF THE RISK OF PROGRESSION (2022) (0)
- New approach of staging and grading in bladder cancer with optical coherence tomography and Raman spectroscopy (2019) (0)
- INCOMPLETENESS OF THE TRANSURETHRAL RESECTION AS A PREDICTOR OF ADVERSE PATHOLOGICAL FEATURES AT THE TIME OF RADICAL CYSTECTOMY: IMPLICATIONS FOR NEOADJUVANT CHEMOTHERAPY SELECTION: MP58‐01 (2017) (0)
- Incremental utility of mp-MRI performed before confirmatory biopsy in reducing the risk of progression during active surveillance for men with low risk prostate cancer: Is imaging always useful? (2019) (0)
- PD16-02 ONCOLOGICAL AND FUNCTIONAL OUTCOMES OF CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IN MEN WITH METASTATIC HORMONE-NAIVE PROSTATE CANCER (MHNPCA) (2020) (0)
- Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international multi-institutional study (2016) (0)
- ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer? (2021) (0)
- Trends of lymphadenectomy in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: The impact of surgical technique (2017) (0)
- Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma (2021) (0)
- MP32-16 INCIDENCE AND IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN CANDIDATES FOR RADICAL CYSTECTOMY: RESULTS FROM A MULTICENTER COLLABORATION (2019) (0)
- 814 Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder (2013) (0)
- Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy (2022) (0)
- Assessing the need for and the optimal duration of hormonal therapy in association with post-prostatectomy radiation therapy: Results from a multi-institutional study (2018) (0)
- MP51-11 HAS THE INTRODUCTION OF MPMRI IN THE DIAGNOSTIC PATHWAY OF PROSTATE CANCER LED TO IMPROVED ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY? RESULT FROM A LARGE SINGLE-INSTITUTIONAL SERIES (2022) (0)
- Biological and prognostic implications of biopsy upgrading for high‐grade upper tract urothelial carcinoma at nephroureterectomy (2022) (0)
- PD63-02 RELIABILITY OF MODERN IMAGING STUDIES FOR DETECTION AND FINAL PATHOHISTOLOGICAL STAGE IN MEN UNDERGOING RADICAL SALVAGE PROSTATECTOMY (RSP) FOR RADIORECURRENT PROSTATE CANCER (RPC) (2020) (0)
- 1904 EXTRANODAL EXTENSION IS A POWERFUL PROGNOSTIC FACTOR IN BLADDER CANCER PATIENTS WITH LYMPH NODE METASTASIS (2012) (0)
- PD15-08 A MORE EXTENSIVE PELVIC LYMPH NODE DISSECTION IS ASSOCIATED WITH IMPROVED SURVIVAL OF PATIENTS WITH NODE POSITIVE PROSTATE CANCER (2014) (0)
- PD60-05 NEOADJUVANT CHEMOTHERAPY PLUS RADICAL CYSTECTOMY VERSUS RADICAL CYSTECTOMY ALONE IN CLINICAL T2 BLADDER CANCER PATIENTS WITHOUT HYDRONEPHROSIS (2020) (0)
- Reliability of modern imaging studies for detection and final pathohistological stage in men undergoing radical salvage prostatectomy (RSP) for radiorecurrent prostate cancer (rPC) (2020) (0)
- 1591 AGE, COMORBIDITIES, AND RACE ARE PREDICTORS TO UNDERGO RADICAL CYSTECTOMY AT LOW VOLUME INSTITUTIONS (2012) (0)
- MP-02.11 Collecting System Invasion and Fuhrman Grading but not Tumor Size Facilitate Prognostic Stratification of Patients with pT2 Renal Cell Carcinoma: Can the Current 7th Edition of TNM Classification Be Improved? (2011) (0)
- The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages (2020) (0)
- 1578: BMI and its Ability to Improve Prediction of Biochemical Recurrence (BCR) after Radical Prostatectomy (RP): Does a Statistically Significant Marker Always Improve Predictive Accuracy in Multivariate Models? (2006) (0)
- Histological patterns, subtypes and aspects of prostate cancer: different aspects, different outcomes (2022) (0)
- 1445 DOES CIGARETTE SMOKING AND SMOKING CESSATION INFLUENCE OUTCOMES IN BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY (2013) (0)
- 1798 NO SURVIVAL BENEFIT IS ASSOCIATED WITH INCREASING EXTENT OF LYMPH NODE DISSECTION AT NEPHRECTOMY IN PATIENTS WITH POSITIVE LYMPH NODES: A CRITICAL RE-ANALYSIS (2012) (0)
- 1798 LOW SOCIOECONOMIC STATUS IS A PREDICTOR OF LOCALLY-ADVANCED RENAL CELL CARCINOMA: A POPULATION-BASED STUDY (2010) (0)
- Prognostic value of SPINK1 expression in bladder cancer after radical cystectomy. (2012) (0)
- Randomized comparator-controlled study evaluating efficacy and safety of pembrolizumab plus Bacillus Calmette-Guérin (BCG) in patients with high-risk nonmuscle-invasive bladder cancer (HR NMIBC): KEYNOTE-676 cohort B. (2022) (0)
- 2120 LIVE DONOR NEPHRECTOMY VS. KIDNEY TRANSPLANTS IN MINORITY POPULATIONS: A POPULATION BASED ANALYSIS OF TRENDS (2013) (0)
- MP56-17 THE IMPACT OF BASELINE CHRONIC KIDNEY DISEASE ON LONG-TERM SURVIVALS OF PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS (2023) (0)
- IMPORTANCE OF TUMOR SIZE AS RISK STRATIFICATION PARAMETER IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC): MP78‐14 (2017) (0)
- Prognostic value of Gleason score at positive surgical margin in prostate cancer. A systematic review and meta-analysis (2020) (0)
- 1341 THE MAJORITY OF MEN UNDERGOING RADICAL PROSTATECTOMY AFTER REPEAT BIOPSY HARBOR SIGNIFICANT PROSTATE CANCER (2012) (0)
- Can Sural Nerve Grafting Restore Potency in Humans ? (2001) (0)
- Biopsy, Diagnosis, and Staging of Prostate Cancer (2009) (0)
- Abstract CT564: KEYNOTE-992: A randomized phase 3 trial of pembrolizumab versus placebo in patients with muscle-invasive bladder cancer receiving concurrent chemoradiotherapy (2022) (0)
- African American vs. Caucasian race/ethnicity in adrenocortical carcinoma patients. (2023) (0)
- PD33-10 THE PRESENCE OF RESIDUAL CARCINOMA IN SITU ALONE (PTIS) IN PATIENTS TREATED WITH RADICAL CYSTECTOMY DOES NOT AFFECT LONG TERM RECURRENCE AND SURVIVAL RATES (2016) (0)
- SURGICAL TREATMENT FOR CLINICAL NODE POSITIVE BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY: MP58‐19 (2017) (0)
- PD27-06 THE IMPACT OF CIGARETTE SMOKING AND SMOKING CESSATION ON ONCOLOGICAL AGGRESSIVENESS AT RADICAL CYSTECTOMY – A PROSPECTIVE, EUROPEAN, MULTICENTER STUDY OF THE EAU YOUNG ACADEMIC UROLOGISTS (YAU) BLADDER CANCER WORKING GROUP (2016) (0)
- 392 DISEASE-FREE SURVIVAL AS A SURROGATE FOR 5-YEAR OVERALL SURVIVAL IN UPPER TRACT UROTHELIAL CARCINOMA (2012) (0)
- Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysis. (2021) (0)
- 543 TREATMENT MANAGEMENT OF T1A RENAL CELL CARCINOMA IN THE 21ST CENTURY: A POPULATION-BASED ANALYSIS (2011) (0)
- Prognostication and Risk Assessment (2015) (0)
- Association of Hyponatremia With Survival in Patients With Castration-resistant Prostate Cancer: A Clinical Commentary. (2019) (0)
- PD27-05 RELIABILITY OF 68GA-PSMA PET/CT IN ASSESSING REAL NODAL BURDEN IN MEN WITH CN1 DISEASE: CLINICAL IMPLICATIONS FOR PATIENT COUNSELLING AND MULTI-MODAL TREATMENTS (2022) (0)
- A Systematic Review and Meta-Analysis of Clinicopathologic Factors Predicting Upper Urinary Tract Recurrence After Radical Cystectomy for Urothelial Bladder Cancer. (2022) (0)
- COVID-19 crisis and minimally invasive surgery: a narrative review on intraoperative aerosol viral transmission and their impact on guidelines and clinical practice in Austria (2021) (0)
- MP40-16 EXPRESSION ANALYSIS AND MUTATIONAL STATUS OF HISTONE METHYLTRANSFERASE KMT2D IN UPPER TRACT UROTHELIAL CARCINOMA (2022) (0)
- Prognostic impact of primary tumor location in advanced urothelial tract cancer (UCC); a pooled analysis of EORTC 30924, 30986, and 30987 trials (2017) (0)
- 1831 THE PROGNOSTIC ABILITY OF VARIOUS NODAL CODING SCHEMES IN BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY: RESULTS FROM THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS DATABASE (2010) (0)
- 677 The effect of hospital vs. surgical volume on outcomes after radical prostatectomy: A head-to-head comparison using decision-curve analyses (2012) (0)
- Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: The key role of PSA kinetics (2021) (0)
- 1845 RATES OF CONTINENT URINARY DIVERSION AFTER RADICAL CYSTECTOMY: IS THERE A PLACE FOR IMPROVEMENT? (2011) (0)
- 371 Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy: Results from a single institution series (2015) (0)
- 142 Next generation sequencing to determine the clonal origin of lymph node metastasis in multifocal prostate cancer: Defining the biologically dominant nodule (2016) (0)
- Urine cytology and commercially available urine-based markers for monitoring of bladder urothelial carcinoma (2007) (0)
- Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy (2020) (0)
- Prevalence and trends in urinary incontinence among adult women in the United States 2005-2016 (2020) (0)
- MP77-04 MULTI-INSTITUTIONAL EVALUATION OF THE PROGNOSTIC SIGNIFICANCE OF ALTERED MAMMALIAN TARGET OF RAPAMYCIN (MTOR) PATHWAY BIOMARKERS IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC) (2014) (0)
- DEVELOPMENT OF PROGNOSTIC MODELS FOR INDIVIDUAL RISK STRATIFICATION IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY: A NEW TOOL TO HELP WITH PATIENT SELECTION FOR ADJUVANT THERAPY (2009) (0)
- 415 PROGNOSTIC VALUE OF CONCOMITANT CARCINOMA IN SITU IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (2010) (0)
- 815 Validation of prognostic value of Bajorin criteria for cancer-specific survival in patients who have disease recurrence after radical cystectomy for urothelial carcinoma of the bladder (2013) (0)
- Pilot study on the correlation of multiphoton microscopy of human testicular tumors with histology. (2012) (0)
- 149 RISK ASSESSMENT OF PATIENTS WHO PRESENT WITH ASYMPTOMATIC HEMATURIA: DEVELOPMENT AND VALIDATION OF A NOMOGRAM FOR PREDICTION OF BLADDER CANCER PRESENCE (2011) (0)
- MP56-07 COMPARISON OF THE EORTC TABLES AND THE NEWLY INTRODUCED EAU CATEGORIES FOR RISK STRATIFICATION OF PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER (2014) (0)
- MP55-14 THE IMPACT OF TREATMENT MODALITY ON SURVIVAL IN PATIENTS WITH CLINICAL NODE POSITIVE BLADDER CANCER (2020) (0)
- 154 COULD SCREENING FOR BLADDER CANCER PRODUCE A STAGE MIGRATION TOWARDS DETECTION OF NON-MUSCLE-INVASIVE CANCERS? (2011) (0)
- MP56-05 EARLY POST-OPERATIVE PSA AFTER RADICAL PROSTATECTOMY IS A MAJOR PREDICTOR OF PROGRESSION AND DEATH IN PATIENTS WITH LYMPH NODE METASTASES. RESULTS FROM A TERTIARY CARE CENTER (2015) (0)
- Nonurothelial cancers of the bladder (2015) (0)
- Definition and impact on oncologic outcomes of persistently elevated PSA after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: Clinical Implications for multi-modal therapy (2021) (0)
- MP77-17 IS THERE EVIDENCE OF DISCORDANT BIOLOGY IN UROTHELIAL CANCER OF THE LOWER AND UPPER URINARY TRACT? PROSPECTIVE COMPARISON OF MOLECULAR SIGNATURES (2014) (0)
- 412 Pathological validation of adjuvant anti-fibroblast growth factor receptor 3 (FGFR3) treatment for bladder cancer (2014) (0)
- MP67-24 ASSESSING ONLINE CROWDFUNDING FOR UROLOGIC CANCER CARE USING AUTOMATED DATA EXTRACTION (2021) (0)
- The Combination of Multiple Cell Cycle Regulators Improves Prognosis in Patients with Pathologic Organ-Confined Bladder Cancer: A Multicenter External Validation Study (2010) (0)
- MP15-01 CONTEMPORARY ANALYSIS OF MEDICARE REIMBURSEMENTS RELATED TO TREATMENT OF LOCALIZED PROSTATE CANCER (2016) (0)
- Increased risk of postoperative in‐hospital complications after radical prostatectomy in patients with prior organ transplant (2021) (0)
- MP48-01 HOW TO OPTIMIZE PATIENT SELECTION BEFORE SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENT PROSTATE CANCER: A NOVEL RISK STRATIFICATION TOOL (2022) (0)
- The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis. (2022) (0)
- MP21-04 THE EFFECT OF AGE ON CANCER-SPECIFIC MORTALITY IN T1A STAGE RENAL CELL CARCINOMA PATIENTS ACROSS ALL TREATMENT’S MODALITIES: A SEER-BASED STUDY (2020) (0)
- Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review (2023) (0)
- Response to [177Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastases (2022) (0)
- A NEW VISUAL POINT-OF-CONTACT PSA TEST: RESULTS OF A PILOT STUDY (1999) (0)
- SOLUBLE FAS IS A NEW SENSITIVE AND SPECIFIC URINE MARKER FOR BLADDER CANCER PRESENCE AND STAGING (2006) (0)
- EXPRESSION OF CYCLOOXYGENASE-2 IN PATIENTS TREATED WITH RADICAL CYSTECTOMY (2006) (0)
- Ureteral stenting does not increase the risk of metachronous upper tract urothelial carcinoma in patients with bladder cancer presenting with hydronephrosis in comparison with percutaneous nephrostomy: A multicenter analysis (2021) (0)
- 455 A detailed analysis on the association between post-operative phosphodiesterase type 5 inhibitors use and the risk of biochemical recurrence after radical prostatectomy (2015) (0)
- Harnableitung und Rekonstruktion nach Zystektomie (2015) (0)
- Urothelkarzinom der Nieren und Harnleiter (2016) (0)
- Die Erteilung der Venia legendi als Gradmesser einer einsetzenden Fachdifferenzierung (2022) (0)
- Palliative Chirurgie beim metastasierten Urothelkarzinom (2018) (0)
- Mitteilungen der DGU (2016) (0)
- Nur die Chirurgie? Multimodalkonzepte mit kurativer Intention für das Urothelkarzinom der Harnblase (2020) (0)
- Metastasenchirurgie beim Harnblasenkarzinom: Sinn oder Unsinn (2020) (0)
- Organerhaltende Therapie beim Urothelkarzinom des oberen Harntraktes (UTUC) (2018) (0)
- Über Exzellenz und Reputation in Medizin und Urologie (2021) (0)
- Verwendung und Bedeutung der „number needed to treat“ in der urologischen Praxis (2013) (0)
- Langzeitergebnisse nach Vaporisation der Prostata : GreenLight™-Laservaporisation der Prostata und Elektrovaporisation. (2016) (0)
- Chirurgische Therapie des Harnblasenkarzinoms (2019) (0)
- Urologie Scan: Aktuelle Publikationen für Sie gescannt (2016) (0)
- Vorzeitiger Abbruch randomisierter kontrollierter Studien (2013) (0)
- Rauchen erhöht Rezidivrisiko (2016) (0)
- Erstvorstellung der onkologischen TRIFECTA- und PENTAFECTA-Kriterien zur Verbesserung der Prognosestratifizierung nach radikaler Zystektomie (2015) (0)
- Organerhaltende Therapie beim Urothelkarzinom des oberen Harntraktes (UTUC) (2018) (0)
- Vorzeitiger Abbruch randomisierter tudien (2013) (0)
- Das fortgeschrittene Urothelkarzinom des oberen Harntrakts (2019) (0)
- Urothelkarzinom der Nieren und Harnleiter: Therapie (2016) (0)
- Das Harnblasenkarzinom der Frau (2021) (0)
- Does combined anterior and posterior reconstruction improve early continence in robotic assisted radical prostatectomy? (2019) (0)
This paper list is powered by the following services:
Other Resources About Shahrokh Shariat
What Schools Are Affiliated With Shahrokh Shariat?
Shahrokh Shariat is affiliated with the following schools:
